<!DOCTYPE html
  PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html
      xmlns="http://www.w3.org/1999/xhtml"
      xml:lang="en"
      lang="en">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
      <title>Treatment of plague: promising alternatives to antibiotics </title>
      <meta name="googlebot" content="NOODP" />
      <meta name="HW.ad-path" content="/cgi/content/full/55/11/1461" />
      <meta content="/medmicro/55/11/1461.atom" name="HW.identifier" />
      <meta name="DC.Format" content="text/html" />
      <meta name="DC.Language" content="en" />
      <meta content="Treatment of plague: promising alternatives to antibiotics"
            name="DC.Title" />
      <meta content="10.1099/jmm.0.46697-0" name="DC.Identifier" />
      <meta content="2006-11-01" name="DC.Date" />
      <meta content="Society for General Microbiology" name="DC.Publisher" />
      <meta content="Andrey P. Anisimov" name="DC.Contributor" />
      <meta content="Kingsley K. Amoako" name="DC.Contributor" />
      <meta content="Journal of Medical Microbiology" name="citation_journal_title" />
      <meta content="J Med Microbiol" name="citation_journal_abbrevAnisimov" name="DC.Contr" />
      <meta content="0022-2615" name="citation_issn" />
      <meta content="1473-5644" name="citation_issn" />
      <meta name="citation_author" content="Andrey P. Anisimov" />
      <meta name="citation_author" content="Kingsley K. Amoako" />
      <meta content="Treatment of plague: promising alternatives to antibiotics"
            name="citation_title" />
      <meta content="11/01/2006" name="citation_date" />
      <meta content="55" name="citation_volume" />
      <meta content="11" name="citation_issue" />
      <meta content="1461" name="citation_firstpage" />
      <meta content="1475" name="citation_lastpage" />
      <meta content="55/11/1461" name="citation_id" />
      <meta content="55/11/1461" name="citation_id_from_sass_path" />
      <meta content="medmicro;55/11/1461" name="citation_mjid" />
      <meta content="10.1099/jmm.0.46697-0" name="citation_doi" />
      <meta content="http://jmm.sgmjournals.org/content/55/11/1461.abstract"
            name="citation_abstract_html_url" />
      <meta content="http://jmm.sgmjournals.org/content/55/11/1461.full"
            name="citation_fulltext_html_url" />
      <meta content="http://jmm.sgmjournals.org/content/55/11/1461.full.pdf"
            name="citation_pdf_url" />
      <meta content="/content/55/11.cover.gif" name="issue_cover_image" />
      <meta content="http://jmm.sgmjournals.org/content/55/11/1461"
            name="citation_public_url" />
      <meta content="17030904" name="citation_pmid" />
      <meta name="citation_section" content="REVIEW" />
      <meta name="robots" content="noarchive,nofollow" />
      <meta name="googlebot" content="noarchive" />
      <link href="/content/55/10/1457.short" rel="prev" />
      <link href="/content/55/11/1477.short" rel="next" />
      <link rel="stylesheet" type="text/css" media="all" href="/shared/css/hw-global.css" />
      <link rel="stylesheet" type="text/css" media="print" href="/shared/css/hw-print.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/standard-designs/design25/main.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-global.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/local/css/hw-local-global.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/hw-page-content.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/jquery.fancybox-1.3.4.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/hw-global-colexpand.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-page-content.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/hw-global-colexpand.css" /><script type="text/javascript" id="session-d305264982e1">var callbackToken='5775A4BB1B35350';</script><script type="text/javascript" src="/shared/js/jquery-min.js"></script><script type="text/javascript" src="/shared/js/fingerprint.js"></script><script type="text/javascript" src="/shared/js/hw-shared.js"></script><script type="text/javascript" src="/shared/js/design/hw-design1.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-shared.js"></script><script type="text/javascript" src="/shared/js/pages/hw-content.js"></script><script type="text/javascript" src="/shared/js/fancybox/jquery.fancybox-1.3.4.js"></script><script type="text/javascript" src="/shared/js/fancybox/jquery.easing-1.3.pack.js"></script><script type="text/javascript"
              src="/shared/js/fancybox/jquery.mousewheel-3.0.4.pack.js"></script><script type="text/javascript" src="/shared/js/util/content.jquery.addVariantLink.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-custom-free.js"></script><script type="text/javascript" src="/shared/js/util/hw-col-expand.js"></script></head>
   <body>
      <div class="hw-gen-page pagetype-content" id="pageid-content" itemscope="itemscope"
           itemt/publisher/js/hw-publisher-custom-free.js"></script><script type="text/javascript" src="/shared/js/util/hw-col-expand.js"></script></head>
   <body>
      <div class="hw-gen-page pagetype-contentype="http://schema.org/ScholarlyArticle">
         <div id="header">
            
            <h1><a id="logo" href="/"><span>Journal of Medical Microbiology</span></a></h1>
            
            <p id="skip-link">
               <a href="#content-block">Skip to main page content</a>
               
            </p>
            
            <ul class="button-list header-buttons">
               <li class="first"><a href="/" title="HOME"><span>HOME</span></a></li>
               <li><a href="/content/current" title="CURRENT ISSUE"><span>CURRENT ISSUE</span></a></li>
               <li><a href="/content" title="ARCHIVE"><span>ARCHIVE</span></a></li>
               <li><a href="/search" title="SEARCH"><span>SEARCH</span></a></li>
               <li><a href="/help" title="HELP"><span>HELP</span></a></li>
               <li class="last"><a href="/feedback" title="CONTACT US"><span>CONTACT US</span></a></li>
            </ul>
            
            
            <div class="header-qs">
               
               <form class="searchbox" action="/search" method="get">
                  <div>
                     	<label for="header-qs-input" id="header-qs-search-label">Search for Keyword:</label>
                     <input value="" title="Search" type="text" name="fulltext" id="header-qs-input" /><input type="hidden" name="submit" value="yes" /><label for="header-qs-search" id="header-qs-search-label">GO</label><input value="GO" alt="Link: Go" type="image" id="header-qs-search-go"
                            src="/shared/img/standard-design/design2/go.gif" /> 
                     
                  </div>
                  <div class="adv-search-link"><a href="/search">Advanced Search</a></div>
               </form>
               
               
            </div>
            
            <div class="header-ac-elements">
               
               <div id="authstring" class="suppress-header-login">
                  
                  
               </div> 
               
               <div id="hdr-login" class="suppress-header-login"></div>
               
            </div>
            
            <div class="banner-ads">
               		
               <ul>
                  <li class="position-1 no-ad hdr_left"><span>  </span></li>
               </ul>
               	
            </div>
            
            <div class="bar">
               
               <div class="bar-inner"></div>
               
            </div>
            
         </div>
         <div id="content-block">
            <div class="article fulltext-view" itemprop="articleBody"><span class="highwire-journal-article-marker-start"></span><h1 id="article-title-1" itemprop="headline">Treatment of plague: promising alternatives to antibiotics</h1>
               <div class="contributors">
                  <ol class="contributor-list" id="contrib-group-1">
                     <li class="contributor" id="contrib-1" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Andrey+P.+Anisimov&amp;sortspec=date&amp;submit=Submit">Andrey P. Anisimov</a></span><a id="xref-aff-1-1" class="xref-aff" href="#aff-1"><sup>1</sup></a> and 
                     </li>
                     <li class="last" id="contrib-2"><span class="name"><a class="name-search"
                              href="/search?author1=Kingsley+K.+Amoako&amp;sortspec=date&amp;submit=Submit">Kingsley K. Amoako</a></span><a id="xref-aff-2-1" class="xref-aff" href="#aff-2"><sup>2</sup></a></li>
                  </ol>
                  <ol class="affiliation-list">
                     <li class="aff"><a id="aff-1" name="aff-1"></a><address><sup>1</sup>Laboratory for Plague Microbiology, Department of Infectious Diseases, State Research Center for Applied Microbiology and
                           Biotechnology, 142279 Obolensk, Serpukhov District, Moscow Region, Russia
                        </address>
                     </li>
                     <li class="aff"><a id="aff-2" name="aff-2"></a><address><sup>2</sup>Canadian Food Inspection Agency, Animal Diseases Research Institute, P.O. 640, Township Road 9-1, Lethbridge, AB T1J 3Z4,
                           Canada
                        </address>
                     </li>
                  </ol>
                  <ol class="corresp-list">
                     <li class="corresp" id="corresp-1"><strong>Correspondence</strong><br />Andrey P. Anisimov<br /> <span class="em-link"><span class="em-addr">anisimov{at}obolensk.org</span></span></li>
                  </ol>
               </div>
               <div class="section abstract" id="abstract-1" itemprop="description">
                  <div class="section-nav">
                     <div class="nav-placeholder"> </div><a href="#ack-1" title="Acknowledgments" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Abstract</h2>
                  <p id="p-1">Plague still poses a significant threat to human health, and interest has been renewed recently in the possible use of <em>Yersinia pestis</em> as a biological weapon by terrorists. The septicaemic and pneumonic forms are always lethal if untreated. Attempts to treat
                     this deadly disease date back to the era of global pandemics, when various methods were explored. The successful isolation
          by terrorists. The septicaemic and pneumonic forms are always lethal if untreated. Attempts to trea           of the plague pathogen led to the beginning of more scientific approaches to the treatment and cure of plague. This subsequently
                     led to specific antibiotic prophylaxis and therapy for <em>Y. pestis</em>. The use of antibiotics such as tetracycline and streptomycin for the treatment of plague has been embraced by the <a id="xref-ref-166-1" class="xref-bibr" href="#ref-166">World Health Organization Expert Committee on Plague</a> as the ‘gold standard’ treatment. However, concerns regarding the development of antibiotic-resistant <em>Y. pestis</em> strains have led to the exploration of alternatives to antibiotics. Several investigators have looked into the use of alternatives,
                     such as immunotherapy, non-pathogen-specific immunomodulatory therapy, phage therapy, bacteriocin therapy, and treatment with
                     inhibitors of virulence factors. The alternative therapies reported in this review should be further investigated by comprehensive
                     studies of their clinical application for the treatment of plague.
                  </p>
               </div>
               <ul class="kwd-group ABR">
                  <li class="kwd"><span><a class="kwd-search"
                           href="/search?fulltext=DIC,+diffuse+intravascular+coagulation&amp;sortspec=date&amp;submit=Submi </p>
               </div>
               <ul class="kwd-group ABR">
                  <li class="kwd"><span><a class="kwd-search"
                      t&amp;andorexactfulltext=phrase">DIC, diffuse intravascular coagulation</a></span></li>
                  <li class="kwd"><span><a class="kwd-search"
                           href="/search?fulltext=WHO,+World+Health+Organization&amp;sortspec=date&amp;submit=Submit&amp;andorexactfulltext=phrase">WHO, World Health Organization</a></span></li>
               </ul>
               <div id="sec-1" class="subsection">
                  <div id="sec-2" class="subsection">
                     <h3>Overview</h3>
                     <p id="p-2">As a Gram-negative bacterium, the causative agent of plague, <em>Yersinia pestis</em> (<a id="xref-ref-168-1" class="xref-bibr" href="#ref-168">Yersin, 1894</a>), has been the cause of three pandemics (<a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">Achtman <em>et al.</em>, 1999</a>; <a id="xref-ref-49-1" class="xref-bibr" href="#ref-49">Drancourt <em>et al.</em>, 2004</a>; <a id="xref-ref-64-1" class="xref-bibr" href="#ref-64">Guiyoule <em>et al.</em>, 1994</a>; <a id="xref-ref-125-1" class="xref-bibr" href="#ref-125">Raoult <em>et al.</em>, 2000</a>), and has led to the deaths of millions of people, the devastation of cities and villages, and the collapse of governments
                        and civilizations (<a id="xref-ref-175-1" class="xref-bibr" href="#ref-175">Zietz &amp; Dunkelberg, 2004</a>). At the present time, the circulation of <em>Y. pestis</em> has been detected within the populations of more than 200 species of wild rodent inhabiting natural plague foci on all continents,
                        except for Australia and Antarctica, and the transmission of plague is provided for by a minimum of 80 species of flea. Plague
                        epizootics, during which the pathogen spreads through new territories, alternate with a decrease in epizootic activity. When
                        natural foci of infection are investigated during periods between epizootics, no antibodies to <em>Y. pestis</em> are detected in the animals, and the plague microbe is not detected by bacteriological and biological methods. Morbidity
                        in humans is noted, as a rule, when epizootics become acute, and is a consequence of bites of fleas, direct contact with infected
                        animal tissues, the consumption of insufficiently cooked meat products, or the inhalation of aerosolized respiratory excreta
                        of animals or patients with the pneumonic form of infection (<a id="xref-ref-11-1" class="xref-bibr" href="#ref-11">Anisimov, 2002a</a>, <a id="xref-ref-12-1" class="xref-bibr" href="#ref-12">b</a>; <a id="xref-ref-13-1" class="xref-bibr" href="#ref-13">Anisimov <em>et al.</em>, 2004</a>; <a id="xref-ref-15-1" class="xref-bibr" href="#ref-15">Aparin &amp; Golubinskii, 1989</a>; <a id="xref-ref-26-1" class="xref-bibr" href="#ref-26">Brubaker, 1991</a>; <a id="xref-ref-31-1" class="xref-bibr" href="#ref-31">Butler, 1983</a>; <a id="xref-ref-43-1" class="xref-bibr" href="#ref-43">Dennis <em>et al.</em>, 1999</a>; <a id="xref-ref-47-1" class="xref-bibr" href="#ref-47">Domaradskii, 1993</a>, <a id="xref-ref-48-1" class="xref-bibr" href="#ref-48">1998</a>; <a id="xref-ref-59-1" class="xref-bibr" href="#ref-59">Gage &amp; Kosoy, 2005</a>; <a id="xref-ref-68-1" class="xref-bibr" href="#ref-68">Hinnebusch, 2003</a>; <a id="xref-ref-72-1" class="xref-bibr" href="#ref-72">Inglesby <em>et al.</em>, 2000</a>; <a id="xref-ref-92-1" class="xref-bibr" href="#ref-92">Lien-Teh <em>et al.</em>, 1936</a>; <a id="xref-ref-110-1" class="xref-bibr" href="#ref-110">Naumov &amp; Samoilova, 1992</a>; <a id="xref-ref-113-1" class="xref-bibr" href="#ref-113">Nikolaev, 1972</a>; <a id="xref-ref-119-1" class="xref-bibr" href="#ref-119">Perry &amp; Fetherston, 1997</a>; <a id="xref-ref-121-1" class="xref-bibr" href="#ref-121">Pollitzer, 1954</a>).
                     </p>
                     <p id="p-3">Plague remains a serious problem for international public health. Small outbreaks of plague continue to occur throughout the
                        world, and at least 2000 cases of plague are reported annually (<a id="xref-ref-59-2" class="xref-bibr" href="#ref-59">Gage &amp; Kosoy, 2005</a>). Plague has recently been recognized as a reemerging disease, and <em>Y. pestis</em>, if used by the aerosol route of exposure as a bioterrorism agent, could cause mass casualties (<a id="xref-ref-59-3" class="xref-bibr" href="#ref-59">Gage &amp; Kosoy, 2005</a>; <a id="xref-ref-72-2" class="xref-bibr" href="#ref-72">Inglesby <em>et al.</em>, 2000</a>). According to World Health Organization (WHO) data, if 50 kg of the plague pathogen was released as an aerosol over a city
                        with a population of 5 million, 150 000 people might fall ill with pneumonic plague, 36 000 of whom would die (<a id="xref-ref-165-1" class="xref-bibr" href="#ref-165">WHO, 1970</a>).
                     </p>
                     <p id="p-4">Immunization against plague is one of the major approaches being pursued to deal with potential infection. Commercially available
                        human plague vaccines are based on either a live, attenuated strain or a killed, whole-cell preparation. The live, attenuated
                        vaccine is produced in the former Soviet Union, and is based on <em>Y. pestis</em> strain EV, line NIIEG. This strain is attenuated due to deletion of the 102 kb <em>pgm</em> locus that includes the <em>hms</em> locus r attenuated
                        vaccine is produced in the former Soviet Union, and is based on <em>Y.esponsible for the ability to store haemin, and a cluster of genes needed for production of the siderophore-based
                        yersiniabactin biosynthetic/transport systems. The parental wild-type strain was isolated in Madagascar. The second vaccine
                        is a formalin-fixed virulent <em>Y. pestis</em> strain 195/P (originally isolated in India) that was developed in the USA, although at present it is manufactured only in
                        Australia. Both these types of vaccines have unacceptable side effects when used (<a id="xref-ref-100-1" class="xref-bibr" href="#ref-100">Meyer, 1970</a>; <a id="xref-ref-111-1" class="xref-bibr" href="#ref-111">Naumov <em>et al.</em>, 1992</a>). A number of subunit-based vaccines are currently under development and/or at different stages of preclinical/clinical trials.
                        These offer the advantage of employing a defined antigen that possesses the ability to elicit high-level protection, and they
                        are also less reactogenic than the currently used whole-cell vaccines (<a id="xref-ref-13-2" class="xref-bibr" href="#ref-13">Anisimov <em>et al.</em>, 2004</a>; <a id="xref-ref-160-1" class="xref-bibr" href="#ref-160">Williamson, 2001</a>; <a id="xref-ref-161-1" class="xref-bibr" href="#ref-161">Williamson <em>et al.</em>, 2005</a>). The main limitation of the prevention of plague by vaccination is that protection is delayed for at least 1 week after
                        immunization, and this time may be crucial with respect to the lethal outcome of the disease (<a id="xref-ref-31-2" class="xref-bibr" href="#ref-31">Butler, 1983</a>; <a id="xref-ref-43-2" class="xref-bibr" href="#ref-43">Dennis <em>et al.</em>, 1999</a>; <a id="xref-ref-47-2" class="xref-bibr" href="#ref-47">Domaradskii, 1993</a>, <a id="xref-ref-48-2" class="xref-bibr" href="#ref-48">1998</a>; <a id="xref-ref-72-3" class="xref-bibr" href="#ref-72">Inglesby <em>et al.</em>, 2000</a>; <a id="xref-ref-92-2" class="xref-bibr" href="#ref-92">Lien-Teh <em>et al.</em>, 1936</a>; <a id="xref-ref-110-2" class="xref-bibr" href="#ref-110">Naumov &amp; Samoilova, 1992</a>; <a id="xref-ref-113-2" class="xref-bibr" href="#ref-113">Nikolaev, 1972</a>; <a id="xref-ref-119-2" class="xref-bibr" href="#ref-119">Perry &amp; Fetherston, 1997</a>; <a id="xref-ref-121-2" class="xref-bibr" href="#ref-121">Pollitzer, 1954</a>; <a id="xref-ref-130-1" class="xref-bibr" href="#ref-130">Rudnev, 1940</a>). As a consequence, antibiotics are employed for the early initiation of prophylaxis and therapy of plague.
                     </p>
                     <p id="p-5">The overwhelming majority of <em>Y. pestis</em> natural isolates are susceptible <em>in vitro</em> and <em>in vivo</em> to antimicrobials such as tetracycline, doxycycline, ciprofloxacin, streptomycin, gentamicin, chloramphenicol, fluoroquinolones,
                        sulphonamides, and trimethoprim-sulfamethoxazole (<a id="xref-ref-47-3" class="xref-bibr" href="#ref-47">Domaradskii, 1993</a>; <a id="xref-ref-57-1" class="xref-bibr" href="#ref-57">Frean <em>et al.</em>, 2003</a>; <a id="xref-ref-72-4" class="xref-bibr" href="#ref-72">Inglesby <em>et al.</em>, 2000</a>). The infrequent recovery of natural drug-resistant isolates of <em>Y. pestis</em> has been explained by the relative rarity of cases of human plague at the present time and by the acute nature of the disease
                        (<a id="xref-ref-47-4" class="xref-bibr" href="#ref-47">Domaradskii, 1993</a>). However, a ‘natural’ strain with resistance to multiple antibiotics, including all of those recommended for plague prophylaxis
                        and treatment, was isolated in 1995 in the Ambalavao district of Madagascar from a 16-year-old boy. The <em>Y. pestis</em> strain 17/95 was resistant to ampicillin, chloramphenicol, kanamycin, streptomycin, spectinomycin, sulfonamides, tetracycline
                        and minocycline. The resistance genes were carried by a plasmid that could conjugate with high frequency to other <em>Y. pestis</em> strains <em>in vitro</em> (<a id="xref-ref-60-1" class="xref-bibr" href="#ref-60">Galimand <em>et al.</em>, 1997</a>) or in fleas (<a id="xref-ref-69-1" class="xref-bibr" href="#ref-69">Hinnebusch <em>et al.</em>, 2002</a>). The possibility of the rise of such multidrug-resistant strains in the natural environment, the ease of generation of such
                        strains under laboratory conditions (<a id="xref-ref-69-2" class="xref-bibr" href="#ref-69">Hinnebusch <em>et al.</em>, 2002</a>; <a id="xref-ref-71-1" class="xref-bibr" href="#ref-71">Hurtle <em>et al.</em>, 2003</a>), the potential use of such strains for bioterrorist attack, together with the rapidity and high lethality of the disease
                        (<a id="xref-ref-31-3" class="xref-bibr" href="#ref-31">Butler, 1983</a>; <a id="xref-ref-43-3" class="xref-bibr" href="#ref-43">Dennis <em>et al.</em>, 1999</a>; <a id="xref-ref-47-5" class="xref-bibr" href="#ref-47">Domaradskii, 1993</a>, <a id="xref-ref-48-3" class="xref-bibr" href="#ref-48">1998</a>; <a id="xref-ref-72-5" class="xref-bibr" href="#ref-72">Inglesby <em>et al.</em>, 2000</a>; <a id="xref-ref-92-3" class="xref-bibr" href="#ref-92">Lien-Teh <em>et al.</em>, 1936</a>; <a id="xref-ref-110-3" class="xref-bibr" href="#ref-110">Naumov &amp; Samoilova, 1992</a>; <a id="xref-ref-113-3" class="xref-bibr" href="#ref-113">Nikolaev, 1972</a>; <a id="xref-ref-119-3" class="xref-bibr" href="#ref-119">Perry &amp; Fetherston, 1997</a>; <a id="xref-ref-121-3" class="xref-bibr" href="#ref-121">Pollitzer, 1954</a>; <a id="xref-ref-130-2" class="xref-bibr" href="#ref-130">Rudnev, 1940</a>), are evidence of the necessity for a search for novel antimicrobial alternatives to antibiotics. Here, we will briefly review
                        the existing methods, as well as promising current strategies under investigation for the treatment of plague.
                     </p>
                  </div>
                  <div id="sec-3" class="subsection">
                     <h3>Pathogenesis and virulence factors</h3>
                     <p id="p-6">For constant circulation in natural foci, the plague pathogen must penetrate into the host organism, counteract the protective
                        bactericidal systems of the rodent, and reproduce to ensure bacteraemia, essential for further transmission of the infection
                        by fleas to a new host. In the case of a human pneumonic plague outbreak, the bacteria must also overcome host innate immunity
                        to develop pneumonia with abundant exhalation of <em>Y. pestis</em>, causing plague pneumonia in naïve persons. Each of these stages in the cyclic existence of <em>Y. pestis</em> is supported by numerous factors of the plague pathogen, including pathogenicity factors and housekeeping genes (Table 1<a id="xref-table-wrap-1-1" class="xref-down-link" href="#T1"><span>⇓</span></a>), which may exert an influence, jointly or individually, upon various stages of the infectious process or transmission. The
                        removal of any one of these components may or may not render the organism avirulent. However, only in aggregate do these factors
                        ensure survival of <em>Y. pestis</em> in the host organism, no matter how significant or insignificant their individual effect might be (<a id="xref-ref-13-3" class="xref-bibr" href="#ref-13">Anisimov <em>et al.</em>, 2004</a>; <a id="xref-ref-26-2" class="xref-bibr" href="#ref-26">Brubaker, 1991</a>; <a id="xref-ref-119-4" class="xref-bibr" href="#ref-119">Perry &amp; Fetherston, 1997</a>).
                     </p>
                     <div class="table pos-float" id="T1">
                        <div class="table-inline">
                           <div class="callout"><span>View this table:</span><ul class="callout-links">
                                 <li><a href="1461/T1.expansion.html">In this window</a></li>
                                 <li><a class="in-nw" href="1461/T1.expansion.html">In a new window</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="table-caption"><span class="table-label">
                              <strong>Table 1.</strong>
                              </span> 
                           <p id="p-42" class="first-child">Selected factors ensuring survival of <em>Y. pestis</em> in the host organism
                           </p>
                           <p id="p-43">Compiled from <a id="xref-ref-11-4" class="xref-ref" href="#ref-11">Anisimov, 2002a</a>, <a id="xref-ref-12-4" class="xref-ref" href="#ref-12">b</a>, <a id="xref-ref-13-8" class="xref-ref" href="#ref-13">Anisimov <em>et al.</em>, 2004</a>; <a id="xref-ref-26-4" class="xref-ref" href="#ref-26">Brubaker, 1991</a>; <a id="xref-ref-116-2" class="xref-ref" href="#ref-116">Oyston <em>et al.</em>, 2000</a>; <a id="xref-ref-119-7" class="xref-ref" href="#ref-119">Perry &amp; Fetherston, 1997</a>; <a id="xref-ref-127-1" class="xref-ref" href="#ref-127">Robinson <em>et al.</em>, 2005</a>; <a id="xref-ref-137-1" class="xref-ref" href="#ref-137">Sing <em>et al.</em>, 2002</a>; <a id="xref-ref-140-1" class="xref-ref" href="#ref-140">Sodhi <em>et al.</em>, 2004</a>. <span class="sc">nd</span>, Not determined.
                           </p>
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     <p id="p-7">The main pathogenicity factor of <em>Yersinia</em> resides in the complex traits encoded by the plasmid pCad (also termed pCD, pVW, pYV or pLcr), the presence of which in the
                        cell is essential for the manifestation of virulence (<a id="xref-ref-123-1" class="xref-bibr" href="#ref-123">Portnoy &amp; Falkow, 1981</a>). It is considered as the Yop virulon: the system that permits extracellular bacteria to disarm the cells involved in the
                        host immune response, disrupt their binding, and induce their apoptosis by injection of bacterial effector proteins. This
                        system consists of the Yop proteins and the apparatus of their type III secretion, called Ysc. The Ysc apparatus consists
                        of 25 proteins, while most of the Yops can be divided into two groups according to their functions. Some of them are intracellular
                        effectors (YopE, YopH, YpkA/YopO, YopP/YopJ, YopM, YopT), whereas others (YopB, YopD, LcrV) form the translocation apparatus,
                        which is unfolded on the surface of the bacterium to deliver the effectors into eukaryotic cells through the plasma membrane.
                        The secretion of Yops proteins is triggered by contact with eukaryotic cells. In the absence of attachment, yersiniae do not
                        release Yops from the bacterial cell. The adhesion mechanism is not yet known, but it seems that close contact with eukaryotic
                        membrane lipids alone might be enough to trigger secretion. The secretion channel may be blocked at different levels by proteins
                        of the virulon, including YopN, TyeA and LcrG, which cover the bacterial secretory channel, presumably in the form of a trap
                        door. The precise functioning of the system also requires several chaperones, called Syc proteins, that assist Yops to be
                        secreted by the injectisome. Each of these chaperones serves only one Yop, and they do not leave the bacterial cytosol. Transcription
                        of the genes is controlled by the temperature and activity of the secretion apparatus (<a id="xref-ref-40-1" class="xref-bibr" href="#ref-40">Cornelis, 2002</a>; <a id="xref-ref-155-1" class="xref-bibr" href="#ref-155">Viboud &amp; Bliska, 2005</a>).
                     </p>
                     <p id="p-8">Infective doses of 10 bacteria or less are sufficient to cause lethal infection in naïve rodents and primates via the intradermal,
                        subcutaneous and intravenous routes (<a id="xref-ref-13-4" class="xref-bibr" href="#ref-13">Anisimov <em>et al.</em>, 2004</a>; <a id="xref-ref-26-3" class="xref-bibr" href="#ref-26">Brubaker, 1991</a>; <a id="xref-ref-119-5" class="xref-bibr" href="#ref-119">Perry &amp; Fetherston, 1997</a>). LD<sub>50</sub> values in the case of the respiratory and oral routes of infection increase to 10<sup>2</sup>–10<sup>4</sup> c.f.u. (<a id="xref-ref-11-2" class="xref-bibr" href="#ref-11">Anisimov, 2002a</a>; <a id="xref-ref-13-5" class="xref-bibr" href="#ref-13">Anisimov <em>et al.</em>, 2004</a>; <a id="xref-ref-50-1" class="xref-bibr" href="#ref-50">Ehrenkranz &amp; Meyer, 1955</a>) and 10<sup>5</sup>–10<sup>9</sup> c.f.u. (<a id="xref-ref-11-3" class="xref-bibr" href="#ref-11">Anisimov, 2002a</a>), respectively.
                     </p>
                     <p id="p-9"><em>Y. pestis</em> is primarily a rodent pathogen, and is usually transmitted to another mammalian host by fleas, following the death of the
                        rodent. After being introduced into the host, the bacterium is initially susceptible to phagocytosis and killing by neutrophils
                        (<a id="xref-ref-37-1" class="xref-bibr" href="#ref-37">Cavanaugh &amp; Randall, 1959</a>) and CD11c<sup>+</sup> cells (<a id="xref-ref-21-1" class="xref-bibr" href="#ref-21">Bosio <em>et al.</em>, 2005</a>), but it may survive and multiply within macrophages. Released bacteria are resistant to capture bf-37">Cavanaugh &amp; Randall, 1959</a>) and CD11c<sup>+</sup> cells (<a id="xref-ref-21-1" class="xref-bibr" href="#ref-21">Bosio <em>et al.</em>, 2005</a>), but it may survive and multiply within macrophages. Released bacteria are resistant to capturey neutrophils and begin
                        an unchecked propagation (<a id="xref-ref-37-2" class="xref-bibr" href="#ref-37">Cavanaugh &amp; Randall, 1959</a>). The bacteria then spread from the initial flea-bite site to the lymph nodes, where local replication causes a suppurative
                        lymphadenitis (bubo). If the lymphatic system becomes overwhelmed, septicaemia results, with <em>Y. pestis</em> spreading to other organs. The LPS of <em>Y. pestis</em> causes the development of endotoxic shock peculiar to other Gram-negative infections (<a id="xref-ref-31-4" class="xref-bibr" href="#ref-31">Butler, 1983</a>; <a id="xref-ref-46-1" class="xref-bibr" href="#ref-46">Dmitrovskii, 1994</a>; <a id="xref-ref-154-1" class="xref-bibr" href="#ref-154">Van Amersfoort <em>et al.</em>, 2003</a>). After the development of highly contagious plague pneumonia, the disease spreads in the air in droplets (<a id="xref-ref-91-1" class="xref-bibr" href="#ref-91">Lien-Teh, 1926</a>; <a id="xref-ref-92-4" class="xref-bibr" href="#ref-92">Lien-Teh <em>et al.</em>, 1936</a>; <a id="xref-ref-130-3" class="xref-bibr" href="#ref-130">Rudnev, 1940</a>).
                     </p>
                  </div>
                  <div id="sec-4" class="subsection">
                     <h3>Clinical manifestations</h3>
                     <p id="p-10">There are three main primary forms of human plague, bubonic, septicaemic and pneumonic. Complications such as secondary septicaemic
                        plague, secondary pneumonic plague, plague meningitis, plague endophthalmitis and multiple lymph node involvement result from
                        bacteraemic dissemination of the pathogen (<a id="xref-ref-31-5" class="xref-bibr" href="#ref-31">Butler, 1983</a>; <a id="xref-ref-43-4" class="xref-bibr" href="#ref-43">Dennis <em>et al.</em>, 1999</a>; <a id="xref-ref-92-5" class="xref-bibr" href="#ref-92">Lien-Teh <em>et al.</em>, 1936</a>; <a id="xref-ref-110-4" class="xref-bibr" href="#ref-110">Naumov &amp; Samoilova, 1992</a>; <a id="xref-ref-113-4" class="xref-bibr" href="#ref-113">Nikolaev, 1972</a>; <a id="xref-ref-121-4" class="xref-bibr" href="#ref-121">Pollitzer, 1954</a>; <a id="xref-ref-130-4" class="xref-bibr" href="#ref-130">Rudnev, 1940</a>). Septicaemia may be followed by digital gangrene (<a id="xref-ref-83-1" class="xref-bibr" href="#ref-83">Kuberski <em>et al.</em>, 2003</a>).
                     </p>
                     <p id="p-11">Irrespective of clinical form, the mean incubation period is 3–6 days, but may decrease to 1–2 days in patients with primary
                        septicaemic or pneumonic plague, and increase in vaccinated people. All of the clinical forms may be characterized by sudden
                        onset of illness, malaise, chills and temperature increase up to 39–40 °C, headache, myalgia, insomnia, indistinct speech,
                        wobbly walk, and sometimes vomiting. In the case of serious illness, patients are delirious, and violent and aggressive. Attempts
                        to make an escape from a patient care institution may be considered as a sign of developing meningitis. In extremely severe
                        cases, a profound prostration and cyanosis can be observed.
                     </p>
                     <p id="p-12">Fatality for untreated bubonic plague varies from 40 to 60 %, while untreated septicaemic and pneumonic forms of the disease
                        are always lethal (<a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">Albizo &amp; Surgalla, 1970</a>; <a id="xref-ref-31-6" class="xref-bibr" href="#ref-31">Butler, 1983</a>; <a id="xref-ref-43-5" class="xref-bibr" href="#ref-43">Dennis <em>et al.</em>, 1999</a>; <a id="xref-ref-46-2" class="xref-bibr" href="#ref-46">Dmitrovskii, 1994</a>; <a id="xref-ref-81-1" class="xref-bibr" href="#ref-81">Kool, 2005</a>; <a id="xref-ref-82-1" class="xref-bibr" href="#ref-82">Krishna &amp; Chitkara, 2003</a>; <a id="xref-ref-91-2" class="xref-bibr" href="#ref-91">Lien-Teh, 1926</a>; <a id="xref-ref-92-6" class="xref-bibr" href="#ref-92">Lien-Teh <em>et al.</em>, 1936</a>; <a id="xref-ref-110-5" class="xref-bibr" href="#ref-110">Naumov &amp; Samoilova, 1992</a>; <a id="xref-ref-113-5" class="xref-bibr" href="#ref-113">Nikolaev, 1972</a>; <a id="xref-ref-121-5" class="xref-bibr" href="#ref-121">Pollitzer, 1954</a>; <a id="xref-ref-130-5" class="xref-bibr" href="#ref-130">Rudnev, 1940</a>).
                     </p>
                     <div id="sec-5" class="subsection">
                        <h4>Bubonic plague</h4>
                        <p id="p-13">Bubonic plague results from a flea bite or direct contact of an open skin lesion with plague-infected material. Sometimes,
                           a vesicle, pustule or ulcer develops at the inoculation site. <em>Y. pestis</em> spreads via the lymphatic vessels to the regional lymph nodes, causing inflammation and swelling in one or several nodes:
                           buboes (‘bubo’ is derived from the Greek ‘boubon’, groin). Buboes are usually no greater than 5 cm in diameter, extremely
                           tender, erythematous, and surrounded by a boggy haemorrhagic area. Buboes typically arise in the inguinal and femoral regions,
                           but also occur in other regional lymph node sites, including popliteal, axillary, supraclavicular, cervical, post-auricular,
                           pharyngeal and other sites. Deeper nodes (such as intrabdominal or intrathoracic nodes) may also be involved through the lymphatic
                           or haematogenous spread of <em>Y. pestis</em>. Initial symptoms include malaise, high fever, and one or more painful lymph nodes. Pulse rate is increased to 110–140 min<sup>−1</sup>. Blood pressure is low, usually about 100/60 mm Hg, due to extreme vasodilatation. Circulatory collapse, haemorrhage and
                           peripheral thrombosis are the terminal events (<a id="xref-ref-31-7" class="xref-bibr" href="#ref-31">Butler, 1983</a>; <a id="xref-ref-43-6" class="xref-bibr" href="#ref-43">Dennis <em>et al.</em>, 1999</a>; <a id="xref-ref-92-7" class="xref-bibr" href="#ref-92">Lien-Teh <em>et al.</em>, 1936</a>; <a id="xref-ref-110-6" class="xref-bibr" href="#ref-110">Naumov &amp; Samoilova, 1992</a>; <a id="xref-ref-113-6" class="xref-bibr" href="#ref-113">Nikolaev, 1972</a>; <a id="xref-ref-121-6" class="xref-bibr" href="#ref-121">Pollitzer, 1954</a>; <a id="xref-ref-130-6" class="xref-bibr" href="#ref-130">Rudnev, 1940</a>).
                        </p>
                     </div>
                     <div id="sec-6" class="subsection">
                        <h4>Septicaemic plague</h4>
                        <p id="p-14">Septicaemic plague may occur primarily as a result of infection with massive doses of the pathogen, or when the bacillus is
                           deposited in the vasculature, bypassing the lymphatics. In this case, bacteria proliferate in the body without producing a
                           bubo. Secondary septicaemic plague is a complication of haematogenous dissemination of bubonic plague. The presenting signs
                           and symptoms of primary septicaemic plague are essentially the same as those of any Gram-negative septicaemia: fever, chills,
                           nausea, vomiting and diarrhoea. Later, purpura, disseminated intravascular coagulation, and acral cyanosis and necrosis may
                           be seen. Other symptoms include abdominal pain and digital gangrene (<a id="xref-ref-3-2" class="xref-bibr" href="#ref-3">Albizo &amp; Surgalla, 1970</a>; <a id="xref-ref-31-8" class="xref-bibr" href="#ref-31">Butler, 1983</a>; <a id="xref-ref-43-7" class="xref-bibr" href="#ref-43">Dennis <em>et al.</em>, 1999</a>; <a id="xref-ref-46-3" class="xref-bibr" href="#ref-46">Dmitrovskii, 1994</a>; <a id="xref-ref-92-8" class="xref-bibr" href="#ref-92">Lien-Teh <em>et al.</em>, 1936</a>; <a id="xref-ref-110-7" class="xref-bibr" href="#ref-110">Naumov &amp; Samoilova, 1992</a>; <a id="xref-ref-113-7" class="xref-bibr" href="#ref-113">Nikolaev, 1972</a>; <a id="xref-ref-121-7" class="xref-bibr" href="#ref-121">Pollitzer, 1954</a>; <a id="xref-ref-130-7" class="xref-bibr" href="#ref-130">Rudnev, 1940</a>; <a id="xref-ref-154-2" class="xref-bibr" href="#ref-154">Van Amersfoort <em>et al.</em>, 2003</a>).
                        </p>
                     </div>
                     <div id="sec-7" class="subsection">
                        <h4>Pneumonic plague</h4>
                        <p id="p-15">Pneumonic plague is rare, but is the most dangerous and fatal form of the disease, and is spread via respiratory droplets.
                           It can develop as a secondary complication of septicaemic plague or result from the inhalation of infectious respiratory excreta
                           of humans or animals with the pneumonic form of infection. The onset of pneumonic plague is acute and fulminant, with high
                           fever, chills, headache, malaise, myalgia and productive cough (with sputum that may be clear, bloody or purulent) within
                           24 h of the onset of symptoms. Buboes on the neck are rare, but are a symptom of pneumonic plague. Nausea, diarrhoea, vomiting
                           and abdominal pain may also accompany the disease. The pneumonia progresses rapidly, resulting in dyspnoea, stridor and cyanosis.
                           The disease rapidly engulfs the lungs and haemorrhages develop, filling them with fluid (a haemorrhagic pneumonia). The terminal
                           events are respiratory failure, circulatory collapse, and bleeding diathesis (<a id="xref-ref-3-3" class="xref-bibr" href="#ref-3">Albizo &amp; Surgalla, 1970</a>; <a id="xref-ref-31-9" class="xref-bibr" href="#ref-31">Butler, 1983</a>; <a id="xref-ref-43-8" class="xref-bibr" href="#ref-43">Dennis <em>et al.</em>, 1999</a>; <a id="xref-ref-46-4" class="xref-bibr" href="#ref-46">Dmitrovskii, 1994</a>; <a id="xref-ref-81-2" class="xref-bibr" href="#ref-81">Kool, 2005</a>; <a id="xref-ref-82-2" class="xref-bibr" href="#ref-82">Krishna &amp; Chitkara, 2003</a>; <a id="xref-ref-91-3" class="xref-bibr" href="#ref-91">Lien-Teh, 1926</a>; <a id="xref-ref-92-9" class="xref-bibr" href="#ref-92">Lien-Teh <em>et al.</em>, 1936</a>; <a id="xref-ref-110-8" class="xref-bibr" href="#ref-110">Naumov &amp; Samoilova, 1992</a>; <a id="xref-ref-113-8" class="xref-bibr" href="#ref-113">Nikolaev, 1972</a>; <a id="xref-ref-121-8" class="xref-bibr" href="#ref-121">Pollitzer, 1954</a>; <a id="xref-ref-130-8" class="xref-bibr" href="#ref-130">Rudnev, 1940</a>).
                        </p>
                     </div>
                  </div>
                  <div id="sec-8" class="subsection">
                     <h3>Methods of plague treatment</h3>
                     <p id="p-16">Until the nineteenth century, the treatment of plague was based on mysticism and superstition. Such ‘remedies' as magic and
                        talismans, mixtures of bird and animal blood, tablets made from rattlesnake meat, and even material squeezed from fresh horse
                        dung, were widely used (<a id="xref-ref-2-1" class="xref-bibr" href="#ref-2">Afanas'ev &amp; Vaks, 1903</a>). Later, methods such as phlebotomy, emetics, purgatives and diaphoretics were also applied to plague treatment (<a id="xref-ref-130-9" class="xref-bibr" href="#ref-130">Rudnev, 1940</a>). The isolation of the plague pathogen, <em>Y. pestis</em>, in 1894 (<a id="xref-ref-168-2" class="xref-bibr" href="#ref-168">Yersin, 1894</a>) made possible scientific approaches to the cure of plague-infected patients. The local application of antiseptics such as
                        iodine, mercuric chloride, carbolic acid or quinine, together with the incision or even searing of bubos, were promising in
                        some cases, as were attempts to surmount severe systemic disease by the use of the same remedies, specific bacteriophages
                        or animal hyperimmune sera (<a id="xref-ref-92-10" class="xref-bibr" href="#ref-92">Lien-Teh <em>et al.</em>, 1936</a>; <a id="xref-ref-130-10" class="xref-bibr" href="#ref-130">Rudnev, 1940</a>); however, real success in plague therapy was observed when sulfanilamides (<a id="xref-ref-34-1" class="xref-bibr" href="#ref-34">Carman, 1938</a>) and then streptomycin (<a id="xref-ref-70-1" class="xref-bibr" href="#ref-70">Hornibrook, 1946</a>) became available.
                     </p>
                     <div id="sec-9" class="subsection">
                        <h4>Antibiotic prophylaxis and therapy</h4>
                        <p id="p-17">Currently, antibiotics are the cornerstone of plague treatment. The antibiotic prophylaxis and therapy for <em>Y. pestis</em> infection, as suggested by the <a id="xref-ref-166-2" class="xref-bibr" href="#ref-166">WHO Expert Committee on Plague (1970)</a>, focuses on the use of tetracycline, streptomycin, and chloramphenicol for eradication of the organism. More recently, the
                           US Working Group on Civilian Biodefence has added gentamicin, doxycycline and ciprofloxacin to this list (<a id="xref-ref-72-6" class="xref-bibr" href="#ref-72">Inglesby <em>et al.</em>, 2000</a>). Chloramphenicol is optional for the treatment of plague meningitis (<a id="xref-ref-16-1" class="xref-bibr" href="#ref-16">Becker <em>et al.</em>, 1987</a>). Aminoglycosides (streptomycin, kanamycin, tobramycin, gentamicin and amikacin) and cephalosporins (ceftriaxone and ceftazidim)
                           are recommended for the treatment of plague caused by F1-negative <em>Y. pestis</em> strains that are resistant to doxycycline, ampicillin and cefoperazone <em>in vivo</em>. Studies in mice suggest that an increase in the daily doses of less-efficient drugs such as cefotaxime, cefoperazone, sulbactam/ampicillin,
                           azthreonam, ciprofloxacin and rifampicin, along with prolongation of the treatment course for up to 7 days, make it possible
                           to increase the protective effects to 80–100 % (<a id="xref-ref-13-6" class="xref-bibr" href="#ref-13">Anisimov <em>et al.</em>, 2004</a>; <a id="xref-ref-133-1" class="xref-bibr" href="#ref-133">Ryzhko <em>et al.</em>, 1998</a>). Furthermore, studies using ciprofloxacin, doxycycline and the newer fluoroquinolones gatifloxacin and moxifloxacin have
                           shown an increase in the survival of mice presenting with pneumonic plague (<a id="xref-ref-32-1" class="xref-bibr" href="#ref-32">Byrne <em>et al.</em>, 1998</a>; <a id="xref-ref-131-1" class="xref-bibr" href="#ref-131">Russell <em>et al.</em>, 1998</a>; <a id="xref-ref-142-1" class="xref-bibr" href="#ref-142">Steward <em>et al.</em>, 2004</a>).
                        </p>
                        <p id="p-18">It is recommended that antibiotic therapy be started as early as possible. A delay in antibiotic therapy will result in an
                           increase in bacterial biomass, and in a more harmful subsequent inflammatory response caused by endotoxin release induced
                           by both lytic and non-lytic antimicrobials (<a id="xref-ref-109-1" class="xref-bibr" href="#ref-109">Nau &amp; Eiffert, 2002</a>). During the first few hours of antibiotic treatment, patients should be monitored closely, because shock may develop after
                           the start of antibiotic application due to bacteriolysis, with the subsequent release of large amounts of endotoxin (<a id="xref-ref-73-1" class="xref-bibr" href="#ref-73">Jacobs <em>et al.</em>, 1990</a>). Those in contact with pneumonic plague patients and persons who have been exposed to aerosols should receive doxycycline,
                           ciprofloxacin or chloramphenicol as post-exposure prophylaxis (<a id="xref-ref-72-7" class="xref-bibr" href="#ref-72">Inglesby <em>et al.</em>, 2000</a>). The recent increase in multidrug-resistant strains (<a id="xref-ref-60-2" class="xref-bibr" href="#ref-60">Galimand <em>et al.</em>, 1997</a>; <a id="xref-ref-164-1" class="xref-bibr" href="#ref-164">Wong <em>et al.</em>, 2000</a>) has led to renewed efforts to find alternatives to antibiotics.
                        </p>
                     </div>
                     <div id="sec-10" class="subsection">
                        <h4>Immunotherapy</h4>
                        <div id="sec-11" class="subsection">
                           <h5>Serum therapy.</h5>
                           <p id="p-19">A. Yersin and others were the first to use the serum of vaccinated rabbits to cure infected animals (<a id="xref-ref-170-1" class="xref-bibr" href="#ref-170">Yersin <em>et al.</em>, 1895</a>). In 1896, Yersin was able to cure several patients in Asia with a horse serum (<a id="xref-ref-169-1" class="xref-bibr" href="#ref-169">Yersin, 1897</a>). However, the experiences of other researchers with the use of plague serum were conflicting. The horse, mule or bull sera
                              were produced in different laboratories with the use of different immunization schemes involving killed or live bacteria of
                              different strains. In the course of treatment, patients were injected subcutaneously or intravenously with up to 1000 ml immune
                              serum (200–500 ml for one subcutaneous or intramuscular injection, and 50–100 ml for one intravenous injection). In the case
                              of bubonic plague, the reported death rate in treated (13 %) and untreated (64 %) patients differed significantly. In patients
                              with septicaemic or pneumonic plague, treatment did not cause a detectable decrease in mortality. The sooner treatment was
                              started the better the result. Even in patients that succumbed to infection, an up to twofold increase in time to death was
                              usually reported. The dangers of serum sickness and anaphylactic shock frequently induced by serum therapy were believed to
                              be less significant than that of septic shock (<a id="xref-ref-92-11" class="xref-bibr" href="#ref-92">Lien-Teh <em>et al.</em>, 1936</a>; <a id="xref-ref-121-9" class="xref-bibr" href="#ref-121">Pollitzer, 1954</a>; <a id="xref-ref-130-11" class="xref-bibr" href="#ref-130">Rudnev, 1940</a>). In 1970, the WHO Expert Committee on Plague recommended the continuation of further development of plague antitoxic sera
                              that might be used for the treatment of plague patients with severe toxicosis (<a id="xref-ref-165-2" class="xref-bibr" href="#ref-165">WHO, 1970</a>).
                           </p>
                        </div>
                        <div id="sec-12" class="subsection">
                           <h5>Antibody therapy.</h5>
                           <p id="p-20">Beginning in the 1960s, separate antibody preparations were introduced into clinical practice for preventing and treating
                              infectious diseases. In contrast to older remedies based on animal sera, these specific immunoglobulins contained antibodies
                              derived from immunized human donors, and so had minimal side effects. Although human-specific globulins lack the toxicities
                              associated with animal sera, they have several limitations, such as high cost, low availability, and the potential to transmit
                              infectious disease (<a id="xref-ref-29-1" class="xref-bibr" href="#ref-29">Buchwald &amp; Pirofski, 2003</a>; <a id="xref-ref-35-1" class="xref-bibr" href="#ref-35">Casadevall, 2002</a>; <a id="xref-ref-36-1" class="xref-bibr" href="#ref-36">2005</a>; <a id="xref-ref-78-1" class="xref-bibr" href="#ref-78">Keller &amp; Stiehm, 2000</a>).
                           </p>
                           <p id="p-21">Hybridoma technology, introduced in 1975 (<a id="xref-ref-80-1" class="xref-bibr" href="#ref-80">Kohler &amp; Milstein, 1975</a>), provides a method for the unlimited production of homogeneous mAbs. The construction of mouse–human chimeric or humanized
                              mAbs (<a id="xref-ref-104-1" class="xref-bibr" href="#ref-104">Morrison, 1992</a>), completely human mAbs (<a id="xref-ref-75-1" class="xref-bibr" href="#ref-75">Kang <em>et al.</em>, 1991</a>) from hybridomas or combinatorial libraries, and recombinant human polyclonal antibodies (<a id="xref-ref-24-1" class="xref-bibr" href="#ref-24">Bregenholt &amp; Haurum, 2004</a>), makes it possible to reduce the immunogenicity of rodent mAbs in humans. These approaches provide the possibility of raising
                              relevant antibodies against protective antigens only, and even against protective epitopes of protective antigens.
                           </p>
                           <p id="p-22">In the case of <em>Y. pestis</em>, several antigens have been shown to be able to produce protective immunity. Among them are F1 capsular antigen (<a id="xref-ref-101-1" class="xref-bibr" href="#ref-101">Meyer <em>et al.</em>, 1974</a>; <a id="xref-ref-136-1" class="xref-bibr" href="#ref-136">Simpson <em>et al.</em>, 1990</a>), LcrV or simply V antigen (<a id="xref-ref-86-1" class="xref-bibr" href="#ref-86">Leary <em>et al.</em>, 1995</a>; <a id="xref-ref-107-1" class="xref-bibr" href="#ref-107">Motin <em>et al.</em>, 1994</a>; <a id="xref-ref-153-1" class="xref-bibr" href="#ref-153">Une &amp; Brubaker, 1984</a>), YopD (<a id="xref-ref-10-1" class="xref-bibr" href="#ref-10">Andrews <em>et al.</em>, 1999</a>), and type III secretion system needle complex protein, YscF (<a id="xref-ref-97-1" class="xref-bibr" href="#ref-97">Matson <em>et al.</em>, 2005</a>). Immunodominant epitopes have been found for the F1 (<a id="xref-ref-134-1" class="xref-bibr" href="#ref-134">Sabhnani &amp; Rao, 2000</a>; <a id="xref-ref-135-1" class="xref-bibr" href="#ref-135">Sabhnani <em>et al.</em>, 2003</a>; <a id="xref-ref-172-1" class="xref-bibr" href="#ref-172">Zav'yalov <em>et al.</em>, 1995</a>) and V (<a id="xref-ref-66-1" class="xref-bibr" href="#ref-66">Hill <em>et al.</em>, 1997</a>) antigens. Passive administration of antibodies against target antigens protects macrophages from <em>Y. pestis</em>-induced cell death, promotes phagocytosis (<a id="xref-ref-41-1" class="xref-bibr" href="#ref-41">Cowan <em>et al.</em>, 2005</a>; <a id="xref-ref-120-1" class="xref-bibr" href="#ref-120">Philipovskiy <em>et al.</em>, 2005</a>; <a id="xref-ref-157-1" class="xref-bibr" href="#ref-157">Weeks <em>et al.</em>, 2002</a>), and protects animals against both bubonic and pneumonic plague (<a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">Anderson <em>et al.</em>, 1997</a>; <a id="xref-ref-58-1" class="xref-bibr" href="#ref-58">Friedlander <em>et al.</em>, 1995</a>; <a id="xref-ref-63-1" class="xref-bibr" href="#ref-63">Green <em>et al.</em>, 1999</a>; <a id="xref-ref-67-1" class="xref-bibr" href="#ref-67">Hill <em>et al.</em>, 2006</a>; <a id="xref-ref-107-2" class="xref-bibr" href="#ref-107">Motin <em>et al.</em>, 1994</a>; <a id="xref-ref-128-1" class="xref-bibr" href="#ref-128">Roggenkamp <em>et al.</em>, 1997</a>; <a id="xref-ref-153-2" class="xref-bibr" href="#ref-153">Une &amp; Brubaker, 1984</a>; <a id="xref-ref-161-2" class="xref-bibr" href="#ref-161">Williamson <em>et al.</em>, 2005</a>). Importantly, therapy based on a single antibody against a single antigen or epitope will be ineffective in the case of
                              infection with a virulent strain lacking the antigen or expressing a different serological variant of the antigen (<a id="xref-ref-13-7" class="xref-bibr" href="#ref-13">Anisimov <em>et al.</em>, 2004</a>; <a id="xref-ref-58-2" class="xref-bibr" href="#ref-58">Friedlander <em>et al.</em>, 1995</a>; <a id="xref-ref-128-2" class="xref-bibr" href="#ref-128">Roggenkamp <em>et al.</em>, 1997</a>).
                           </p>
                        </div>
                        <div id="sec-13" class="subsection">
                           <h5>Non-pathogen-specific immunomodulatory therapy.</h5>
                           <p id="p-23"><em>Y. pestis</em> is known to efficiently overcome the innate immune system of many mammals. However, it has been shown that neutrophils (<a id="xref-ref-37-3" class="xref-bibr" href="#ref-37">Cavanaugh &amp; Randall, 1959</a>) and CD11c<sup>+</sup> cells (<a id="xref-ref-21-2" class="xref-bibr" href="#ref-21">Bosio <em>et al.</em>, 2005</a>), which represent the initial line of host defence against invading pathogens, play an important role in suppressing the
                              initial replication and dissemination of inhaled <em>Y. pestis</em>. Recent studies (<a id="xref-ref-93-1" class="xref-bibr" href="#ref-93">Liles, 2001</a>) conducted <em>in vitro</em> and <em>in vivo</em> have shown that granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor and interferon-<em>γ</em> can augment the functional antimicrobial activities of neutrophils. Studies conducted in animal models have shown the potential
                              use of each of these cytokines for the treatment of bacterial infections. We can speculate that such adjunctive treatment
                              may be useful for plague therapy.
                           </p>
                           <p id="p-24"><em>Y. pestis</em> mediates septic shock, which contributes significantly to host death (<a id="xref-ref-31-10" class="xref-bibr" href="#ref-31">Butler, 1983</a>; <a id="xref-ref-46-5" class="xref-bibr" href="#ref-46">Dmitrovskii, 1994</a>). Sepsis and the systemic inflammatory response syndrome are accompanied by the inability to regulate the inflammatory response
                          f-31">Butler, 1983</a>; <a id="xref-ref-46-5" class="xref-bibr" href="#ref-46">Dmitrovskii, 1994</a>). Sepsis and the systemic inflammato    (<a id="xref-ref-154-3" class="xref-bibr" href="#ref-154">Van Amersfoort <em>et al.</em>, 2003</a>). The most potent class of cholesterol-lowering drugs, statins, has been shown to also possess cholesterol-independent effects,
                              including diverse immunomodulatory and anti-inflammatory properties (<a id="xref-ref-5-1" class="xref-bibr" href="#ref-5">Almog, 2003</a>). Recent studies have demonstrated that simvastatin (<a id="xref-ref-99-1" class="xref-bibr" href="#ref-99">Merx <em>et al.</em>, 2004</a>) and cerivastatin (<a id="xref-ref-9-1" class="xref-bibr" href="#ref-9">Ando <em>et al.</em>, 2000</a>) pretreatment profoundly improves survival in a murine model of sepsis. Another retrospective study has shown that statin
                              therapy reduces both overall and attributable mortality in patients with bacteraemia (<a id="xref-ref-90-1" class="xref-bibr" href="#ref-90">Liappis <em>et al.</em>, 2001</a>). The lipid profiles of the statin-pretreated patients were considerably higher than those of the no-statin group, and it
                              has been suggested that the medicinal efficacy is a result of the attenuation of the intensity of the inflammatory response
                              due to binding of endotoxins by increased amounts of lipids (<a id="xref-ref-6-1" class="xref-bibr" href="#ref-6">Almog <em>et al.</em>, 2004</a>).
                           </p>
                           <p id="p-25">Several other immune response modifiers that target different stages of innate immunity and might be useful for plague therapy
                              have recently been reviewed (<a id="xref-ref-7-1" class="xref-bibr" href="#ref-7">Amlie-Lefond <em>et al.</em>, 2005</a>; <a id="xref-ref-96-1" class="xref-bibr" href="#ref-96">Masihi, 2000</a>), but only one, glutoxim, a sulfur-containing hexapeptide with an immunomodulatory effect on lymphocytes (<a id="xref-ref-53-1" class="xref-bibr" href="#ref-53">Fimiani <em>et al.</em>, 2002</a>), has been used in an animal model of plague (<a id="xref-ref-174-1" class="xref-bibr" href="#ref-174">Zhemchugov, 2004</a>). When injected into mice (12.5 mg per animal) 6 h before challenge with 10 LD<sub>50</sub> of the virulent <em>Y. pestis</em> strain 231, it protected half of the animals from death. Glutoxim has also been shown to protect mice from tularaemia and
                              melioidosis. However, the data thus far are inconclusive, as they were obtained in isolated experiments that employed a minimal
                              number of laboratory animals.
                           </p>
                        </div>
                     </div>
                     <div id="sec-14" class="subsection">
                        <h4>Phage therapy</h4>
                        <p id="p-26">Bacteriophages seem to be good candidates for antibacterial therapy: they often possess high species specificity, they are
                           non-toxic to eukaryotes, and they kill the target bacteria that they infect and within which they multiply. After the discovery
                           of bacteriophages by Twort in 1915, and independently by d'Herelle in 1917, a number of researchers and physicians were overenthusiastic
                           in the use of bacteriophages for the therapy of bacterial disease (<a id="xref-ref-138-1" class="xref-bibr" href="#ref-138">Skurnik &amp; Strauch, 2006</a>; <a id="xref-ref-145-1" class="xref-bibr" href="#ref-145">Sulakvelidze, 2005</a>; <a id="xref-ref-146-1" class="xref-bibr" href="#ref-146">Summers, 1999</a>, <a id="xref-ref-147-1" class="xref-bibr" href="#ref-147">2001</a>). With respect to plague, in 1925, d'Herelle used a highly virulent anti-plague phage that had been isolated in 1920 in Indo-China
                           from rat faeces to treat four cases of bubonic plague as the first bacteriophage therapy (<a id="xref-ref-44-1" class="xref-bibr" href="#ref-44">d'Herelle, 1925</a>). All the patients had laboratory-diagnosed bubonic plague with very serious clinical signs. d'Herelle treated all four with
                           anti-plague phage preparations by single/double direct injection of phage (0.5–1 ml) into the buboes. Within several hours
                           of injection, the patients felt better, a 2 °C average fall in temperature was recorded, and severe pain in the buboes decreased.
                           All four patients recovered in what was considered a remarkable fashion. On the basis of this work, a number of attempts to
                           confirm the efficacy of the phage therapy of plague both in animal models and in clinical trials were performed (<a id="xref-ref-44-2" class="xref-bibr" href="#ref-44">d'Herelle, 1925</a>; <a id="xref-ref-55-1" class="xref-bibr" href="#ref-55">Flu, 1929</a>; <a id="xref-ref-56-1" class="xref-bibr" href="#ref-56">Fonquernie, 1932</a>; <a id="xref-ref-92-12" class="xref-bibr" href="#ref-92">Lien-Teh <em>et al.</em>, 1936</a>; <a id="xref-ref-108-1" class="xref-bibr" href="#ref-108">Naidu &amp; Avari, 1932</a>; <a id="xref-ref-130-12" class="xref-bibr" href="#ref-130">Rudnev 1940</a>). However, a poor understanding of the mechanisms of phage–bacterial interactions, including lysogeny and phage DNA restriction,
                           and poorly designed and executed experiments and clinical trials, together with the use of undefined phages in the form of
                           non-purified phage preparations, led to conflicting results (<a id="xref-ref-138-2" class="xref-bibr" href="#ref-138">Skurnik &amp; Strauch, 2006</a>; <a id="xref-ref-145-2" class="xref-bibr" href="#ref-145">Sulakvelidze, 2005</a>; <a id="xref-ref-146-2" class="xref-bibr" href="#ref-146">Summers, 1999</a>, <a id="xref-ref-147-2" class="xref-bibr" href="#ref-147">2001</a>).
                        </p>
                        <p id="p-27">Bacteriophages have received renewed attention as possible agents against bacterial pathogens. Evidence from several recent
                           trials designed and executed in accordance with good laboratory practice (GLP) regulations indicates that phage therapy can
                           be effective, although the efficacy of the phage treatment depends greatly on the route (oral, intramuscular, aerosol spray,
                           etc.) and/or frequency of phage application (<a id="xref-ref-138-3" class="xref-bibr" href="#ref-138">Skurnik &amp; Strauch, 2006</a>; <a id="xref-ref-145-3" class="xref-bibr" href="#ref-145">Sulakvelidze, 2005</a>; <a id="xref-ref-146-3" class="xref-bibr" href="#ref-146">Summers, 1999</a>, <a id="xref-ref-147-3" class="xref-bibr" href="#ref-147">2001</a>). Numerous obstacles to the use of phage as antimicrobials for clinical practice remain. Among them are the issue of phage
                           resistance, and the possibility of phage-mediated transfer of undesirable genetic material to bacterial hosts. Therapy based
                           on the simultaneous use of several phages with known genetic sequences and targeting different bacterial receptors can help
                           in overcoming these obstacles. Currently, the genomes of several <em>Y. pestis</em>-specific phages have been sequenced (<a id="xref-ref-52-1" class="xref-bibr" href="#ref-52">Filippov <em>et al.</em>, 2005</a>; <a id="xref-ref-61-1" class="xref-bibr" href="#ref-61">Garcia <em>et al.</em>, 2003</a>), and they could be candidates for the revival of plague phage therapy.
                        </p>
                        <p id="p-28">A phage-encoded peptidoglycan-degrading activity is responsible for the cell-wall-hydrolysing action of bacteriophages. At
                           least four types of these enzymes, endolysins, are responsible for this activity in different phages (<a id="xref-ref-171-1" class="xref-bibr" href="#ref-171">Young, 1992</a>). Taking into account that if a sufficiently high phage dose is given, phages are able to control infection through a non-proliferative
                           lytic mechanism (<a id="xref-ref-18-1" class="xref-bibr" href="#ref-18">Berchieri <em>et al.</em>, 1991</a>; <a id="xref-ref-62-1" class="xref-bibr" href="#ref-62">Goode <em>et al.</em>, 2003</a>), the therapeutic use of endolysins in a controlled fashion seems advantageous in comparison with the uncontrollable increase
                           of the live active agent.
                        </p>
                     </div>
                     <div id="sec-15" class="subsection">
                        <h4>Bacteriocin therapy</h4>
                        <p id="p-29">Bacteriocins, bacterially produced antimicrobial peptides, range from the well-studied, narrow spectrum, high-molecular-mass
                           colicins produced by <em>Escherichia coli</em> and the short polypeptide lantibiotics of lactic acid bacteria to the relatively unknown halocins produced almost universally
                           by halobacteria. Purified bacteriocins could be used for the reduction or elimination of certain pathogens (<a id="xref-ref-22-1" class="xref-bibr" href="#ref-22">Braude &amp; Siemienski, 1965</a>; <a id="xref-ref-126-1" class="xref-bibr" href="#ref-126">Riley &amp; Wertz, 2002</a>). It has been shown in assays for potency that purified colicins V and K have similar inhibitory activities on a per weight
                           basis to those of the therapeutic antibiotics kanamycin, streptomycin and oxytetracycline (<a id="xref-ref-98-1" class="xref-bibr" href="#ref-98">McGeachie, 1970</a>). Bacteriocins nisin A (produced by <em>Lactococcus lactis</em>) and mutacin B-Ny266 (produced by <em>Streptococcus mutans</em>) are as active as vancomycin and oxacillin against most strains tested (<em>Bacillus</em>, <em>Enterococcus</em>, <em>Lactococcus</em>, <em>Listeria</em>, <em>Mycobacterium</em>, <em>Pediococcus</em>, <em>Staphylococcus</em>, <em>Bordetella</em>, <em>Clostridium</em>, <em>Peptostreptococcus</em>, <em>Propionibacterium</em>, <em>Streptococcus</em> and <em>Micrococcus</em>). Furthermore, mutacin B-Ny266 remains active against strains that are resistant to nisin A, oxacillin and vancomycin (<a id="xref-ref-105-1" class="xref-bibr" href="#ref-105">Mota-Meira <em>et al.</em>, 2000</a>).
                        </p>
                        <p id="p-30">Intraperitoneal injections of mutacin B-Ny266 have been used for the treatment of mice infected with <em>Staphylococcus aureus</em>. While there was 100 % mortality in the control group of mice, no mortality was observed in the mice injected with vancomycin
                           or mutacin B-Ny266 (<a id="xref-ref-106-1" class="xref-bibr" href="#ref-106">Mota-Meira <em>et al.</em>, 2005</a>). Lacticin 3147, a broad-spectrum bacteriocin produced by the food-grade organism <em>L. lactis</em>, reduced the incidence of mastitis after experimental challenge with <em>Streptococcus dysgalactiae</em> in non-lactating dairy cows (<a id="xref-ref-132-1" class="xref-bibr" href="#ref-132">Ryan <em>et al.</em>, 1999</a>). Local injections of staphylococcin A-1262a were used to treat 50 patients with a variety of staphylococcal lesions. Complete
                           recovery was observed in 42 of the patients (<a id="xref-ref-84-1" class="xref-bibr" href="#ref-84">Lachowicz, 1965</a>). The streptococcal bacteriocin tomicide was used for protection of white mice from staphylococcal infection. Tomicide, administered
                           in the maximum dose admissible for mice, ensured the protection of up to two-thirds of the total number of mice. A single
                           oral administration of the preparation immediately after infection protected one-third of the surviving mice from local staphylococcal
                           infection (<a id="xref-ref-20-1" class="xref-bibr" href="#ref-20">Blinkova <em>et al.</em>, 2003</a>). The pronounced prophylactic effect of tomicide, manifested by a reliable decrease of group A streptococcal carrier state,
                           as well as by a decrease in morbidity in respiratory streptococcal infection among children in a test group in comparison
                           with controls, has been reported (<a id="xref-ref-25-1" class="xref-bibr" href="#ref-25">Briko &amp; Zhuravlev, 2004</a>). Enterocoliticin, a phage-tail-like bacteriocin, has been administered as an antimicrobial compound by the oral route for
                           the treatment of BALB/c mice infected with <em>Yersinia enterocolitica</em>, the nearest relative of <em>Y. pestis</em>. The increase in the number of <em>Y. enterocolitica</em> c.f.u. in animals was retarded at time points shortly after the application of enterocoliticin, indicating that the bacteriocin
                           was effective during the early phase of infection (<a id="xref-ref-42-1" class="xref-bibr" href="#ref-42">Damasko <em>et al.</em>, 2005</a>). A purified class IIa bacteriocin, secreted by <em>Paenibacillus polymyxa</em> NRRL-B-30509, has been incorporated into chicken feed, and dramatically reduced both intestinal levels and the frequency
                           of chicken colonization by <em>Campylobacter jejuni</em> (<a id="xref-ref-141-1" class="xref-bibr" href="#ref-141">Stern <em>et al.</em>, 2005</a>). The same bacteriocin has been shown to inhibit the growth of <em>Y. pestis in vitro</em> (E. A. Svetoch and B. V. Eruslanov, personal communication) in doses similar to those recommended by the WHO Expert Committee
                           on Plague (<a id="xref-ref-165-3" class="xref-bibr" href="#ref-165">WHO, 1970</a>) for antibiotics. The above studies suggest that there is a potential therapeutic effect associated with bacteriocins. When
                           contemplating the clinical use of bacteriocins, one important consideration is their possible pathological effects. In early
                           studies with partially purified bacteriocins (<a id="xref-ref-103-1" class="xref-bibr" href="#ref-103">Montgomerie <em>et al.</em>, 1973</a>; <a id="xref-ref-148-1" class="xref-bibr" href="#ref-148">Tagg &amp; McGiven, 1972</a>; <a id="xref-ref-152-1" class="xref-bibr" href="#ref-152">Turnowsky <em>et al.</em>, 1973</a>) or strain pairs differing in their expression (<a id="xref-ref-28-1" class="xref-bibr" href="#ref-28">Brubaker <em>et al.</em>, 1965</a>; <a id="xref-ref-30-1" class="xref-bibr" href="#ref-30">Burrows, 1965</a>; <a id="xref-ref-139-1" class="xref-bibr" href="#ref-139">Smith, 1974</a>), the data showed their potential toxicity, and also a relationship between the carriage of bacteriocinogenic factors and
                           the virulence of certain strains. However, studies with purified substances have in many cases failed to confirm toxicity
                           (<a id="xref-ref-22-2" class="xref-bibr" href="#ref-22">Braude &amp; Siemienski, 1965</a>; <a id="xref-ref-149-1" class="xref-bibr" href="#ref-149">Tagg <em>et al.</em>, 1976</a>). Although intraperitoneal injection of 10 mg mutacin B-Ny266 kg<sup>−1</sup> did not apparently affect the health of mice, these results will have to be confirmed with more relevant toxicity tests (<a id="xref-ref-106-2" class="xref-bibr" href="#ref-106">Mota-Meira <em>et al.</em>, 2005</a>). The investigation of the <em>in vitro</em> cytotoxicities of two bacteriocins, gallidermin (<em>Staphylococcus gallinarum</em>) and nisin A, in comparison with those of antimicrobial peptides of eukaryotic origin, magainin I, magainin II and melittin,
                           indicated that gallidermin was the least cytotoxic antimicrobial peptide, followed by nisin A, magainin I, magainin II and
                           melittin. Nisin caused haemolysis, but at concentrations which were 1000-fold higher than those required for antimicrobial
                           activity. Gallidermin shows the most promise as a therapeutic agent, with relatively low cytotoxicity and potent antimicrobial
                           activities (<a id="xref-ref-94-1" class="xref-bibr" href="#ref-94">Maher &amp; McClean, 2006</a>). In considering the potential toxicity of bacteriocins, the well-known toxicity of antibiotics such as quinolones, doxycycline,
                           streptomycin and gentamicin, and the possible problems associated with massive use of antimicrobial agents for prophylaxis
                           or therapy during a bioterrorist attack, should be noted (<a id="xref-ref-112-1" class="xref-bibr" href="#ref-112">Navas, 2002</a>).
                        </p>
                     </div>
                     <div id="sec-16" class="subsection">
                        <h4>Inhibitors of virulence factors</h4>
                        <p id="p-31">Virulence refers to the ability of an organism to establish an infection and cause disease. Many steps are involved in the
                           infection process, including adherence, invasion and the evasion of host defences (<a id="xref-ref-54-1" class="xref-bibr" href="#ref-54">Finlay &amp; Falkow, 1997</a>). Microbial factors involved in the process of virulence are unique, in that their inhibition, by definition, should interfere
                           with the process of infection rather than with bacterial viability. Inhibitors of such targets would be unlikely to affect
                           host cells, to be cross-resistant to existing therapies, or to induce resistance themselves. Bacterial virulence may therefore
                           offer unique opportunities to inhibit the establishment of infection or alter its course as a method of antimicrobial chemotherapy
                           (<a id="xref-ref-4-1" class="xref-bibr" href="#ref-4">Alksne, 2002</a>; <a id="xref-ref-87-1" class="xref-bibr" href="#ref-87">Y. M. Lee <em>et al.</em>, 2003</a>; <a id="xref-ref-95-1" class="xref-bibr" href="#ref-95">Marra, 2004</a>).
                        </p>
                        <p id="p-32">A necessary step in the successful colonization and, ultimately, production of disease by microbial pathogens is the ability
                           to adhere to host surfaces (<a id="xref-ref-54-2" class="xref-bibr" href="#ref-54">Finlay &amp; Falkow, 1997</a>), in many cases involving oligosaccharides located on the host cell surface and bacterial adhesins. The terminal di- or trisaccharide
                           units of these oligosaccharides may be used to inhibit these interactions, preventing attachment and therefore disease. The
                           validity of this approach has been unequivocally demonstrated in experiments performed in a wide variety of animals, from
                           mice to monkeys, and also in humans (<a id="xref-ref-115-1" class="xref-bibr" href="#ref-115">Ofek <em>et al.</em>, 2003</a>).
                        </p>
                        <p id="p-33"><em>Y. pestis</em> expresses a range of adhesins, including pH 6 (PsaA), F1 (Caf1), Pla and S-layer protein (<a id="xref-ref-12-2" class="xref-bibr" href="#ref-12">Anisimov, 2002b</a>; <a id="xref-ref-79-1" class="xref-bibr" href="#ref-79">Kienle <em>et al.</em>, 1992</a>; <a id="xref-ref-117-1" class="xref-bibr" href="#ref-117">Parkhill <em>et al.</em>, 2001</a>; <a id="xref-ref-118-1" class="xref-bibr" href="#ref-118">Payne <em>et al.</em>, 1998</a>). pH 6 antigen binds to several human immunoglobulin G subclasses by acting as a bacterial Fc receptor (<a id="xref-ref-173-1" class="xref-bibr" href="#ref-173">Zav'yalov <em>et al.</em>, 1996</a>). It is also able to bind to gangliotetraosylceramide, gangliotriaosylceramide and lactosylceramide, and also to attach to
                           hydroxylated galactosylceramide. Recombinant pH 6 antigen, present on the surface of intact <em>E. coli</em> cells, possesses the same specificity as the purified antigen, with the exception of binding to non-hydroxylated galactosylceramide.
                           The observed binding patterns indicate that the presence of <em>β</em>1-linked galactosyl residues in glycosphingolipids is the minimum requirement for binding of the pH 6 antigen. The glycosphingolipids
                           recognized by the pH 6 antigen are common and may be found on a range of host cell types (<a id="xref-ref-118-2" class="xref-bibr" href="#ref-118">Payne <em>et al.</em>, 1998</a>). In fact, pH 6 antigen preparations are able to agglutinate human, rabbit, guinea pig and murine erythrocytes (<a id="xref-ref-19-1" class="xref-bibr" href="#ref-19">Bichowsky-Slomnicki &amp; Ben-Efraim, 1963</a>). Studies that are currently in progress in the Laboratory for Plague Microbiology, Department of Infectious Diseases, State
                           Research Center for Applied Microbiology and Biotechnology, indicate that pH 6 antigen is capable of promoting the adhesion
                           of macrophage-like eukaryotic cells to each other and to plastic surfaces, and the formation of cell monolayers. The high-molecular-weight
                           capsular antigen F1 possesses haemagglutinating activity on account of its ability to bind specifically to <span class="sc">d</span>-galactosamine-HCl and glucuronic acid (<a id="xref-ref-12-3" class="xref-bibr" href="#ref-12">Anisimov, 2002b</a>). An analysis of the complete genome of <em>Y. pestis</em> has revealed the presence of eight more gene clusters similar to the operons <em>psa</em> and <em>caf1</em>, each of which is potentially capable of promoting the expression of the pilus adhesins (<a id="xref-ref-117-2" class="xref-bibr" href="#ref-117">Parkhill <em>et al.</em>, 2001</a>). Transfer of the <em>pla</em> locus, which encodes the production of the plasminogen activator Pla, to <em>E. coli</em> cells imparted adhesive activity to the latter with respect to a number of eukaryotic cells (<a id="xref-ref-79-2" class="xref-bibr" href="#ref-79">Kienle <em>et al.</em>, 1992</a>), on account of the ability of Pla to bind to the mammalian extracellular matrix (<a id="xref-ref-85-1" class="xref-bibr" href="#ref-85">Lähteenmäki <em>et al.</em>, 1998</a>). <em>Y. pestis</em> S-layer protein at a concentration of 8–16 μg ml<sup>−1</sup> agglutinated rabbit erythrocytes; this agglutination was inhibited by 0.1 M sugars: rhamnose (fourfold) and dulcitol (eightfold)
                           (<a id="xref-ref-45-1" class="xref-bibr" href="#ref-45">Diatlov &amp; Antonova, 1999</a>). Until recently it was customarily considered that the plague pathogen had lost the ability to synthesize adhesin/invasin
                           Ail on account of the insertion of IS<em>285</em> (<a id="xref-ref-27-1" class="xref-bibr" href="#ref-27">Brubaker, 2004</a>); however, in the genome of the <em>Y. pestis</em> virulent strain CO92, this gene is intact (<a id="xref-ref-117-3" class="xref-bibr" href="#ref-117">Parkhill <em>et al.</em>, 2001</a>). More recently, the <em>Y. pestis</em> genome has been shown to possess two homologues to the <em>Erwinia</em> HecA adhesin (<a id="xref-ref-129-1" class="xref-bibr" href="#ref-129">Rojas <em>et al.</em>, 2002</a>). <em>Y. pestis</em> lipopolysaccharide is also reported to be an adhesin (<a id="xref-ref-143-1" class="xref-bibr" href="#ref-143">Straley, 1993</a>).
                        </p>
                        <p id="p-34"><em>Y. pestis</em>, as a species associated with pneumonic infections, adheres more efficiently to an alveolar epithelial A549 cell line than
                           enteric bacteria, including enteric yersiniae. The plague pathogen demonstrates a restricted tropism for oligosaccharides
                           compared with environmental and opportunistic bacteria. It has been shown that the compound with the greatest anti-adhesion
                           activity toward A549 cells is <em>p</em>-nitrophenol (<a id="xref-ref-150-1" class="xref-bibr" href="#ref-150">Thomas &amp; Brooks, 2004</a>). As an alternative to antibiotics, the inhibition of attachment can be mediated through the use of oligosaccharide receptor
                           mimics. In a more recent report, <a id="xref-ref-151-1" class="xref-bibr" href="#ref-151">Thomas &amp; Brooks (2006)</a> have demonstrated that the attachment of <em>Y. pestis</em> strain GB to the murine monocyte cell line J774A.1 and a range of human respiratory epithelial cell lines is reduced by 55–65 %
                           after pre-treatment of the cell lines with tunicamycin (an inhibitor of the biosynthesis and processing of <em>N</em>-linked oligosaccharides, produced by <em>Streptomyces lysosuperificus</em>). This further demonstrates the potential of oligosaccharides as anti-adhesion therapeutics. Other generic attachment inhibitors
                           include polymeric saccharides (dextran and heparin), GalNAc<em>β</em>1-4Gal, GalNAc<em>β</em>1-3Gal, Gal<em>β</em>1-4GlcNAc and Gal<em>β</em>1-3GlcNAc (<a id="xref-ref-150-2" class="xref-bibr" href="#ref-150">Thomas &amp; Brooks, 2004</a>). It is possible that mixtures of such compounds may serve as a novel class of therapeutics for respiratory tract infections,
                           including pneumonic plague.
                        </p>
                        <p id="p-35">The Ysc-Yop-‘type III’ weaponry delivering effector proteins into the cytosol of the eukaryotic target cell seems to be the
                           main pathogenicity factor of <em>Yersinia</em>. Inhibitors specifically targeting type III secretion are attracting attention (<a id="xref-ref-38-1" class="xref-bibr" href="#ref-38">Chen <em>et al.</em>, 2003</a>; <a id="xref-ref-87-2" class="xref-bibr" href="#ref-87">K. Lee <em>et al.</em>; 2003</a>, <a id="xref-ref-89-1" class="xref-bibr" href="#ref-89">2005</a>; <a id="xref-ref-76-1" class="xref-bibr" href="#ref-76">Kauppi <em>et al.</em>, 2003a</a>,<a id="xref-ref-77-1" class="xref-bibr" href="#ref-77">b</a>; <a id="xref-ref-114-1" class="xref-bibr" href="#ref-114">Nordfelth <em>et al.</em>, 2005</a>; <a id="xref-ref-167-1" class="xref-bibr" href="#ref-167">Xie <em>et al.</em>, 2004</a>). The majority of them target YopH, protein tyrosine phosphatase (<a id="xref-ref-38-2" class="xref-bibr" href="#ref-38">Chen <em>et al.</em>, 2003</a>; <a id="xref-ref-87-3" class="xref-bibr" href="#ref-87">K. Lee <em>et al.</em>, 2003</a>, <a id="xref-ref-89-2" class="xref-bibr" href="#ref-89">2005</a>; <a id="xref-ref-167-2" class="xref-bibr" href="#ref-167">Xie <em>et al.</em>, 2004</a>) or YopE, a GTPase-activating protein (<a id="xref-ref-77-2" class="xref-bibr" href="#ref-77">Kauppi <em>et al.</em>, 2003b</a>). Among such inhibitors are compounds that belong to a class of acylated hydrazones of different salicylaldehydes (<a id="xref-ref-114-2" class="xref-bibr" href="#ref-114">Nordfelth <em>et al.</em>, 2005</a>), monoanionic squaric acids (<a id="xref-ref-167-3" class="xref-bibr" href="#ref-167">Xie <em>et al.</em>, 2004</a>), peptidic <em>α</em>-ketocarboxylic acids, and sulfonamides (<a id="xref-ref-38-3" class="xref-bibr" href="#ref-38">Chen <em>et al.</em>, 2003</a>). A eukaryotic cell model that mimics <em>in vivo</em> conditions has shown that some of the inhibitors attenuate the pathogen to the advantage of the host cell.
                        </p>
                        <p id="p-36">Iron is a necessary nutrient for all pro- and eukaryotic cells, and at physiological pH values, iron salts (Fe<sup>3+</sup>) form an almost-insoluble ferric hydroxide, Fe(OH)<sub>3</sub>. To assimilate the negligible portion of the iron that is still present in the dissolved state, both in the mammalian organism
                           and in micro-organisms, special iron-binding molecules, siderophores, are synthesized. Bacterial siderophores have a critical
                           role in the competition between parasite and host for iron acquisition (<a id="xref-ref-23-1" class="xref-bibr" href="#ref-23">Braun, 2001</a>; <a id="xref-ref-54-3" class="xref-bibr" href="#ref-54">Finlay &amp; Falkow, 1997</a>). Therefore, the <em>Y. pestis</em> siderophore yersiniabactin, as well as its receptor Psn (<a id="xref-ref-119-6" class="xref-bibr" href="#ref-119">Perry &amp; Fetherston, 1997</a>), are promising targets for the development of new antimicrobial inhibitors to treat plague. An inhibitor of the domain salicylation
                           enzymes required for siderophore biosynthesis in <em>Y. pestis</em>, the arylic acyl adenylate analogue 5′-<em>O</em>-[<em>N</em>-(salicyl)-sulfamoyl] adenosine, has recently been designed, synthesized, and shown to inhibit yersiniabactin biosynthesis
                           and the growth of <em>Y. pestis</em> under iron-limiting conditions (<a id="xref-ref-51-1" class="xref-bibr" href="#ref-51">Ferreras <em>et al.</em>, 2005</a>). More recently, a set of newly synthesized aryl sulfamoyl adenosine derivatives has also been shown to inhibit yersiniabactin
                           biosynthesis <em>in vitro</em> (<a id="xref-ref-102-1" class="xref-bibr" href="#ref-102">Miethke <em>et al.</em>, 2006</a>).
                        </p>
                        <p id="p-37">Other possible targets for inhibiting <em>Y. pestis</em> virulence are quorum sensing (<a id="xref-ref-144-1" class="xref-bibr" href="#ref-144">Suga &amp; Smith, 2003</a>), the two-component regulatory systems (<a id="xref-ref-116-1" class="xref-bibr" href="#ref-116">Oyston <em>et al.</em>, 2000</a>; <a id="xref-ref-162-1" class="xref-bibr" href="#ref-162">Winfield <em>et al.</em>, 2005</a>) that govern virulence, and/or the enzymes for the biosynthesis of the LPS that is believed to determine antimicrobial-cationic-peptide
                           (<a id="xref-ref-14-1" class="xref-bibr" href="#ref-14">Anisimov <em>et al.</em>, 2005</a>; <a id="xref-ref-17-1" class="xref-bibr" href="#ref-17">Bengoechea <em>et al.</em>, 1998</a>) and serum resistance (<a id="xref-ref-14-2" class="xref-bibr" href="#ref-14">Anisimov <em>et al.</em>, 2005</a>; <a id="xref-ref-122-1" class="xref-bibr" href="#ref-122">Porat <em>et al.</em>, 1995</a>).
                        </p>
                     </div>
                     <div id="sec-17" class="subsection">
                        <h4>Symptomatic treatment</h4>
                        <p id="p-38">Severe cases of plague are characterized by shock and extensive diffuse intravascular coagulation (DIC), two interrelated
                           processes that have common causal mechanisms and reinforce each other (<a id="xref-ref-65-1" class="xref-bibr" href="#ref-65">Hardaway, 1982</a>). The standard treatment of the pathophysiological changes accompanying endotoxic shock and DIC consists of administration
                           of fluid and vasopressors to restore blood pressure and organ blood flow, and oxygenation (<a id="xref-ref-39-1" class="xref-bibr" href="#ref-39">Cohen &amp; Glauser, 1991</a>; <a id="xref-ref-110-9" class="xref-bibr" href="#ref-110">Naumov &amp; Samoilova, 1992</a>; <a id="xref-ref-124-1" class="xref-bibr" href="#ref-124">Rackow &amp; Astiz, 1991</a>; <a id="xref-ref-159-1" class="xref-bibr" href="#ref-159">Wheeler &amp; Bernard, 1999</a>).
                        </p>
                        <p id="p-39">Very important to the management of shock is early fluid resuscitation and the immediate start of mechanical ventilation (<a id="xref-ref-33-1" class="xref-bibr" href="#ref-33">Carcillo <em>et al.</em>, 1991</a>). In addition to extensive capillary leakage, severe plague cases are characterized by severe cardiac depression (<a id="xref-ref-3-4" class="xref-bibr" href="#ref-3">Albizo &amp; Surgalla, 1970</a>; <a id="xref-ref-31-11" class="xref-bibr" href="#ref-31">Butler, 1983</a>; <a id="xref-ref-43-9" class="xref-bibr" href="#ref-43">Dennis <em>et al.</em>, 1999</a>; <a id="xref-ref-46-6" class="xref-bibr" href="#ref-46">Dmitrovskii, 1994</a>; <a id="xref-ref-92-13" class="xref-bibr" href="#ref-92">Lien-Teh <em>et al.</em>, 1936</a>; <a id="xref-ref-110-10" class="xref-bibr" href="#ref-110">Naumov &amp; Samoilova, 1992</a>; <a id="xref-ref-113-9" class="xref-bibr" href="#ref-113">Nikolaev, 1972</a>; <a id="xref-ref-121-10" class="xref-bibr" href="#ref-121">Pollitzer, 1954</a>; <a id="xref-ref-130-13" class="xref-bibr" href="#ref-130">Rudnev, 1940</a>; <a id="xref-ref-154-4" class="xref-bibr" href="#ref-154">Van Amersfoort <em>et al.</em>, 2003</a>). Consequently, pulmonary congestion may develop early, and this limits the amount of fluid that can be administered. In
                           general, inotropic and vasopressive support is needed from an early stage. Dobutamine is preferred for its beneficial effects
                           on cardiac function and peripheral oxygenation (<a id="xref-ref-156-1" class="xref-bibr" href="#ref-156">Vincent <em>et al.</em>, 1990</a>; <a id="xref-ref-163-1" class="xref-bibr" href="#ref-163">Winslow <em>et al.</em>, 1973</a>). As for the anti-DIC therapy, currently the only undoubtedly successful treatment is anti-shock therapy. Bleeding due to
                           DIC should probably be treated with replacement therapy: platelets for thrombocytopenia, cryoprecipitate for hypofibrinogenaemia
                           and fresh frozen plasma for decreased coagulation factors (<a id="xref-ref-74-1" class="xref-bibr" href="#ref-74">Jacobson &amp; Young, 1986</a>). DIC may cause severe distal necrosis (<a id="xref-ref-158-1" class="xref-bibr" href="#ref-158">Welty <em>et al.</em>, 1985</a>), and if gangrene has completely demarcated then plastic surgery or amputation may be needed (<a id="xref-ref-83-2" class="xref-bibr" href="#ref-83">Kuberski <em>et al.</em>, 2003</a>). In the case of evolving gangrene, in a patient with good peripheral blood supply and no bleeding diathesis, sympathetic
                           blockade to preserve peripheral feet tissues has been shown to be successful (<a id="xref-ref-83-3" class="xref-bibr" href="#ref-83">Kuberski <em>et al.</em>, 2003</a>).
                        </p>
                     </div>
                  </div>
                  <div id="sec-18" class="subsection">
                     <h3>Concluding remarks</h3>
                     <p id="p-40">The treatment dynamics of plague are of critical interest because of the high human mortality rate of the disease, and current
                        threat for use in bioterrorism. Even though antibiotics such as ciprofloxacin, doxycycline and the newer fluoroquinolones
                        have shown an increase in survival in mice presenting with pneumonic plague, there has recently been a worrying increase in
                        multidrug-resistant <em>Y. pestis</em> strains. This has necessitated the need to look at alternatives to antibiotics as treatment regimens for plague. This review
                        has highlighted some of the promising non-antibiotic therapeutic strategies that can be explored further. Thus, a novel treatment
                        mechanism of pneumonic plague infection may be via inhibiting adhesion of <em>Y. pestis</em> to the respiratory tract. Recent progress in the use of short-chain oligosaccharides as potential anti-adhesion therapeutics,
                        and also a set of newly synthesized aryl sulfamoyl adenosine derivatives as inhibitors of yersiniabactin biosynthesis, make
                        these receptor mimics potential alternatives to antibiotici-adhesion therapeutics,
                        and also a set of newly synthesized aryl sulfamoyl adenosine derivatives as inhibitors of yersiniabactin biosynthesis, ms. Although hopes remain high that these alternative strategies
                        of plague treatment, alone or as part of combination therapies, will provide a valuable new line of defence against multdrug-resistant
                        <em>Y. pestis</em> strains, they remain a long way from clinical practice. The alternative therapies reported in this review should be investigated
                        by comprehensive studies of their clinical applications as a form of preparedness against any possible bioterrorist attack
                        involving the use of antibiotic-resistant <em>Y. pestis</em>.
                     </p>
                  </div>
               </div>
               <div class="section ack" id="ack-1">
                  <div class="section-nav"><a href="#abstract-1" title="Abstract" class="prev-section-link"><span>Previous Section</span></a><a href="#ref-list-1" title="References" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Acknowledgments</h2>
                  <p id="p-41">This work was partially funded by US Civilian Research and Development Foundation (CRDF) grant RBO-11012-MO-01 (DOE/LAB agreement
                     325786-A-K6) and by the International Science and Technology Center (ISTC) grant 2927.
                  </p>
               </div>
               <div class="section ref-list" id="ref-list-1">
                  <div class="section-nav"><a href="#ack-1" title="Acknowledgments" class="prev-section-link"><span>Previous Section</span></a><div class="nav-placeholder"> </div>
                  </div>
                  <h2>References</h2>
                  <ol class="cit-list ref-use-labels">
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference in text"
                           id="ref-1">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.1"
                             data-doi="10.1073/pnas.96.24.14043">
                           <div class="cit-metadata"><cite><strong>Achtman, M., Zurth, K., Morelli, G., Torrea, G., Guiyoule, A. &amp; Carniel, E.</strong> <strong>(</strong><span class="cit-pub-date">1999</span><strong>).</strong> <em>Yersinia pestis</em>, the cause of plague, is a recently emerged clone of <em>Yersinia pseudotuberculosis</em>. <span class="cit-source">Proc Natl Acad Sci U S A</span> <span class="cit-vol">96</span>, <span class="cit-fpage">14043</span>–14048.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=96/24/14043"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference in text"
                           id="ref-2">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.2">
                           <div class="cit-metadata"><cite><strong>Afanas'ev, M. I. &amp; Vaks, P. B.</strong> <strong>(</strong><span class="cit-pub-date">1903</span><strong>).</strong> <em>Human Plague</em>. St Petersburg, Russia: Modern Medicine and Hygiene Press (in Russian).</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference in text"
                           id="ref-3">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.3">
                           <div class="cit-metadata"><cite><strong>Albizo, J. M. &amp; Surgalla, M. J.</strong> <strong>(</strong><span class="cit-pub-date">1970</span><strong>).</strong> Isolation and biological characterization of <em>Pasteurella pestis</em> endotoxin. <span class="cit-source">Infect Immun</span> <span class="cit-vol">2</span>, <span class="cit-fpage">229</span>–236.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=iai&amp;resid=2/3/229"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference in text"
                           id="ref-4">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.4"
                             data-doi="10.1517/13543784.11.8.1149">
                           <div class="cit-metadata"><cite><strong>Alksne, L. E.</strong> <strong>(</strong><span class="cit-pub-date">2002</span><strong>).</strong> Virulence as a target for antimicrobial chemotherapy. <span class="cit-source">Expert Opin Investig Drugs</span> <span class="cit-vol">11</span>, <span class="cit-fpage">1149</span>–1159.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1517/13543784.11.8.1149&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12150708&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference in text"
                           id="ref-5">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.5"
                             data-doi="10.1378/chest.124.2.740">
                           <div class="cit-metadata"><cite><strong>Almog, Y.</strong> <strong>(</strong><span class="cit-pub-date">2003</span><strong>).</strong> Statins, inflammation, and sepsis: hypothesis. <span class="cit-source">Chest</span> <span class="cit-vol">124</span>, <span class="cit-fpage">740</span>–743.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1378/chest.124.2.740&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12907568&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference in text"
                           id="ref-6">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.6"
                             data-doi="10.1161/01.CIR.0000138932.17956.F1">
                           <div class="cit-metadata"><cite><strong>Almog, Y., Shefer, A., Novack, V., Maimon, N., Barski, L., Eizinger, M., Friger, M., Zeller, L. &amp; Danon, A.</strong> <strong>(</strong><span class="cit-pub-date">2004</span><strong>).</strong> Prior statin therapy is associated with a decreased rate of severe sepsis. <span class="cit-source">Circulation</span> <span class="cit-vol">110</span>, <span class="cit-fpage">880</span>–885.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=circulationaha&amp;resid=110/7/880"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference in text"
                           id="ref-7">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.7"
                             data-doi="10.1016/j.jaci.2005.08.048">
                           <div class="cit-metadata"><cite><strong>Amlie-Lefond, C., Paz, D. A., Connelly, M. P., Huffnagle, G. B., Dunn, K. S., Whelan, N. T. &amp; Whelan, H. T.</strong> <strong>(</strong><span class="cit-pub-date">2005</span><strong>).</strong> Innate immunity for biodefense: a strategy whose time has come. <span class="cit-source">J Allergy Clin Immunol</span> <span class="cit-vol">116</span>, <span class="cit-fpage">1334</span>–1342.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.jaci.2005.08.048&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=16337468&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference in text"
                           id="ref-8">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.8">
                           <div class="cit-metadata"><cite><strong>Anderson, G. W., Worsham, P. L., Bolt, C., Andrews, G. P., Welkos, S., Friedlander, A. M. &amp; Burans, J. P.</strong> <strong>(</strong><span class="cit-pub-date">1997</span><strong>).</strong> Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the
                                 F1 protein of <em>Yersinia pestis</em>. <span class="cit-source">Am J Trop Med</span> <span class="cit-vol">56</span>, <span class="cit-fpage">471</span>–473.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=tropmed&amp;resid=56/4/471"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="s="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"><#xref-ref-9-1" title="View reference in text"
                           id="ref-9">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.9">
                           <div class="cit-metadata"><cite><strong>Ando, H., Takamura, T., Ota, T., Nagai, Y. &amp; Kobayashi, K.</strong> <strong>(</strong><span class="cit-pub-date">2000</span><strong>).</strong> Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis. <span class="cit-source">J Pharmacol Exp Ther</span> <span class="cit-vol">294</span>, <span class="cit-fpage">1043</span>–1046.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jpet&amp;resid=294/3/1043"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference in text"
                           id="ref-10">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.10">
                           <div class="cit-metadata"><cite><strong>Andrews, G. P., Strachan, S. T., Benner, G. E., Sample, A. K., Anderson, G. W., Jr, Adamovicz, J. J., Welkos, S. L., Pullen,
                                    J. K. &amp; Friedlander, A. M.</strong> <strong>(</strong><span class="cit-pub-date">1999</span><strong>).</strong> Protective efficacy of recombinant <em>Yersinia</em> outer proteins against bubonic plague caused by encapsulated and nonencapsulated <em>Yersinia pestis</em>. <span class="cit-source">Infect Immun</span> <span class="cit-vol">67</span>, <span class="cit-fpage">1533</span>–1537.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=iai&amp;resid=67/3/1533"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference in text"
                           id="ref-11">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.11">
                           <div class="cit-metadata"><cite><strong>Anisimov, A. P.</strong> <strong>(</strong><span class="cit-pub-date">2002a</span><strong>).</strong> Factors of <em>Yersinia pestis</em> proving circulation and persistence of plague pathogen in ecosystems of natural foci. Communication 2. <span class="cit-source">Mol Gen Mikrobiol Virusol</span> <span class="cit-vol">4</span>, <span class="cit-fpage">3</span>–11 (in Russian).</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=12534263&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference in text"
                           id="ref-12">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.12">
                           <div class="cit-metadata"><cite><strong>Anisimov, A. P.</strong> <strong>(</strong><span class="cit-pub-date">2002b</span><strong>).</strong> <em>Yersinia pestis</em> factors, assuring circulation and maintenance of the plague pathogen in natural foci ecosystems. Report 1. <span class="cit-source">Mol Gen Mikrobiol Virusol</span> <span class="cit-vol">3</span>, <span class="cit-fpage">3</span>–23 (in Russian).</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=12243063&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference in text"
                           id="ref-13">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.13"
                             data-doi="10.1128/CMR.17.2.434-464.2004">
                           <div class="cit-metadata"><cite><strong>Anisimov, A. P., Lindler, L. E. &amp; Pier, G. B.</strong> <strong>(</strong><span class="cit-pub-date">2004</span><strong>).</strong> Intraspecific diversity of <em>Yersinia pestis</em>. <span class="cit-source">Clin Microbiol Rev</span> <span class="cit-vol">17</span>, <span class="cit-fpage">434</span>–464 (erratum <strong>17</strong>, 695).</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=cmr&amp;resid=17/2/434"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference in text"
                           id="ref-14">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.14"
                             data-doi="10.1128/IAI.73.11.7324-7331.2005">
                           <div class="cit-metadata"><cite><strong>Anisimov, A. P., Dentovskaya, S. V., Titareva, G. M. &amp; 9 other authors</strong> <strong>(</strong><span class="cit-pub-date">2005</span><strong>).</strong> Intraspecies and temperature-dependent variations in susceptibility of <em>Yersinia pestis</em> to bactericidal action of serum and polymyxin B. <span class="cit-source">Infect Immun</span> <span class="cit-vol">73</span>, <span class="cit-fpage">7324</span>–7331.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=iai&amp;resid=73/11/7324"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference in text"
                           id="ref-15">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.15">
                           <div class="cit-metadata"><cite><strong>Aparin, G. P. &amp; Golubinskii, E. P.</strong> <strong>(</strong><span class="cit-pub-date">1989</span><strong>).</strong> <em>Plague Microbiology Manual</em>. Irkutsk, USSR: Irkutsk State University (in Russian).</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference in text"
                           id="ref-16">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.16">
                           <div class="cit-metadata"><cite><strong>Becker, T. M., Poland, J. D., Quan, T. J., White, M. E., Mann, J. M. &amp; Barnes, A. M.</strong> <strong>(</strong><span class="cit-pub-date">1987</span><strong>).</strong> Plague meningitis – a retrospective analysis of cases reported in the United States, 1970–1979. <span class="cit-source">West J Med</span> <span class="cit-vol">147</span>, <span class="cit-fpage">554</span>–557.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=3424819&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference in text"
                           id="ref-17">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.17"
                             data-doi="10.1099/00221287-144-6-1509">
                           <div class="cit-metadata"><cite><strong>Bengoechea, J.-A., Lindner, B., Seydel, U., Díaz, R. &amp; Moriyón, I.</strong> <strong>(</strong><span class="cit-pub-date">1998</span><strong>).</strong> <em>Yersinia pseudotuberculosis</em> and <em>Yersinia pestis</em> are more resistant to bactericidal cationic peptides than <em>Yersinia enterocolitica</em>. <span class="cit-source">Microbiology</span> <span class="cit-vol">144</span>, <span class="cit-fpage">1509</span>–1515.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=mic&amp;resid=144/6/1509"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference in text"
                           id="ref-18">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.18"
                             data-doi="10.1016/0923-2508(91)90187-F">
                           <div class="cit-metadata"><cite><strong>Berchieri, A. J., Lovell, M. A. &amp; Barrow, P. A.</strong> <strong>(</strong><span class="cit-pub-date">1991</span><strong>).</strong> The activity in the chicken alimentary tract of bacteriophages lytic for <em>Salmonella typhimurium</em>. <span class="cit-source">Res Microbiol</span> <span class="cit-vol">142</span>, <span class="cit-fpage">541</span>–549.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/0923-2508(91)90187-F&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=1947426&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference in text"
                           id="ref-19">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.19">
                           <div class="cit-metadata"><cite><strong>Bichowsky-Slomnicki, L. &amp; Ben-Efraim, S.</strong> <strong>(</strong><span class="cit-pub-date">1963</span><strong>).</strong> Biological activities in extracts of <em>Pasteurella pestis</em> and their relation to the ‘pH 6 antigen’. <span class="cit-source">J Bacteriol</span> <span class="cit-vol">86</span>, <span class="cit-fpage">101</span>–111.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jb&amp;resid=86/1/101"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference in text"
                           id="ref-20">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.20">
                           <div class="cit-metadata"><cite><strong>Blinkova, L. P., Butova, L. G., Sergeev, V. V., Elkina, S. I., Al'tshuler, M. L. &amp; Kalina, N. G.</strong> <strong>(</strong><span class="cit-pub-date">2003</span><strong>).</strong> Effectiveness of the oral administration of tomicide in experimental infection. <span class="cit-source">Zh Mikrobiol Epidemiol Immunobiol</span> <span class="cit-vol">1</span>, <span class="cit-fpage">74</span>–77 (in Russian).</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=12630361&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference in text"
                           id="ref-21">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.21"
                             data-doi="10.4049/jimmunol.175.10.6750">
                           <div class="cit-metadata"><cite><strong>Bosio, C. M., Goodyear, A. W. &amp; Dow, S. W.</strong> <strong>(</strong><span class="cit-pub-date">2005</span><strong>).</strong> Early interaction of <em>Yersinia pestis</em> with APCs in the lung. <span class="cit-source">J Immunol</span> <span class="cit-vol">175</span>, <span class="cit-fpage">6750</span>–6756.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jimmunol&amp;resid=175/10/6750"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference in text"
                           id="ref-22">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.22">
                           <div class="cit-metadata"><cite><strong>Braude, A. I. &amp; Siemienski, J. S.</strong> <strong>(</strong><span class="cit-pub-date">1965</span><strong>).</strong> The influence of bacteriocins on resistance to infection by Gram-negative bacteria. I. The effect of colicin on bactericidal
                                 power of blood. <span class="cit-source">J Clin Invest</span> <span class="cit-vol">44</span>, <span class="cit-fpage">849</span>–859.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=14276142&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-23-1" title="View reference in text"
                           id="ref-23">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.23"
                             data-doi="10.1078/1438-4221-00103">
                           <div class="cit-metadata"><cite><strong>Braun, V.</strong> <strong>(</strong><span class="cit-pub-date">2001</span><strong>).</strong> Iron uptake mechanisms and their regulation in pathogenic bacteria. <span class="cit-source">Int J Med Microbiol</span> <span class="cit-vol">291</span>, <span class="cit-fpage">67</span>–79.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1078/1438-4221-00103&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=11437341&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference in text"
                           id="ref-24">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.24"
                             data-doi="10.1517/14712598.4.3.387">
                           <div class="cit-metadata"><cite><strong>Bregenholt, S. &amp; Haurum, J.</strong> <strong>(</strong><span class="cit-pub-date">2004</span><strong>).</strong> Pathogen-specific recombinant human polyclonal antibodies: biodefence applications. <span class="cit-source">Expert Opin Biol Ther</span> <span class="cit-vol">4</span>, <span class="cit-fpage">387</span>–396.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1517/14712598.4.3.387&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=15006732&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-25-1" title="View reference in text"
                           id="ref-25">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.25">
                           <div class="cit-metadata"><cite><strong>Briko, N. I. &amp; Zhuravlev, M. V.</strong> <strong>(</strong><span class="cit-pub-date">2004</span><strong>).</strong> Use of tomicid in prophylaxis of respiratory streptococcal infection in the organized groups of children of pre-school age.
                                 <span class="cit-source">Zh Mikrobiol Epidemiol Immunobiol</span> <span class="cit-vol">4</span>, <span class="cit-fpage">17</span>–20 (in Russian).</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=15481913&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-26-1" title="View reference in text"
                           id="ref-26">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.26">
                           <div class="cit-metadata"><cite><strong>Brubaker, R. R.</strong> <strong>(</strong><span class="cit-pub-date">1991</span><strong>).</strong> Factors promoting acute and chronic disease caused by yersiniae. <span class="cit-source">Clin Microbiol Rev</span> <span class="cit-vol">4</span>, <span class="cit-fpage">309</span>–324.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=cmr&amp;resid=4/3/309"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-27-1" title="View reference in text"
                           id="ref-27">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.27">
                           <div class="cit-metadata"><cite><strong>Brubaker, R. R.</strong> <strong>(</strong><span class="cit-pub-date">2004</span><strong>).</strong> The recent emergence of plague: a process of felonious evolution. <span class="cit-source">Microb Ecol</span> <span class="cit-vol">47</span>, <span class="cit-fpage">293</span>–299.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=15037962&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-28-1" title="View reference in text"
                           id="ref-28">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.28"
                             data-doi="10.1126/science.149.3682.422">
                           <div class="cit-metadata"><cite><strong>Brubaker, R. R., Beesley, E. D. &amp; Surgalla, M. J.</strong> <strong>(</strong><span class="cit-pub-date">1965</span><strong>).</strong> <em>Pasteurella pestis</em>: role of pesticin I and iron in experimental plague. <span class="cit-source">Science</span> <span class="cit-vol">149</span>, <span class="cit-fpage">422</span>–424.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=149/3682/422"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-29-1" title="View reference in text"
                           id="ref-29">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.29"
                             data-doi="10.2174/1381612033455189">
                           <div class="cit-metadata"><cite><strong>Buchwald, U. K. &amp; Pirofski, L.</strong> <strong>(</strong><span class="cit-pub-date">2003</span><strong>).</strong> Immune therapy for infectious diseases at the dawn of the 21st century: the past, present and future role of antibody therapy,
                                 therapeutic vaccination and biological response modifiers. <span class="cit-source">Curr Pharm Des</span> <span class="cit-vol">9</span>, <span class="cit-fpage">945</span>–968.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.2174/1381612033455189&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12678861&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-30-1" title="View reference in text"
                           id="ref-30">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.30">
                           <div class="cit-metadata"><cite><strong>Burrows, T. W.</strong> <strong>(</strong><span class="cit-pub-date">1965</span><strong>).</strong> A possible role for pesticin in virulence of <em>Pasteurella pestis</em>. <span class="cit-source">Zentbl Bakteriol Parasitenkd Infektkr Hyg Abt 1 Orig Reihe A</span> <span class="cit-vol">196</span>, <span class="cit-fpage">315</span>–317.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-31-1" title="View reference in text"
                           id="ref-31">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.31">
                           <div class="cit-metadata"><cite><strong>Butler, T.</strong> <strong>(</strong><span class="cit-pub-date">1983</span><strong>).</strong> <em>Plague and Other Yersinia Infections</em>. New York: Plenum.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-32-1" title="View reference in text"
                           id="ref-32">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.32"
                             data-doi="10.1093/jac/42.5.675">
                           <div class="cit-metadata"><cite><strong>Byrne, W. R., Welkos, S. L., Pitt, M. L. &amp; 7 other authors</strong> <strong>(</strong><span class="cit-pub-date">1998</span><strong>).</strong> Antibiotic treatment of experimental pneumonic plague in mice. <span class="cit-source">Antimicrob Agents Chemother</span> <span class="cit-vol">42</span>, <span class="cit-fpage">675</span>–681.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=aac&amp;resid=42/3/675"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-33-1" title="View reference in text"
                           id="ref-33">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.33"
                             data-doi="10.1001/jama.1991.03470090076035">
                           <div class="cit-metadata"><cite><strong>Carcillo, J. A., Davis, A. L. &amp; Zaritsky, A.</strong> <strong>(</strong><span class="cit-pub-date">1991</span><strong>).</strong> Role of early fluid resuscitation in pediatric septic shock. <span class="cit-source">JAMA (J Am Med Assoc)</span> <span class="cit-vol">266</span>, <span class="cit-fpage">1242</span>–1245.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1001/jama.1991.03470090076035&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=1870250&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-34-1" title="View reference in text"
                           id="ref-34">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.34">
                           <div class="cit-metadata"><cite><strong>Carman, J. A.</strong> <strong>(</strong><span class="cit-pub-date">1938</span><strong>).</strong> Prontosil in the treatment of oriental plague. <span class="cit-source">East Afr Med J</span> <span class="cit-vol">14</span>, <span class="cit-fpage">362</span>–366.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-35-1" title="View reference in text"
                           id="ref-35">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.35"
                             data-doi="10.3201/eid0808.010516">
                           <div class="cit-metadata"><cite><strong>Casadevall, A.</strong> <strong>(</strong><span class="cit-pub-date">2002</span><strong>).</strong> Passive antibody administration (immediate immunity) as a specific defense against biological weapons. <span class="cit-source">Emerg Infect Dis</span> <span class="cit-vol">8</span>, <span class="cit-fpage">833</span>–841.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.3201/eid0808.010516&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12141970&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-36-1" title="View reference in text"
                           id="ref-36">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.36">
                           <div class="cit-metadata"><cite><strong>Casadevall, A.</strong> <strong>(</strong><span class="cit-pub-date">2005</span><strong>).</strong> Antibody-based defense strategies against biological weapons. <span class="cit-source">ASM News</span> <span class="cit-vol">71</span>, <span class="cit-fpage">28</span>–33.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-37-1" title="View reference in text"
                           id="ref-37">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.37">
                           <div class="cit-metadata"><cite><strong>Cavanaugh, D. C. &amp; Randall, R.</strong> <strong>(</strong><span class="cit-pub-date">1959</span><strong>).</strong> The role of multiplication of <em>Pasteurella pestis</em> in mononuclear phagocytes in the pathogenesis of fleaborne plague. <span class="cit-source">J Immunol</span> <span class="cit-vol">83</span>, <span class="cit-fpage">348</span>–363.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jimmunol&amp;resid=83/4/348"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-38-1" title="View reference in text"
                           id="ref-38">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.38">
                           <div class="cit-metadata"><cite><strong>Chen, Y. T., Xie, J. &amp; Seto, C. T.</strong> <strong>(</strong><span class="cit-pub-date">2003</span><strong>).</strong> Peptidic <em>α</em>-ketocarboxylic acids and sulphonamides as inhibitors of protein tyrosine phosphatases. <span class="cit-source">J Org Chem</span> <span class="cit-vol">68</span>, <span class="cit-fpage">4123</span>–4125.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=12737607&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-39-1" title="View reference in text"
                           id="ref-39">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.39"
                             data-doi="10.1016/0140-6736(91)91453-2">
                           <div class="cit-metadata"><cite><strong>Cohen, J. &amp; Glauser, M. P.</strong> <strong>(</strong><span class="cit-pub-date">1991</span><strong>).</strong> Septic shock: treatment. <span class="cit-source">Lancet</span> <span class="cit-vol">338</span>, <span class="cit-fpage">736</span>–739.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/0140-6736(91)91453-2&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=1679877&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-40-1" title="View reference in text"
                           id="ref-40">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.40"
                             data-doi="10.1083/jcb.200205077">
                           <div class="cit-metadata"><cite><strong>Cornelis, G. R.</strong> <strong>(</strong><span class="cit-pub-date">2002</span><strong>).</strong> <em>Yersinia</em> type III secretion: send in the effectors. <span class="cit-source">J Cell Biol</span> <span class="cit-vol">158</span>, <span class="cit-fpage">401</span>–408.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jcb&amp;resid=158/3/401"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-41-1" title="View reference in text"
                           id="ref-41">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.41"
                             data-doi="10.1128/IAI.73.9.6127-6137.2005">
                           <div class="cit-metadata"><cite><strong>Cowan, C., Philipovskiy, A. V., Wulff-Strobel, C. R., Ye, Z. &amp; Straley, S. C.</strong> <strong>(</strong><span class="cit-pub-date">2005</span><strong>).</strong> Anti-LcrV antibody inhibits delivery of Yops by <em>Yersinia pestis</em> KIM5 by directly promoting phagocytosis. <span class="cit-source">Infect Immun</span> <span class="cit-vol">73</span>, <span class="cit-fpage">6127</span>–6137.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=iai&amp;resid=73/9/6127"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-42-1" title="View reference in text"
                           id="ref-42">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.42">
                           <div class="cit-metadata"><cite><strong>Damasko, C., Konietzny, A., Kaspar, H., Appel, B., Dersch, P. &amp; Strauch, E.</strong> <strong>(</strong><span class="cit-pub-date">2005</span><strong>).</strong> Studies of the efficacy of enterocoliticin, a phage-tail like bacteriocin, as antimicrobial agent against <em>Yersinia enterocolitica</em> serotype O3 in a cell culture system and in mice. <span class="cit-source">J Vet Med B Infect Dis Vet Public Health</span> <span class="cit-vol">52</span>, <span class="cit-fpage">171</span>–179.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=16000112&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-43-1" title="View reference in text"
                           id="ref-43">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.43">
                           <div class="cit-metadata"><cite><strong>Dennis, D. T., Gratz, N., Poland, J. D. &amp; Tikhomirov, E.</strong> <strong>(</strong><span class="cit-pub-date">1999</span><strong>).</strong> <em>Plague Manual: Epidemiology, Distribution, Surveillance and Control</em>. Geneva: World Health Organization.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-44-1" title="View reference in text"
                           id="ref-44">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.44">
                           <div class="cit-metadata"><cite><strong>d'Herelle, F.</strong> <strong>(</strong><span class="cit-pub-date">1925</span><strong>).</strong> Essai de traitement de la peste bubonique par le bacteriophage. <span class="cit-source">La Presse Medicale</span> <span class="cit-vol">84</span>, <span class="cit-fpage">1393</span>–1394 (in French).</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-45-1" title="View reference in text"
                           id="ref-45">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.45">
                           <div class="cit-metadata"><cite><strong>Diatlov, I. A. &amp; Antonova, O. A.</strong> <strong>(</strong><span class="cit-pub-date">1999</span><strong>).</strong> The detection and characteristics of the <em>Yersinia pestis</em> antigen exhibiting the properties of S-layer proteins. <span class="cit-source">Zh Mikrobiol Epidemiol Immunobiol</span> <span class="cit-vol">4</span>, <span class="cit-fpage">90</span>–91 (in Russian).</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10852065&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-46-1" title="View reference in text"
                           id="ref-46">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.46">
                           <div class="cit-metadata"><cite><strong>Dmitrovskii, V. G.</strong> <strong>(</strong><span class="cit-pub-date">1994</span><strong>).</strong> Toxic component of pathogenesis of plague infectious process: infective toxic shock. In <em>Prophylaxis and Means of Prevention of Plague</em>, pp. 15–16. Edited by V. M. Stepanov. Almaty, Kazakhstan: Scientific-Manufacturing Association of the Plague-Control Establishments
                                 (in Russian).</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-47-1" title="View reference in text"
                           id="ref-47">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.47">
                           <div class="cit-metadata"><cite><strong>Domaradskii, I. V.</strong> <strong>(</strong><span class="cit-pub-date">1993</span><strong>).</strong> <em>Plague: Contemporary State, Assumptions, Problems</em>. Saratov, Russia: Saratov Medical Institute Press (in Russian).</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-48-1" title="View reference in text"
                           id="ref-48">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.48">
                           <div class="cit-metadata"><cite><strong>Domaradskii, I. V.</strong> <strong>(</strong><span class="cit-pub-date">1998</span><strong>).</strong> <em>Plague</em>. Moscow: Meditsina Press (in Russian).</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-49-1" title="View reference in text"
                           id="ref-49">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.49"
                             data-doi="10.3201/eid1009.030933">
                           <div class="cit-metadata"><cite><strong>Drancourt, M., Roux, V., Dang, L. V. &amp; 7 other authors</strong> <strong>(</strong><span class="cit-pub-date">2004</span><strong>).</strong> Genotyping, Orientalis-like <em>Yersinia pestis</em>, and plague pandemics. <span class="cit-source">Emerg Infect Dis</span> <span class="cit-vol">10</span>, <span class="cit-fpage">1585</span>–1592.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.3201/eid1009.030933&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=15498160&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-50-1           class="cit-" title="View reference in text"
                           id="ref-50">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.50"
                             data-doi="10.1093/infdis/96.2.138">
                           <div class="cit-metadata"><cite><strong>Ehrenkranz, N. F. &amp; Meyer, K. F.</strong> <strong>(</strong><span class="cit-pub-date">1955</span><strong>).</strong> Studies on immunization against plague, VIII: study of three immunizing preparations in protecting primates against pneumonic
                                 plague. <span class="cit-source">J Infect Dis</span> <span class="cit-vol">96</span>, <span class="cit-fpage">138</span>–144.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=PDF&amp;journalCode=jinfdis&amp;resid=96/2/138"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-51-1" title="View reference in text"
                           id="ref-51">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.51"
                             data-doi="10.1038/nchembio706">
                           <div class="cit-metadata"><cite><strong>Ferreras, J. A., Ryu, J. S., Lello, F. D., Tan, D. S. &amp; Quadri, L. E.</strong> <strong>(</strong><span class="cit-pub-date">2005</span><strong>).</strong> Small-molecule inhibition of siderophore biosynthesis in <em>Mycobacterium tuberculosis</em> and <em>Yersinia pestis</em>. <span class="cit-source">Nat Chem Biol</span> <span class="cit-vol">1</span>, <span class="cit-fpage">29</span>–32.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1038/nchembio706&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=16407990&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-52-1" title="View reference in text"
                           id="ref-52">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.52">
                           <div class="cit-metadata"><cite><strong>Filippov, A. A., Elliott, J. M., Bobrov, A. G., Kirillina, O. A., Motin, V. L., Chain, P. S. &amp; Garcia, E.</strong> <strong>(</strong><span class="cit-pub-date">2005</span><strong>).</strong> Description of the genomic nucleotide sequence of the plague diagnostic bacteriophage, L-413C. <span class="cit-source">The Problems of Particularly Dangerous Infections (Saratov)</span> <span class="cit-vol">90</span>, <span class="cit-fpage">49</span>–52 (in Russian).</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-53-1" title="View reference in text"
                           id="ref-53">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.53"
                             data-doi="10.1081/IPH-120016039">
                           <div class="cit-metadata"><cite><strong>Fimiani, V., Cavallaro, A., Ainis, T., Baranovskaia, G., Ketlinskaya, O. &amp; Kozhemyakin, L.</strong> <strong>(</strong><span class="cit-pub-date">2002</span><strong>).</strong> Immunomodulatory effect of glutoxim on some activities of isolated human neutrophils and in whole blood. <span class="cit-source">Immunopharmacol Immunotoxicol</span> <span class="cit-vol">24</span>, <span class="cit-fpage">627</span>–638.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1081/IPH-120016039&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12510794&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-54-1" title="View reference in text"
                           id="ref-54">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.54">
                           <div class="cit-metadata"><cite><strong>Finlay, B. B. &amp; Falkow, S.</strong> <strong>(</strong><span class="cit-pub-date">1997</span><strong>).</strong> Common themes in microbial pathogenicity revisited. <span class="cit-source">Microbiol Mol Biol Rev</span> <span class="cit-vol">61</span>, <span class="cit-fpage">136</span>–169.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=mmbr&amp;resid=61/2/136"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-55-1" title="View reference in text"
                           id="ref-55">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.55">
                           <div class="cit-metadata"><cite><strong>Flu, P. C.</strong> <strong>(</strong><span class="cit-pub-date">1929</span><strong>).</strong> Antipest bakteriophag und die prophylaxe und therapie der experimentellen pest. <span class="cit-source">Zentbl Bakteriol I Orig</span> <span class="cit-vol">113</span>, <span class="cit-fpage">468</span>–473 (in German).</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-56-1" title="View reference in text"
                           id="ref-56">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.56">
                           <div class="cit-metadata"><cite><strong>Fonquernie, I.</strong> <strong>(</strong><span class="cit-pub-date">1932</span><strong>).</strong> Essais de traitement de la peste par le bacteriophage. <span class="cit-source">Bull Sol Pathol Exot</span> <span class="cit-vol">25</span>, <span class="cit-fpage">677</span> (in French).</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-57-1" title="View reference in text"
                           id="ref-57">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.57"
                             data-doi="10.1093/jac/dkg363">
                           <div class="cit-metadata"><cite><strong>Frean, J., Klugman, K. P., Arntzen, L. &amp; Bukofzer, S.</strong> <strong>(</strong><span class="cit-pub-date">2003</span><strong>).</strong> Susceptibility of <em>Yersinia pestis</em> to novel and conventional antimicrobial agents. <span class="cit-source">J Antimicrob Chemother</span> <span class="cit-vol">52</span>, <span class="cit-fpage">294</span>–296.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jac&amp;resid=52/2/294"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-58-1" title="View reference in text"
                           id="ref-58">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.58">
                           <div class="cit-metadata"><cite><strong>Friedlander, A. M., Welkos, S. L., Worsham, P. L., Andrews, G. P., Heath, D. G., Anderson, G. W., Jr, Pitt, M. L., Estep,
                                    J. &amp; Davis, K.</strong> <strong>(</strong><span class="cit-pub-date">1995</span><strong>).</strong> Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of <em>Yersinia pestis</em>. <span class="cit-source">Clin Infect Dis</span> <span class="cit-vol">21</span> (Suppl. 2), <span class="cit-fpage">S178</span>–S181.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=8845449&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-59-1" title="View reference in text"
                           id="ref-59">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.59"
                             data-doi="10.1146/annurev.ento.50.071803.130337">
                           <div class="cit-metadata"><cite><strong>Gage, K. L. &amp; Kosoy, M. Y.</strong> <strong>(</strong><span class="cit-pub-date">2005</span><strong>).</strong> Natural history of plague: perspectives from more than a century of research. <span class="cit-source">Annu Rev Entomol</span> <span class="cit-vol">50</span>, <span class="cit-fpage">505</span>–528.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1146/annurev.ento.50.071803.130337&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=15471529&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-60-1" title="View reference in text"
                           id="ref-60">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.60"
                             data-doi="10.1056/NEJM199709043371004">
                           <div class="cit-metadata"><cite><strong>Galimand, M., Guiyoule, A., Gerbaud, G., Rasoamanana, B., Chanteau, S., Carniel, E. &amp; Courvalin, P.</strong> <strong>(</strong><span class="cit-pub-date">1997</span><strong>).</strong> Multiple antibiotic resistance in <em>Yersinia pestis</em> mediated by a self-transferable plasmid. <span class="cit-source">N Engl J Med</span> <span class="cit-vol">337</span>, <span class="cit-fpage">677</span>–680.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1056/NEJM199709043371004&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=9278464&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-61-1" title="View reference in text"
                           id="ref-61">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.61"
                             data-doi="10.1128/JB.185.17.5248-5262.2003">
                           <div class="cit-metadata"><cite><strong>Garcia, E., Elliott, J. M., Ramanculov, E., Chain, P. S., Chu, M. C. &amp; Molineux, I. J.</strong> <strong>(</strong><span class="cit-pub-date">2003</span><strong>).</strong> The genome sequence of <em>Yersinia pestis</em> bacteriophage <em>φ</em>A1122 reveals an intimate history with the coliphage T3 and T7 genomes. <span class="cit-source">J Bacteriol</span> <span class="cit-vol">185</span>, <span class="cit-fpage">5248</span>–5262.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jb&amp;resid=185/17/5248"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-62-1" title="View reference in text"
                           id="ref-62">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.62"
                             data-doi="10.1128/AEM.69.8.5032-5036.2003">
                           <div class="cit-metadata"><cite><strong>Goode, D., Allen, V. M. &amp; Barrow, P. A.</strong> <strong>(</strong><span class="cit-pub-date">2003</span><strong>).</strong> Reduction of experimental <em>Salmonella</em> and <em>Campylobacter</em> contamination of chicken skin by application of lytic bacteriophages. <span class="cit-source">Appl Environ Microbiol</span> <span class="cit-vol">69</span>, <span class="cit-fpage">5032</span>–5036.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=aem&amp;resid=69/8/5032"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-63-1" title="View reference in text"
                           id="ref-63">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.63"
                             data-doi="10.1111/j.1574-695X.1999.tb01229.x">
                           <div class="cit-metadata"><cite><strong>Green, M., Rogers, D., Russell, P., Stagg, A. J., Bell, D. L., Eley, S. M., Titball, R. W. &amp; Williamson, E. D.</strong> <strong>(</strong><span class="cit-pub-date">1999</span><strong>).</strong> The SCID/Beige mouse as a model to investigate protection against <em>Yersinia pestis</em>. <span class="cit-source">FEMS Immunol Med Microbiol</span> <span class="cit-vol">23</span>, <span class="cit-fpage">107</span>–113.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=femsim&amp;resid=23/2/107"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-64-1" title="View reference in text"
                           id="ref-64">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.64">
                           <div class="cit-metadata"><cite><strong>Guiyoule, A., Grimont, F., Iteman, I., Grimont, P. D., Lefèvre, M. &amp; Carniel, E.</strong> <strong>(</strong><span class="cit-pub-date">1994</span><strong>).</strong> Plague pandemics investigated by ribotyping of <em>Yersinia pestis</em> strains. <span class="cit-source">J Clin Microbiol</span> <span class="cit-vol">32</span>, <span class="cit-fpage">634</span>–641.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jcm&amp;resid=32/3/634"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-65-1" title="View reference in text"
                           id="ref-65">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.65">
                           <div class="cit-metadata"><cite><strong>Hardaway, R. M.</strong> <strong>(</strong><span class="cit-pub-date">1982</span><strong>).</strong> Pathology and pathophysiology of disseminated intravascular coagulation. In <em>Pathophysiology of Shock, Anoxia and Ischaemia</em>, pp. 186–197. Edited by R. A. Cowley &amp; B. F. Trump. Baltimore, MD: Williams &amp; Wilkins.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-66-1" title="View reference in text"
                           id="ref-66">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.66">
                           <div class="cit-metadata"><cite><strong>Hill, J., Leary, S. E. C., Griffin, K. F., Williamson, E. D. &amp; Titball, R. W.</strong> <strong>(</strong><span class="cit-pub-date">1997</span><strong>).</strong> Regions of <em>Yersinia pestis</em> V antigen that contribute to protection against plague identified by passive and active immunization. <span class="cit-source">Infect Immun</span> <span class="cit-vol">65</span>, <span class="cit-fpage">4476</span>–4482.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=iai&amp;resid=65/11/4476"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-67-1" title="View reference in text"
                           id="ref-67">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.67"
                             data-doi="10.1128/IAI.74.5.3068-3070.2006">
                           <div class="cit-metadata"><cite><strong>Hill, J., Eyles, J. E., Elvin, S. J., Healey, G. D., Lukaszewski, R. A. &amp; Titball, R. W.</strong> <strong>(</strong><span class="cit-pub-date">2006</span><strong>).</strong> Administration of antibody to the lung protects mice against pneumonic plague. <span class="cit-source">Infect Immun</span> <span class="cit-vol">74</span>, <span class="cit-fpage">3068</span>–3070.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=iai&amp;resid=74/5/3068"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-68-1" title="View reference in text"
                           id="ref-68">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.68"
                             data-doi="10.1007/0-306-48416-1_11">
                           <div class="cit-metadata"><cite><strong>Hinnebusch, B. J.</strong> <strong>(</strong><span class="cit-pub-date">2003</span><strong>).</strong> Transmission factors: <em>Yersinia pestis</em> genes required to infect the flea vector of plague. <span class="cit-source">Adv Exp Med Biol</span> <span class="cit-vol">529</span>, <span class="cit-fpage">55</span>–62.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1007/0-306-48416-1_11&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12756729&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-69-1" title="View reference in text"
                           id="ref-69">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.69"
                             data-doi="10.1046/j.1365-2958.2002.03159.x">
                           <div class="cit-metadata"><cite><strong>Hinnebusch, B. J., Rosso, M. L., Schwan, T. G. &amp; Carniel, E.</strong> <strong>(</strong><span class="cit-pub-date">2002</span><strong>).</strong> High-frequency conjugative transfer of antibiotic resistance genes to <em>Yersinia pestis</em> in the flea midgut. <span class="cit-source">Mol Microbiol</span> <span class="cit-vol">46</span>, <span class="cit-fpage">349</span>–354.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1046/j.1365-2958.2002.03159.x&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12406213&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-70-1" title="View reference in text"
                           id="ref-70">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.70">
                           <div class="cit-metadata"><cite><strong>Hornibrook, J. W.</strong> <strong>(</strong><span class="cit-pub-date">1946</span><strong>).</strong> Streptomycin in experimental plague. <span class="cit-source">Publ Health Rep</span> <span class="cit-vol">61</span>, <span class="cit-fpage">535</span>–538.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=21020110&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-71-1" title="View reference in text"
                           id="ref-71">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.71"
                             data-doi="10.1128/JCM.41.7.3273-3283.2003">
                           <div class="cit-metadata"><cite><strong>Hurtle, W., Lindler, L., Fan, W., Shoemaker, D., Henchal, E. &amp; Norwood, D.</strong> <strong>(</strong><span class="cit-pub-date">2003</span><strong>).</strong> Detection and identification of ciprofloxacin-resistant <em>Yersinia pestis</em> by denaturing high-performance liquid chromatography. <span class="cit-source">J Clin Microbiol</span> <span class="cit-vol">41</span>, <span class="cit-fpage">3273</span>–3283.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jcm&amp;resid=41/7/3273"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-72-1" title="View reference in text"
                           id="ref-72">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.72"
                             data-doi="10.1001/jama.283.17.2281">
                           <div class="cit-metadata"><cite><strong>Inglesby, T. V., Dennis, D. T., Henderson, D. A. &amp; 16 other authors</strong> <strong>(</strong><span class="cit-pub-date">2000</span><strong>).</strong> Plague as a biological weapon: medical and public health management. <span class="cit-source">JAMA (J Am Med Assoc)</span> <span class="cit-vol">283</span>, <span class="cit-fpage">2281</span>–2290.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1001/jama.283.17.2281&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=10807389&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-73-1" title="View reference in text"
                           id="ref-73">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.73">
                           <div class="cit-metadata"><cite><strong>Jacobs, R. F., Sowell, M. K., Moss, M. M. &amp; Fiser, D. H.</strong> <strong>(</strong><span class="cit-pub-date">1990</span><strong>).</strong> Septic shock in children: bacterial etiologies and temporal relationships. <span class="cit-source">Pediatr Infect Dis J</span> <span class="cit-vol">9</span>, <span class="cit-fpage">196</span>–200.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=2336300&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-74-1" title="View reference in text"
                           id="ref-74">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.74">
                           <div class="cit-metadata"><cite><strong>Jacobson, M. A. &amp; Young, L. S.</strong> <strong>(</strong><span class="cit-pub-date">1986</span><strong>).</strong> New developments in the treatment of Gram-negative bacteremia. <span class="cit-source">West J Med</span> <span class="cit-vol">144</span>, <span class="cit-fpage">185</span>–194.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=3513451&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-75-1" title="View reference in text"
                           id="ref-75">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.75"
                             data-doi="10.1016/S1046-2023(05)80211-7">
                           <div class="cit-metadata"><cite><strong>Kang, A. S., Burton, D. R. &amp; Lerner, R. A.</strong> <strong>(</strong><span class="cit-pub-date">1991</span><strong>).</strong> Combinatorial immunoglobulin libraries in phage. <span class="cit-source">Methods: Companion Methods Enzymol</span> <span class="cit-vol">2</span>, <span class="cit-fpage">111</span>–118.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S1046-2023(05)80211-7&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-76-1" title="View reference in text"
                           id="ref-76">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.76"
                             data-doi="10.1007/0-306-48416-1_17">
                           <div class="cit-metadata"><cite><strong>Kauppi, A. M., Nordfelth, R., Hagglund, U., Wolf-Watz, H. &amp; Elofsson, M.</strong> <strong>(</strong><span class="cit-pub-date">2003a</span><strong>).</strong> Salicylanilides are potent inhibitors of type III secretion in <em>Yersinia</em>. <span class="cit-source">Adv Exp Med Biol</span> <span class="cit-vol">529</span>, <span class="cit-fpage">97</span>–100.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1007/0-306-48416-1_17&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12756735&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-77-1" title="View reference in text"
                           id="ref-77">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.77"
                             data-doi="10.1016/S1074-5521(03)00046-2">
                           <div class="cit-metadata"><cite><strong>Kauppi, A. M., Nordfelth, R., Uvell, H., Wolf-Watz, H. &amp; Elofsson, M.</strong> <strong>(</strong><span class="cit-pub-date">2003b</span><strong>).</strong> Targeting bacterial virulence: inhibitors of type III secretion in <em>Yersinia</em>. <span class="cit-source">Chem Biol</span> <span class="cit-vol">10</span>, <span class="cit-fpage">241</span>–249.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S1074-5521(03)00046-2&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12670538&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-78-1" title="View reference in text"
                           id="ref-78">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.78"
                             data-doi="10.1128/CMR.13.4.602-614.2000">
                           <div class="cit-metadata"><cite><strong>Keller, M. A. &amp; Stiehm, E. R.</strong> <strong>(</strong><span class="cit-pub-date">2000</span><strong>).</strong> Passive immunity in prevention and treatment of infectious diseases. <span class="cit-source">Clin Microbiol Rev</span> <span class="cit-vol">13</span>, <span class="cit-fpage">602</span>–614.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=cmr&amp;resid=13/4/602"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-79-1" title="View reference in text"
                           id="ref-79">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.79"
                             data-doi="10.1099/00221287-138-8-1679">
                           <div class="cit-metadata"><cite><strong>Kienle, Z., Emody, L., Svanborg, C. &amp; O'Toole, P. W.</strong> <strong>(</strong><span class="cit-pub-date">1992</span><strong>).</strong> Adhesive properties conferred by the plasminogen activator of <em>Yersinia pestis</em>. <span class="cit-source">J Gen Microbiol</span> <span class="cit-vol">138</span>, <span class="cit-fpage">1679</span>–1687.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=mic&amp;resid=138/8/1679"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-80-1" title="View reference in text"
                           id="ref-80">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.80"
                             data-doi="10.1038/256495a0">
                           <div class="cit-metadata"><cite><strong>Kohler, G. &amp; Milstein, C.</strong> <strong>(</strong><span class="cit-pub-date">1975</span><strong>).</strong> Continuous cultures of fused cells secreting antibody of predefined specificity. <span class="cit-source">Nature</span> <span class="cit-vol">256</span>, <span class="cit-fpage">495</span>–497.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1038/256495a0&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=1172191&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-81-1" title="View reference in text"
                           id="ref-81">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.81" data-doi="10.1086/428617">
                           <div class="cit-metadata"><cite><strong>Kool, J. L.</strong> <strong>(</strong><span class="cit-pub-date">2005</span><strong>).</strong> Risk of person-to-person transmission of pneumonic plague. <span class="cit-source">Clin Infect Dis</span> <span class="cit-vol">40</span>, <span class="cit-fpage">1166</span>–1172.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=cid&amp;resid=40/8/1166"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-82-1" title="View reference in text"
                           id="ref-82">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.82">
                           <div class="cit-metadata"><cite><strong>Krishna, G. &amp; Chitkara, R. K.</strong> <strong>(</strong><span class="cit-pub-date">2003</span><strong>).</strong> Pneumonic plague. <span class="cit-source">Semin Respir Infect</span> <span class="cit-vol">18</span>, <span class="cit-fpage">159</span>–167.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=14505278&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-83-1" title="View reference in text"
                           id="ref-83">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.83" data-doi="10.1086/367570">
                           <div class="cit-metadata"><cite><strong>Kuberski, T., Robinson, L. &amp; Schurgin, A.</strong> <strong>(</strong><span class="cit-pub-date">2003</span><strong>).</strong> A case of plague successfully treated with ciprofloxacin and sympathetic blockade for treatment of gangrene. <span class="cit-source">Clin Infect Dis</span> <span class="cit-vol">36</span>, <span class="cit-fpage">521</span>–523.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=cid&amp;resid=36/4/521"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-84-1" title="View reference in text"
                           id="ref-84">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.84">
                           <div class="cit-metadata"><cite><strong>Lachowicz, T.</strong> <strong>(</strong><span class="cit-pub-date">1965</span><strong>).</strong> Investigations on staphylococcins. <span class="cit-source">Zentbl Bakteriol Parasitenkd Infektkr Hyg Abt 1 Orig Reihe A</span> <span class="cit-vol">196</span>, <span class="cit-fpage">340</span>–351.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-85-1" title="View reference in text"
                           id="ref-85">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.85">
                           <div class="cit-metadata"><cite><strong>Lähteenmäki, K., Virkola, R., Sarén, A., Emödy, L. &amp; Korhonen, T. K.</strong> <strong>(</strong><span class="cit-pub-date">1998</span><strong>).</strong> Expression of plasminogen activator Pla of <em>Yersinia pestis</em> enhances bacterial attachment to the mammalian extracellular matrix. <span class="cit-source">Infect Immun</span> <span class="cit-vol">66</span>, <span class="cit-fpage">5755</span>–5762.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=iai&amp;resid=66/12/5755"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-86-1" title="View reference in text"
                           id="ref-86">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.86">
                           <div class="cit-metadata"><cite><strong>Leary, S. E. C., Williamson, E. D., Griffin, K. F., Russell, P., Eley, S. M. &amp; Titball, R. W.</strong> <strong>(</strong><span class="cit-pub-date">1995</span><strong>).</strong> Active immunization with recombinant V antigen from <em>Yersinia pestis</em> protects mice against plague. <span class="cit-source">Infect Immun</span> <span class="cit-vol">63</span>, <span class="cit-fpage">2854</span>–2858.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=iai&amp;resid=63/8/2854"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-87-1" title="View reference in text"
                           id="ref-87">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.87"
                             data-doi="10.1016/S0960-894X(03)00481-5">
                           <div class="cit-metadata"><cite><strong>Lee, K., Gao, Y., Yao, Z. J., Phan, J., Wu, L., Liang, J., Waugh, D. S., Zhang, Z. Y. &amp; Burke, T. R., Jr</strong> <strong>(</strong><span class="cit-pub-date">2003</span><strong>).</strong> Tripeptide inhibitors of <em>Yersinia</em> protein-tyrosine phosphatase. <span class="cit-source">Bioorg Med Chem Lett</span> <span class="cit-vol">13</span>, <span class="cit-fpage">2577</span>–2581.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0960-894X(03)00481-5&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12852970&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><div class="cit ref-cit ref-other no-rev-xref" id="cit-55.11.1461.88"
                             data-doi="10.1016/j.coph.2003.04.001">
                           <div class="cit-metadata"><cite><strong>Lee, Y. M., Almqvist, F. &amp; Hultgren, S. J.</strong> <strong>(</strong><span class="cit-pub-date">2003</span><strong>).</strong> Targeting virulence for antimicrobial chemotherapy. <span class="cit-source">Curr Opin Pharmacol</span> <span class="cit-vol">3</span>, <span class="cit-fpage">513</span>–519.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.coph.2003.04.001&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=14559097&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-89-1" title="View reference in text"
                           id="ref-89">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.89"
                             data-doi="10.1016/j.bmcl.2005.06.027">
                           <div class="cit-metadata"><cite><strong>Lee, K., Boovanahalli, S. K., Nam, K. Y. &amp; 9 other authors</strong> <strong>(</strong><span class="cit-pub-date">2005</span><strong>).</strong> Synthesis of tripeptides as potent <em>Yersinia</em> protein tyrosine phosphatase inhibitors. <span class="cit-source">Bioorg Med Chem Lett</span> <span class="cit-vol">15</span>, <span class="cit-fpage">4037</span>–4042.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.bmcl.2005.06.027&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=16039123&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-90-1" title="View reference in text"
                           id="ref-90">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.90" data-doi="10.1086/323334">
                           <div class="cit-metadata"><cite><strong>Liappis, A. P., Kan, V. L., Rochester, C. G. &amp; Simon, G. L.</strong> <strong>(</strong><span class="cit-pub-date">2001</span><strong>).</strong> The effect of statins on mortality in patients with bacteremia. <span class="cit-source">Clin Infect Dis</span> <span class="cit-vol">33</span>, <span class="cit-fpage">1352</span>–1357.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=cid&amp;resid=33/8/1352"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-91-1" title="View reference in text"
                           id="ref-91">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.91">
                           <div class="cit-metadata"><cite><strong>Lien-Teh, W.</strong> <strong>(</strong><span class="cit-pub-date">1926</span><strong>).</strong> <em>A Treatise on Pneumonic Plague</em>. League of Nations, Health Organisation. Printed by Berger-Levrault.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-92-1" title="View reference in text"
                           id="ref-92">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.92">
                           <div class="cit-metadata"><cite><strong>Lien-Teh, W., Chun, J. W. H., Pollitzer, R. &amp; Wu, C. Y.</strong> <strong>(</strong><span class="cit-pub-date">1936</span><strong>).</strong> <em>Plague: a Manual for Medical &amp; Public Health Workers</em>. Shanghai.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-93-1" title="View reference in text"
                           id="ref-93">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.93">
                           <div class="cit-metadata"><cite><strong>Liles, W. C.</strong> <strong>(</strong><span class="cit-pub-date">2001</span><strong>).</strong> Immunomodulatory approaches to augment phagocyte-mediated host defense for treatment of infectious diseases. <span class="cit-source">Semin Respir Infect</span> <span class="cit-vol">16</span>, <span class="cit-fpage">11</span>–17.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=11309708&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-94-1" title="View reference in text"
                           id="ref-94">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.94"
                             data-doi="10.1016/j.bcp.2006.01.012">
                           <div class="cit-metadata"><cite><strong>Maher, S. &amp; McClean, S.</strong> <strong>(</strong><span class="cit-pub-date">2006</span><strong>).</strong> Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells <em>in vitro</em>. <span class="cit-source">Biochem Pharmacol</span> <span class="cit-vol">71</span>, <span class="cit-fpage">1289</span>–1298.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.bcp.2006.01.012&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=16530733&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-95-1" title="View reference in text"
                           id="ref-95">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.95"
                             data-doi="10.1586/14787210.2.1.61">
                           <div class="cit-metadata"><cite><strong>Marra, A.</strong> <strong>(</strong><span class="cit-pub-date">2004</span><strong>).</strong> Can virulence factors be viable antibacterial targets? <span class="cit-source">Expert Rev Anti Infect Ther</span> <span class="cit-vol">2</span>, <span class="cit-fpage">61</span>–72.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1586/14787210.2.1.61&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=15482172&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-96-1" title="View reference in text"
                           id="ref-96">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.96"
                             data-doi="10.1016/S0924-8579(99)00161-2">
                           <div class="cit-metadata"><cite><strong>Masihi, K. N.</strong> <strong>(</strong><span class="cit-pub-date">2000</span><strong>).</strong> Immunomodulatory agents for prophylaxis and therapy of infections. <span class="cit-source">Int J Antimicrob Agents</span> <span class="cit-vol">14</span>, <span class="cit-fpage">181</span>–191.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0924-8579(99)00161-2&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=10773486&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-97-1" title="View reference in text"
                           id="ref-97">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.97"
                             data-doi="10.1186/1471-2180-5-38">
                           <div class="cit-metadata"><cite><strong>Matson, J. S., Durick, K. A., Bradley, D. S. &amp; Nilles, M. L.</strong> <strong>(</strong><span class="cit-pub-date">2005</span><strong>).</strong> Immunization of mice with YscF provides protection from <em>Yersinia pestis</em> infections. <span class="cit-source">BMC Microbiol</span> <span class="cit-vol">5</span>, <span class="cit-fpage">38</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1186/1471-2180-5-38&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=15978133&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-98-1" title="View reference in text"
                           id="ref-98">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.98">
                           <div class="cit-metadata"><cite><strong>McGeachie, J.</strong> <strong>(</strong><span class="cit-pub-date">1970</span><strong>).</strong> An <em>in vitro</em> comparison of colicines K and V and some therapeutic antibiotics. <span class="cit-source">Zentbl Bakteriol Parasitenkd Infektkr Hyg Abt 1 Orig Reihe A</span> <span class="cit-vol">215</span>, <span class="cit-fpage">245</span>–251.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-99-1" title="View reference in text"
                           id="ref-99">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.99"
                             data-doi="10.1161/01.CIR.0000129774.09737.5B">
                           <div class="cit-metadata"><cite><strong>Merx, M. W., Liehn, E. A., Janssens, U., Lutticken, R., Schrader, J., Hanrath, P. &amp; Weber, C.</strong> <strong>(</strong><span class="cit-pub-date">2004</span><strong>).</strong> HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis. <span class="cit-source">Circulation</span> <span class="cit-vol">109</span>, <span class="cit-fpage">2560</span>–2565.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=circulationaha&amp;resid=109/21/2560"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-100-1" title="View reference in text"
                           id="ref-100">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.100">
                           <div class="cit-metadata"><cite><strong>Meyer, K. F.</strong> <strong>(</strong><span class="cit-pub-date">1970</span><strong>).</strong> Effectiveness of live or killed plague vaccines in man. <span class="cit-source">Bull W H O</span> <span class="cit-vol">42</span>, <span class="cit-fpage">653</span>–666.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=4988692&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-101-1" title="View reference in text"
                           id="ref-101">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.101">
                           <div class="cit-metadata"><cite><strong>Meyer, K. F., Hightower, J. A. &amp; McCrumb, F. R.</strong> <strong>(</strong><span class="cit-pub-date">1974</span><strong>).</strong> Plague immunization. VI. Vaccination with the fraction I antigen of <em>Yersinia pestis</em>. <span class="cit-source">J Infect Dis</span> <span class="cit-vol">129</span> (Suppl.), <span class="cit-fpage">S41</span>–S45.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=4825248&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-102-1" title="View reference in text"
                           id="ref-102">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.102"
                             data-doi="10.1111/j.1742-4658.2005.05077.x">
                           <div class="cit-metadata"><cite><strong>Miethke, M., Bisseret, P., Beckering, C. L., Vignard, D., Eustache, J. &amp; Marahiel, M. A.</strong> <strong>(</strong><span class="cit-pub-date">2006</span><strong>).</strong> Inhibition of aryl acid adenylation domains involved in bacterial siderophore synthesis. <span class="cit-source">FEBS J</span> <span class="cit-vol">273</span>, <span class="cit-fpage">409</span>–419.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1111/j.1742-4658.2005.05077.x&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=16403027&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-103-1" title="View reference in text"
                           id="ref-103">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.103"
                             data-doi="10.3181/00379727-144-37700">
                           <div class="cit-metadata"><cite><strong>Montgomerie, J. Z., Kalmanson, G. M., Harwick, H. J. &amp; Guze, L. B.</strong> <strong>(</strong><span class="cit-pub-date">1973</span><strong>).</strong> Relation between bacteriocin production and virulence of <em>Streptococcus faecalis</em> var. liquefaciens. <span class="cit-source">Proc Soc Exp Biol Med</span> <span class="cit-vol">144</span>, <span class="cit-fpage">868</span>–870.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=spebm&amp;resid=144/3/868"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-104-1" title="View reference in text"
                           id="ref-104">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.104"
                             data-doi="10.1146/annurev.iy.10.040192.001323">
                           <div class="cit-metadata"><cite><strong>Morrison, S. L.</strong> <strong>(</strong><span class="cit-pub-date">1992</span><strong>).</strong> <em>In vitro</em> antibodies: strategies for production and application. <span class="cit-source">Annu Rev Immunol</span> <span class="cit-vol">10</span>, <span class="cit-fpage">239</span>–265.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1146/annurev.iy.10.040192.001323&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=1590987&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-105-1" title="View reference in text"
                           id="ref-105">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.105"
                             data-doi="10.1128/AAC.44.1.24-29.2000">
                           <div class="cit-metadata"><cite><strong>Mota-Meira, M., LaPointe, G., Lacroix, C. &amp; Lavoie, M. C.</strong> <strong>(</strong><span class="cit-pub-date">2000</span><strong>).</strong> MICs of mutacin B-Ny266, nisin A, vancomycin, and oxacillin against bacterial pathogens. <span class="cit-source">Antimicrob Agents Chemother</span> <span class="cit-vol">44</span>, <span class="cit-fpage">24</span>–29.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=aac&amp;resid=44/1/24"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-106-1" title="View reference in text"
                           id="ref-106">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.106"
                             data-doi="10.1093/jac/dki295">
                           <div class="cit-metadata"><cite><strong>Mota-Meira, M., Morency, H. &amp; Lavoie, M. C.</strong> <strong>(</strong><span class="cit-pub-date">2005</span><strong>).</strong> <em>In vivo</em> activity of mutacin B-Ny266. <span class="cit-source">J Antimicrob Chemother</span> <span class="cit-vol">56</span>, <span class="cit-fpage">869</span>–871.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jac&amp;resid=56/5/869"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-107-1" title="View reference in text"
                           id="ref-107">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.107">
                           <div class="cit-metadata"><cite><strong>Motin, V. L., Nakajima, R., Smirnov, G. B. &amp; Brubaker, R. R.</strong> <strong>(</strong><span class="cit-pub-date">1994</span><strong>).</strong> Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide. <span class="cit-source">Infect Immun</span> <span class="cit-vol">62</span>, <span class="cit-fpage">4192</span>–4201.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=iai&amp;resid=62/10/4192"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-108-1" title="View reference in text"
                           id="ref-108">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.108">
                           <div class="cit-metadata"><cite><strong>Naidu, B. P. B. &amp; Avari, G. R.</strong> <strong>(</strong><span class="cit-pub-date">1932</span><strong>).</strong> Bacteriophage in the treatment of plague. <span class="cit-source">Ind J Med Res</span> <span class="cit-vol">19</span>, <span class="cit-fpage">737</span>–748.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-109-1" title="View reference in text"
                           id="ref-109">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.109"
                             data-doi="10.1128/CMR.15.1.95-110.2002">
                           <div class="cit-metadata"><cite><strong>Nau, R. &amp; Eiffert, H.</strong> <strong>(</strong><span class="cit-pub-date">2002</span><strong>).</strong> Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation
                                 and outcome in sepsis and meningitis. <span class="cit-source">Clin Microbiol Rev</span> <span class="cit-vol">15</span>, <span class="cit-fpage">95</span>–110.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=cmr&amp;resid=15/1/95"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-110-1" title="View reference in text"
                           id="ref-110">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.110">
                           <div class="cit-metadata"><cite><strong>Naumov, A. V. &amp; Samoilova, L. V.</strong> <strong>(</strong><span class="cit-pub-date">1992</span><strong>).</strong> <em>Manual on Plague Prophylaxis</em>. Saratov, Russia: Russian Research Anti-Plague Institute ‘Microbe’ (in Russian).</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-111-1" title="View reference in text"
                           id="ref-111">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.111">
                           <div class="cit-metadata"><cite><strong>Naumov, A. V., Ledvanov, M. Yu. &amp; Drozdov, I. G.</strong> <strong>(</strong><span class="cit-pub-date">1992</span><strong>).</strong> <em>Plague Immunology</em>. Saratov, Russia: Russian Research Anti-Plague Institute ‘Microbe’ (in Russian).</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-112-1" title="View reference in text"
                           id="ref-112">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.112"
                             data-doi="10.1046/j.1469-0691.2002.00495.x">
                           <div class="cit-metadata"><cite><strong>Navas, E.</strong> <strong>(</strong><span class="cit-pub-date">2002</span><strong>).</strong> Problems associated with potential massive use of antimicrobial agents as prophylaxis or therapy of a bioterrorist attack.
                                 <span class="cit-source">Clin Microbiol Infect</span> <span class="cit-vol">8</span>, <span class="cit-fpage">534</span>–539.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1046/j.1469-0691.2002.00495.x&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12197876&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-113-1" title="View reference in text"
                           id="ref-113">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.113">
                           <div class="cit-metadata"><cite><strong>Nikolaev, N. I.</strong> <strong>(</strong><span class="cit-pub-date">1972</span><strong>).</strong> <em>Manual on Plague Prophylaxis</em>. Saratov, USSR: All-Union Research Anti-Plague Institute ‘Microbe’ (in Russian).</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-114-1" title="View reference in text"
                           id="ref-114">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.114"
                             data-doi="10.1128/IAI.73.5.3104-3114.2005">
                           <div class="cit-metadata"><cite><strong>Nordfelth, R., Kauppi, A. M., Norberg, H. A., Wolf-Watz, H. &amp; Elofsson, M.</strong> <strong>(</strong><span class="cit-pub-date">2005</span><strong>).</strong> Small-molecule inhibitors specifically targeting type III secretion. <span class="cit-source">Infect Immun</span> <span class="cit-vol">73</span>, <span class="cit-fpage">3104</span>–3114.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=iai&amp;resid=73/5/3104"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-115-1" title="View reference in text"
                           id="ref-115">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.115"
                             data-doi="10.1016/S0928-8244(03)00228-1">
                           <div class="cit-metadata"><cite><strong>Ofek, I., Hasty, D. L. &amp; Sharon, N.</strong> <strong>(</strong><span class="cit-pub-date">2003</span><strong>).</strong> Anti-adhesion therapy of bacterial diseases: prospects and problems. <span class="cit-source">FEMS Immunol Med Microbiol</span> <span class="cit-vol">38</span>, <span class="cit-fpage">181</span>–191.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0928-8244(03)00228-1&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=14522453&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-116-1" title="View reference in text"
                           id="ref-116">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.116"
                             data-doi="10.1128/IAI.68.6.3419-3425.2000">
                           <div class="cit-metadata"><cite><strong>Oyston, P. C. F., Dorrell, N., Williams, K., Li, S.-R., Green, M., Titball, R. W. &amp; Wren, B. W.</strong> <strong>(</strong><span class="cit-pub-date">2000</span><strong>).</strong> The response regulator PhoP is important for survival under conditions of macrophage-induced stress and virulence in <em>Yersinia pestis</em>. <span class="cit-source">Infect Immun</span> <span class="cit-vol">68</span>, <span class="cit-fpage">3419</span>–3425.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=iai&amp;resid=68/6/3419"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-117-1" title="View reference in text"
                           id="ref-117">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.117"
                             data-doi="10.1038/35097083">
                           <div class="cit-metadata"><cite><strong>Parkhill, J., Wren, B. W., Thomson, N. R. &amp; 32 other authors</strong> <strong>(</strong><span class="cit-pub-date">2001</span><strong>).</strong> Genome sequence of <em>Yersinia pestis</em>, the causative agent of plague. <span class="cit-source">Nature</span> <span class="cit-vol">413</span>, <span class="cit-fpage">523</span>–527.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1038/35097083&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=11586360&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-118-1" title="View reference in text"
                           id="ref-118">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.118">
                           <div class="cit-metadata"><cite><strong>Payne, D., Tatham, D., Williamson, E. D. &amp; Titball, R. W.</strong> <strong>(</strong><span class="cit-pub-date">1998</span><strong>).</strong> The pH 6 antigen of <em>Yersinia pestis</em> binds to <em>β</em>1-linked galactosyl residues in glycosphingolipids. <span class="cit-source">Infect Immun</span> <span class="cit-vol">66</span>, <span class="cit-fpage">4545</span>–4548.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=iai&amp;resid=66/9/4545"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-119-1" title="View reference in text"
                           id="ref-119">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.119">
                           <div class="cit-metadata"><cite><strong>Perry, R. D. &amp; Fetherston, J. D.</strong> <strong>(</strong><span class="cit-pub-date">1997</span><strong>).</strong> <em>Yersinia pestis</em> – etiologic agent of plague. <span class="cit-source">Clin Microbiol Rev</span> <span class="cit-vol">10</span>, <span class="cit-fpage">35</span>–66.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=cmr&amp;resid=10/1/35"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-120-1" title="View reference in text"
                           id="ref-120">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.120"
                             data-doi="10.1128/IAI.73.3.1532-1542.2005">
                           <div class="cit-metadata"><cite><strong>Philipovskiy, A. V., Cowan, C., Wulff-Strobel, C. R., Burnett, S. H., Kerschen, E. J., Cohen, D. A., Kaplan, A. M. &amp; Straley,
                                    S. C.</strong> <strong>(</strong><span class="cit-pub-date">2005</span><strong>).</strong> Antibody against V antigen prevents Yop-dependent growth of <em>Yersinia pestis</em>. <span class="cit-source">Infect Immun</span> <span class="cit-vol">73</span>, <span class="cit-fpage">1532</span>–1542.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=iai&amp;resid=73/3/1532"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-121-1" title="View reference in text"
                           id="ref-121">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.121">
                           <div class="cit-metadata"><cite><strong>Pollitzer, R.</strong> <strong>(</strong><span class="cit-pub-date">1954</span><strong>).</strong> Plague. <span class="cit-source">W H O Monogr Ser</span> <span class="cit-vol">22</span>, <span class="cit-fpage">1</span>–698.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-122-1" title="View reference in text"
                           id="ref-122">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.122"
                             data-doi="10.1177/096805199500200203">
                           <div class="cit-metadata"><cite><strong>Porat, R., McCabe, W. R. &amp; Brubaker, R. R.</strong> <strong>(</strong><span class="cit-pub-date">1995</span><strong>).</strong> Lipopolysaccharide-associated resistance to killing of yersiniae by complement. <span class="cit-source">J Endotoxin Res</span> <span class="cit-vol">2</span>, <span class="cit-fpage">91</span>–97.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1177/096805199500200203&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-123-1" title="View reference in text"
                           id="ref-123">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.123">
                           <div class="cit-metadata"><cite><strong>Portnoy, D. A. &amp; Falkow, S.</strong> <strong>(</strong><span class="cit-pub-date">1981</span><strong>).</strong> Virulence-associated plasmids from <em>Yersinia enterocolitica</em> and <em>Yersinia pestis</em>. <span class="cit-source">J Bacteriol</span> <span class="cit-vol">148</span>, <span class="cit-fpage">877</span>–883.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jb&amp;resid=148/3/877"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-124-1" title="View reference in text"
                           id="ref-124">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.124"
                             data-doi="10.1001/jama.1991.03470040112032">
                           <div class="cit-metadata"><cite><strong>Rackow, E. C. &amp; Astiz, M. E.</strong> <strong>(</strong><span class="cit-pub-date">1991</span><strong>).</strong> Pathophysiology and treatment of septic shock. <span class="cit-source">JAMA (J Am Med Assoc)</span> <span class="cit-vol">266</span>, <span class="cit-fpage">548</span>–554.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1001/jama.1991.03470040112032&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=2061983&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-125-1" title="View reference in text"
                           id="ref-125">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.125"
                             data-doi="10.1073/pnas.220225197">
                           <div class="cit-metadata"><cite><strong>Raoult, D., Aboudharam, G., Crubezy, E., Larrouy, G., Ludes, B. &amp; Drancourt, M.</strong> <strong>(</strong><span class="cit-pub-date">2000</span><strong>).</strong> Molecular indentification by ‘suicide PCR’ of <em>Yersinia pestis</em> as the agent of medieval Black Death. <span class="cit-source">Proc Natl Acad Sci U S A</span> <span class="cit-vol">97</span>, <span class="cit-fpage">12800</span>–12803.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=97/23/12800"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-126-1" title="View reference in text"
                           id="ref-126">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.126"
                             data-doi="10.1146/annurev.micro.56.012302.161024">
                           <div class="cit-metadata"><cite><strong>Riley, M. A. &amp; Wertz, J. E.</strong> <strong>(</strong><span class="cit-pub-date">2002</span><strong>).</strong> Bacteriocins: evolution, ecology, and application. <span class="cit-source">Annu Rev Microbiol</span> <span class="cit-vol">56</span>, <span class="cit-fpage">117</span>–137.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1146/annurev.micro.56.012302.161024&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12142491&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-127-1" title="View reference in text"
                           id="ref-127">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.127"
                             data-doi="10.1016/j.femslabel-empty">le.2005.09.001">
                           <div class="cit-metadata"><cite><strong>Robinson, V. L., Oyston, P. C. &amp; Titball, R. W.</strong> <strong>(</strong><span class="cit-pub-date">2005</span><strong>).</strong> A <em>dam</em> mutant of <em>Yersinia pestis</em> is attenuated and induces protection against plague. <span class="cit-source">FEMS Microbiol Lett</span> <span class="cit-vol">252</span>, <span class="cit-fpage">251</span>–256.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.femsle.2005.09.001&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=16188402&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-128-1" title="View reference in text"
                           id="ref-128">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.128">
                           <div class="cit-metadata"><cite><strong>Roggenkamp, A., Geiger, A. M., Leitritz, L., Kessler, A. &amp; Heesemann, J.</strong> <strong>(</strong><span class="cit-pub-date">1997</span><strong>).</strong> Passive immunity to infection with <em>Yersinia</em> spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen. <span class="cit-source">Infect Immun</span> <span class="cit-vol">65</span>, <span class="cit-fpage">446</span>–451.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=iai&amp;resid=65/2/446"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-129-1" title="View reference in text"
                           id="ref-129">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.129"
                             data-doi="10.1073/pnas.202358699">
                           <div class="cit-metadata"><cite><strong>Rojas, C. M., Ham, J. H., Deng, W. L., Doyle, J. J. &amp; Collmer, A.</strong> <strong>(</strong><span class="cit-pub-date">2002</span><strong>).</strong> HecA, a member of a class of adhesins produced by div       <div class="cit-metadata"><cite><strong>Rojas,erse pathogenic bacteria, contributes to the attachment, aggregation,
                                 epidermal cell killing, and virulence phenotypes of <em>Erwinia chrysanthemi</em> EC16 on <em>Nicotiana clevelandii</em> seedlings. <span class="cit-source">Proc Natl Acad Sci U S A</span> <span class="cit-vol">99</span>, <span class="cit-fpage">13142</span>–13147.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=99/20/13142"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-130-1" title="View reference in text"
                           id="ref-130">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.130">
                           <div class="cit-metadata"><cite><strong>Rudnev, G. P.</strong> <strong>(</strong><span class="cit-pub-date">1940</span><strong>).</strong> <em>Clinical Picture of Plague</em>. Moscow, Leningrad, Russia: Medgiz (in Russian).</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-131-1" title="View reference in text"
                           id="ref-131">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.131"
                             data-doi="10.1093/jac/41.2.301">
                           <div class="cit-metadata"><cite><strong>Russell, P., Eley, S. M., Green, M. &amp; 8 other authors</strong> <strong>(</strong><span class="cit-pub-date">1998</span><strong>).</strong> Efficacy of doxycycline and ciprofloxacin against experimental <em>Yersinia pestis</em> infection. <span class="cit-source">J Antimicrob Chemother</span> <span class="cit-vol">41</span>, <span class="cit-fpage">301</span>–305.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jac&amp;resid=41/2/301"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-132-1" title="View reference in text"
                           id="ref-132">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.132"
                             data-doi="10.3168/jds.S0022-0302(99)75519-0">
                           <div class="cit-metadata"><cite><strong>Ryan, M. P., Flynn, J., Hill, C., Ross, R. P. &amp; Meaney, W. J.</strong> <strong>(</strong><span class="cit-pub-date">1999</span><strong>).</strong> The natural food grade inhibitor, lacticin 3147, reduced the incidence of mastitis after experimental challenge with <em>Streptococcus dysgalactiae</em> in nonlactating dairy cows. <span class="cit-source">J Dairy Sci</span> <span class="cit-vol">82</span>, <span class="cit-fpage">2625</span>–2631.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.3168/jds.S0022-0302(99)75519-0&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=10629810&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-133-1" title="View reference in text"
                           id="ref-133">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.133">
                           <div class="cit-metadata"><cite><strong>Ryzhko, I. V., Samokhodkina, E. D., Tsuraeva, R. I., Shcherbaniuk, A. I. &amp; Tsetskhladze, N. S.</strong> <strong>(</strong><span class="cit-pub-date">1998</span><strong>).</strong> Characteristics of etiotropic therapy of plague infection induced by atypical strains of F1<sup>−</sup> phenotype plague microbe. <span class="cit-source">Antibiot Khimioter</span> <span class="cit-vol">43</span>, <span class="cit-fpage">24</span>–28 (in Russian).</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=9532328&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-134-1" title="View reference in text"
                           id="ref-134">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.134"
                             data-doi="10.1111/j.1574-695X.2000.tb01426.x">
                           <div class="cit-metadata"><cite><strong>Sabhnani, L. &amp; Rao, D. N.</strong> <strong>(</strong><span class="cit-pub-date">2000</span><strong>).</strong> Identification of immunodominant epitope of F1 antigen of <em>Yersinia pestis</em>. <span class="cit-source">FEMS Immunol Med Microbiol</span> <span class="cit-vol">27</span>, <span class="cit-fpage">155</span>–162.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=femsim&amp;resid=27/2/155"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-135-1" title="View reference in text"
                           id="ref-135">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.135"
                             data-doi="10.1016/S0928-8244(03)00170-6">
                           <div class="cit-metadata"><cite><strong>Sabhnani, L., Manocha, M., Sridevi, K., Shashikiran, D., Rayanade, R. &amp; Rao, D. N.</strong> <strong>(</strong><span class="cit-pub-date">2003</span><strong>).</strong> Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of <em>Yersinia pestis</em> using novel delivery vehicles. <span class="cit-source">FEMS Immunol Med Microbiol</span> <span class="cit-vol">38</span>, <span class="cit-fpage">215</span>–229.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0928-8244(03)00170-6&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=14522457&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-136-1" title="View reference in text"
                           id="ref-136">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.136">
                           <div class="cit-metadata"><cite><strong>Simpson, W. J., Thomas, R. E. &amp; Schwan, T. G.</strong> <strong>(</strong><span class="cit-pub-date">1990</span><strong>).</strong> Recombinant capsular antigen (fraction 1) from <em>Yersinia pestis</em> induces a protective antibody response in BALB/c mice. <span class="cit-source">Am J Trop Med Hyg</span> <span class="cit-vol">43</span>, <span class="cit-fpage">389</span>–396.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=tropmed&amp;resid=43/4/389"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-137-1" title="View reference in text"
                           id="ref-137">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.137"
                             data-doi="10.1084/jem.20020908">
                           <div class="cit-metadata"><cite><strong>Sing, A., Rost, D., Tvardovaskaia, N., Roggenkamp, A., Wiedemann, A., Kirschning, C. J., Aepfelbacher, M. &amp; Heesemann, J.</strong> <strong>(</strong><span class="cit-pub-date">2002</span><strong>).</strong> <em>Yersinia</em> V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. <span class="cit-source">J Exp Med</span> <span class="cit-vol">196</span>, <span class="cit-fpage">1017</span>–1024.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jem&amp;resid=196/8/1017"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-138-1" title="View reference in text"
                           id="ref-138">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.138">
                           <div class="cit-metadata"><cite><strong>Skurnik, M. &amp; Strauch, E.</strong> <strong>(</strong><span class="cit-pub-date">2006</span><strong>).</strong> Phage therapy: facts and fiction. <span class="cit-source">Int J Med Microbiol</span> <span class="cit-vol">296</span>, <span class="cit-fpage">5</span>–14.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=16423684&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-139-1" title="View reference in text"
                           id="ref-139">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.139">
                           <div class="cit-metadata"><cite><strong>Smith, H. W.</strong> <strong>(</strong><span class="cit-pub-date">1974</span><strong>).</strong> A search for transmissible pathogenic characters in invasive strains of <em>Escherichia coli</em>: the discovery of a plasmid-controlled toxin and a plasmid-controlled lethal character closely associated, or identical,
                                 with colicin V. <span class="cit-source">J Gen Microbiol</span> <span class="cit-vol">83</span>, <span class="cit-fpage">95</span>–111.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=4606141&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-140-1" title="View reference in text"
                           id="ref-140">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.140"
                             data-doi="10.1016/j.molimm.2004.04.029">
                           <div class="cit-metadata"><cite><strong>Sodhi, A., Sharma, R. K., Batra, H. V. &amp; Tuteja, U.</strong> <strong>(</strong><span class="cit-pub-date">2004</span><strong>).</strong> Mechanism of rLcrV and rYopB mediated immunosuppression in murine peritoneal macrophages. <span class="cit-source">Mol Immunol</span> <span class="cit-vol">41</span>, <span class="cit-fpage">767</span>–774.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.molimm.2004.04.029&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=15234556&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-141-1" title="View reference in text"
                           id="ref-141">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.141">
                           <div class="cit-metadata"><cite><strong>Stern, N. J., Svetoch, E. A., Eruslanov, B. V., Kovalev, Y. N., Volodina, L. I., Perelygin, V. V., Mitsevich, E. V., Mitsevich,
                                    I. P. &amp; Levchuk, V. P.</strong> <strong>(</strong><span class="cit-pub-date">2005</span><strong>).</strong> <em>Paenibacillus polymyxa</em> purified bacteriocin to control <em>Campylobacter jejuni</em> in chickens. <span class="cit-source">J Food Prot</span> <span class="cit-vol">68</span>, <span class="cit-fpage">1450</span>–1453.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=16013385&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-142-1" title="View reference in text"
                           id="ref-142">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.142"
                             data-doi="10.1016/j.ijantimicag.2004.06.011">
                           <div class="cit-metadata"><cite><strong>Steward, J., Lever, M. S., Russell, P., Beedham, R. J., Staga, A. J., Taylor, R. R. &amp; Brooks, T. J. G.</strong> <strong>(</strong><span class="cit-pub-date">2004</span><strong>).</strong> Efficacy of the latest fluoroquinolones against experimental <em>Yersinia pestis</em>. <span class="cit-source">Int J Antimicrob Agents</span> <span class="cit-vol">24</span>, <span class="cit-fpage">609</span>–612.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.ijantimicag.2004.06.011&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=15555886&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-143-1" title="View reference in text"
                           id="ref-143">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.143"
                             data-doi="10.1016/0966-842X(93)90001-8">
                           <div class="cit-metadata"><cite><strong>Straley, S. C.</strong> <strong>(</strong><span class="cit-pub-date">1993</span><strong>).</strong> Adhesins in <em>Yersinia pestis</em>. <span class="cit-source">Trends Microbiol</span> <span class="cit-vol">1</span>, <span class="cit-fpage">285</span>–286.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/0966-842X(93)90001-8&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=8162411&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-144-1" title="View reference in text"
                           id="ref-144">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.144"
                             data-doi="10.1016/j.cbpa.2003.08.001">
                           <div class="cit-metadata"><cite><strong>Suga, H. &amp; Smith, K. M.</strong> <strong>(</strong><span class="cit-pub-date">2003</span><strong>).</strong> Molecular mechanisms of bacterial quorum sensing as a new drug target. <span class="cit-source">Curr Opin Chem Biol</span> <span class="cit-vol">7</span>, <span class="cit-fpage">586</span>–591.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.cbpa.2003.08.001&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=14580562&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-145-1" title="View reference in text"
                           id="ref-145">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.145"
                             data-doi="10.1016/S1359-6446(05)03441-0">
                           <div class="cit-metadata"><cite><strong>Sulakvelidze, A.</strong> <strong>(</strong><span class="cit-pub-date">2005</span><strong>).</strong> Phage therapy: an attractive option for dealing with antibiotic-resistant bacterial infections. <span class="cit-source">Drug Discov Today</span> <span class="cit-vol">10</span>, <span class="cit-fpage">807</span>–809.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S1359-6446(05)03441-0&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=15970258&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-146-1" title="View reference in text"
                           id="ref-146">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.146">
                           <div class="cit-metadata"><cite><strong>Summers, W. C.</strong> <strong>(</strong><span class="cit-pub-date">1999</span><strong>).</strong> <em>Felix d'Herelle and the Origins of Molecular Biology</em>. New Haven, CT: Yale University Press.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-147-1" title="View reference in text"
                           id="ref-147">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.147"
                             data-doi="10.1146/annurev.micro.55.1.437">
                           <div class="cit-metadata"><cite><strong>Summers, W. C.</strong> <strong>(</strong><span class="cit-pub-date">2001</span><strong>).</strong> Bacteriophage therapy. <span class="cit-source">Annu Rev Microbiol</span> <span class="cit-vol">55</span>, <span class="cit-fpage">437</span>–451.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1146/annurev.micro.55.1.437&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=11544363&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-148-1" title="View reference in text"
                           id="ref-148">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.148"
                             data-doi="10.1016/S0140-6736(72)92091-0">
                           <div class="cit-metadata"><cite><strong>Tagg, J. R. &amp; McGiven, A. R.</strong> <strong>(</strong><span class="cit-pub-date">1972</span><strong>).</strong> Some possible autoimmune mechanisms in rheumatic carditis. <span class="cit-source">Lancet</span> <span class="cit-vol">2</span>, <span class="cit-fpage">686</span>–688.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0140-6736(72)92091-0&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=4115822&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-149-1" title="View reference in text"
                           id="ref-149">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.149">
                           <div class="cit-metadata"><cite><strong>Tagg, J. R., Dajani, A. S. &amp; Wannamaker, L. W.</strong> <strong>(</strong><span class="cit-pub-date">1976</span><strong>).</strong> Bacteriocins of Gram-positive bacteria. <span class="cit-source">Bacteriol Rev</span> <span class="cit-vol">40</span>, <span class="cit-fpage">722</span>–756.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=PDF&amp;journalCode=mmbr&amp;resid=40/3/722"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-150-1" title="View reference in text"
                           id="ref-150">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.150"
                             data-doi="10.1099/jmm.0.45643-0">
                           <div class="cit-metadata"><cite><strong>Thomas, R. &amp; Brooks, T.</strong> <strong>(</strong><span class="cit-pub-date">2004</span><strong>).</strong> Common oligosaccharide moieties inhibit the adherence of typical and atypical respiratory pathogens. <span class="cit-source">J Med Microbiol</span> <span class="cit-vol">53</span>, <span class="cit-fpage">833</span>–840.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=medmicro&amp;resid=53/9/833"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-151-1" title="View reference in text"
                           id="ref-151">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.151"
                             data-doi="10.1099/jmm.0.46102-0">
                           <div class="cit-metadata"><cite><strong>Thomas, R. &amp; Brooks, T.</strong> <strong>(</strong><span class="cit-pub-date">2006</span><strong>).</strong> Attachment of <em>Yersinia pestis</em> to human respiratory cell lines is inhibited by certain oligosaccharides. <span class="cit-source">J Med Microbiol</span> <span class="cit-vol">55</span>, <span class="cit-fpage">309</span>–315.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=medmicro&amp;resid=55/3/309"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-152-1" title="View reference in text"
                           id="ref-152">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.152"
                             data-doi="10.1016/0006-291X(73)90991-1">
                           <div class="cit-metadata"><cite><strong>Turnowsky, F., Drews, J., Eich, F. &amp; Hogenauer, G.</strong> <strong>(</strong><span class="cit-pub-date">1973</span><strong>).</strong> <em>In vitro</em> inactivation of ascites ribosomes by colicin E3. <span class="cit-source">Biochem Biophys Res Commun</span> <span class="cit-vol">52</span>, <span class="cit-fpage">327</span>–334.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/0006-291X(73)90991-1&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=4736471&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-153-1" title="View reference in text"
                           id="ref-153">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.153">
                           <div class="cit-metadata"><cite><strong>Une, T. &amp; Brubaker, R. R.</strong> <strong>(</strong><span class="cit-pub-date">1984</span><strong>).</strong> Roles of V antigen in promoting virulence and immunity in yersiniae. <span class="cit-source">J Immunol</span> <span class="cit-vol">133</span>, <span class="cit-fpage">2226</span>–2230.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jimmunol&amp;resid=133/4/2226"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-154-1" title="View reference in text"
                           id="ref-154">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.154"
                             data-doi="10.1128/CMR.16.3.379-414.2003">
                           <div class="cit-metadata"><cite><strong>Van Amersfoort, E. S., Van Berkel, T. J. &amp; Kuiper, J.</strong> <strong>(</strong><span class="cit-pub-date">2003</span><strong>).</strong> Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. <span class="cit-source">Clin Microbiol Rev</span> <span class="cit-vol">16</span>, <span class="cit-fpage">379</span>–414.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=cmr&amp;resid=16/3/379"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-155-1" title="View reference in text"
                           id="ref-155">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.155"
                             data-doi="10.1146/annurev.micro.59.030804.121320">
                           <div class="cit-metadata"><cite><strong>Viboud, G. I. &amp; Bliska, J. B.</strong> <strong>(</strong><span class="cit-pub-date">2005</span><strong>).</strong> <em>Yersinia</em> outer proteins: role in modulation of host cell signaling responses and pathogenesis. <span class="cit-source">Annu Rev Microbiol</span> <span class="cit-vol">59</span>, <span class="cit-fpage">69</span>–89.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1146/annurev.micro.59.030804.121320&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=15847602&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-156-1" title="View reference in text"
                           id="ref-156">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.156">
                           <div class="cit-metadata"><cite><strong>Vincent, J.-L., Roman, A. &amp; Kahn, R. J.</strong> <strong>(</strong><span class="cit-pub-date">1990</span><strong>).</strong> Dobutamine administration in septic shock: addition to a standard protocol. <span class="cit-source">Crit Care Med</span> <span class="cit-vol">18</span>, <span class="cit-fpage">689</span>–693.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=2364708&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-157-1" title="View reference in text"
                           id="ref-157">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.157"
                             data-doi="10.1006/mpat.2002.0498">
                           <div class="cit-metadata"><cite><strong>Weeks, S., Hill, J., Friedlander, A. &amp; Welkos, S.</strong> <strong>(</strong><span class="cit-pub-date">2002</span><strong>).</strong> Anti-V antigen antibody protects macrophages from <em>Yersinia pestis</em>-induced cell death and promotes phagocytosis. <span class="cit-source">Microb Pathog</span> <span class="cit-vol">32</span>, <span class="cit-fpage">227</span>–237.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1006/mpat.2002.0498&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12071679&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-158-1" title="View reference in text"
                           id="ref-158">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.158">
                           <div class="cit-metadata"><cite><strong>Welty, T. K., Grabman, J., Kompare, E., Wood, G., Welty, E., Van Duzen, J., Rudd, P. &amp; Poland, J.</strong> <strong>(</strong><span class="cit-pub-date">1985</span><strong>).</strong> Nineteen cases of plague in Arizona: a spectrum including ecthyma gangrenosum due to plague and plague in pregnancy. <span class="cit-source">West J Med</span> <span class="cit-vol">142</span>, <span class="cit-fpage">641</span>–646.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=4013279&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-159-1" title="View reference in text"
                           id="ref-159">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.159"
                             data-doi="10.1056/NEJM199901213400307">
                           <div class="cit-metadata"><cite><strong>Wheeler, A. P. &amp; Bernard, G. R.</strong> <strong>(</strong><span class="cit-pub-date">1999</span><strong>).</strong> Treating patients with severe sepsis. <span class="cit-source">N Engl J Med</span> <span class="cit-vol">340</span>, <span class="cit-fpage">207</span>–214.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1056/NEJM199901213400307&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=9895401&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-160-1" title="View reference in text"
                           id="ref-160">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.160"
                             data-doi="10.1046/j.1365-2672.2001.01497.x">
                           <div class="cit-metadata"><cite><strong>Williamson, E. D.</strong> <strong>(</strong><span class="cit-pub-date">2001</span><strong>).</strong> Plague vaccine research and development. <span class="cit-source">J Appl Microbiol</span> <span class="cit-vol">91</span>, <span class="cit-fpage">606</span>–608.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1046/j.1365-2672.2001.01497.x&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=11576295&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-161-1" title="View reference in text"
                           id="ref-161">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.161"
                             data-doi="10.1128/IAI.73.6.3598-3608.2005">
                           <div class="cit-metadata"><cite><strong>Williamson, E. D., Flick-Smith, H. C., Lebutt, C. &amp; 7 other authors</strong> <strong>(</strong><span class="cit-pub-date">2005</span><strong>).</strong> Human immune response to a plague vaccine comprising recombinant F1 and V antigens. <span class="cit-source">Infect Immun</span> <span class="cit-vol">73</span>, <span class="cit-fpage">3598</span>–3608.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=iai&amp;resid=73/6/3598"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-162-1" title="View reference in text"
                           id="ref-162">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.162"
                             data-doi="10.1074/jbc.M413900200">
                           <div class="cit-metadata"><cite><strong>Winfield, M. D., Latifi, T. &amp; Groisman, E. A.</strong> <strong>(</strong><span class="cit-pub-date">2005</span><strong>).</strong> Transcriptional regulation of the 4-amino-4-deoxy-<span class="sc">l</span>-arabinose biosynthetic genes in <em>Yersinia pestis</em>. <span class="cit-source">J Biol Chem</span> <span class="cit-vol">280</span>, <span class="cit-fpage">14765</span>–14772.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=280/15/14765"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-163-1" title="View reference in text"
                           id="ref-163">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.163"
                             data-doi="10.1016/0002-9343(73)90038-7">
                           <div class="cit-metadata"><cite><strong>Winslow, E. J., Loeb, H. S., Rahimtoola, S. H., Kamath, S. &amp; Gunnar, R. M.</strong> <strong>(</strong><span class="cit-pub-date">1973</span><strong>).</strong> Hemodynamic studies and results of therapy in 50 patients with bacteremic shock. <span class="cit-source">Am J Med</span> <span class="cit-vol">54</span>, <span class="cit-fpage">421</span>–432.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/0002-9343(73)90038-7&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=4696004&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-164-1" title="View reference in text"
                           id="ref-164">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.164"
                             data-doi="10.1128/AAC.44.7.1995-1996.2000">
                           <div class="cit-metadata"><cite><strong>Wong, J. D., Baresh, J. R., Sandfort, R. F. &amp; Janda, J. M.</strong> <strong>(</strong><span class="cit-pub-date">2000</span><strong>).</strong> Susceptibilities of <em>Yersinia pestis</em> strains to 12 antimicrobial agents. <span class="cit-source">Antimicrob Agents Chemother</span> <span class="cit-vol">44</span>, <span class="cit-fpage">1995</span>–1996.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=aac&amp;resid=44/7/1995"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-165-1" title="View reference in text"
                           id="ref-165">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.165">
                           <div class="cit-metadata"><cite><strong>WHO</strong> <strong>(</strong><span class="cit-pub-date">1970</span><strong>).</strong> <em>Health Aspects of Chemical and Biological Weapons: Report of a WHO Group of Consultants</em>. Geneva: World Health Organization.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-166-1" title="View reference in text"
                           id="ref-166">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.166">
                           <div class="cit-metadata"><cite><strong>WHO Expert Committee on Plague</strong> <strong>(</strong><span class="cit-pub-date">1970</span><strong>).</strong> Fourth report. <span class="cit-source">World Health Organ Tech Rep Ser</span> <span class="cit-vol">447</span>, <span class="cit-fpage">1</span>–25.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=4986823&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-167-1" title="View reference in text"
                           id="ref-167">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.167"
                             data-doi="10.1021/ol036121w">
                           <div class="cit-metadata"><cite><strong>Xie, J., Comeau, A. B. &amp; Seto, C. T.</strong> <strong>(</strong><span class="cit-pub-date">2004</span><strong>).</strong> Squaric acids: a new motif for designing inhibitors of protein tyrosine phosphatases. <span class="cit-source">Org Lett</span> <span class="cit-vol">6</span>, <span class="cit-fpage">83</span>–86.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1021/ol036121w&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=14703356&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-168-1" title="View reference in text"
                           id="ref-168">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.168">
                           <div class="cit-metadata"><cite><strong>Yersin, A.</strong> <strong>(</strong><span class="cit-pub-date">1894</span><strong>).</strong> La peste bubonique à Hong-Kong. <span class="cit-source">Ann Inst Pasteur</span> <span class="cit-vol">8</span>, <span class="cit-fpage">662</span>–667 (in French).</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-169-1" title="View reference in text"
                           id="ref-169">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.169">
                           <div class="cit-metadata"><cite><strong>Yersin, A.</strong> <strong>(</strong><span class="cit-pub-date">1897</span><strong>).</strong> Sur la peste bubonique (sérothérapie). <span class="cit-source">Ann Inst Pasteur</span> <span class="cit-vol">11</span>, <span class="cit-fpage">81</span>–93 (in French).</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-170-1" title="View reference in text"
                           id="ref-170">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.170">
                           <div class="cit-metadata"><cite><strong>Yersin, A., Calmette, A. &amp; Borrel, A.</strong> <strong>(</strong><span class="cit-pub-date">1895</span><strong>).</strong> La peste bubonique (deuxiéme note). <span class="cit-source">Ann Inst Pasteur</span> <span class="cit-vol">9</span>, <span class="cit-fpage">589</span>–592 (in French).</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-171-1" title="View reference in text"
                           id="ref-171">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.171">
                           <div class="cit-metadata"><cite><strong>Young, R.</strong> <strong>(</strong><span class="cit-pub-date">1992</span><strong>).</strong> Bacteriophage lysis: mechanism and regulation. <span class="cit-source">Microbiol Rev</span> <span class="cit-vol">56</span>, <span class="cit-fpage">430</span>–481.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=mmbr&amp;resid=56/3/430"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-172-1" title="View reference in text"
                           id="ref-172">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.172"
                             data-doi="10.1016/0165-2478(94)00194-V">
                           <div class="cit-metadata"><cite><strong>Zav'yalov, V., Denesyuk, A., Zav'yalova, G. &amp; Korpela, T.</strong> <strong>(</strong><span class="cit-pub-date">1995</span><strong>).</strong> Molecular modeling of the steric structure of the envelope F1 antigen of <em>Yersinia pestis</em>. <span class="cit-source">Immunol Lett</span> <span class="cit-vol">45</span>, <span class="cit-fpage">19</span>–22.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/0165-2478(94)00194-V&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=7542626&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-173-1" title="View reference in text"
                           id="ref-173">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.173"
                             data-doi="10.1111/j.1574-695X.1996.tb00267.x">
                           <div class="cit-metadata"><cite><strong>Zav'yalov, V. P., Abramov, V. M., Cherepanov, P. G., Spirina, G. V., Chernovskaya, T. V., Vasiliev, A. M. &amp; Zav'yalov, G.
                                    A.</strong> <strong>(</strong><span class="cit-pub-date">1996</span><strong>).</strong> pH6 antigen (PsaA protein) of <em>Yersinia pestis</em>, a novel bacterial Fc-receptor. <span class="cit-source">FEMS Immunol Med Microbiol</span> <span class="cit-vol">14</span>, <span class="cit-fpage">53</span>–57.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=femsim&amp;resid=14/1/53"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-174-1" title="View reference in text"
                           id="ref-174">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.174">
                           <div class="cit-metadata"><cite><strong>Zhemchugov, V. Ye.</strong> <strong>(</strong><span class="cit-pub-date">2004</span><strong>).</strong> <em>How We Developed Chemical Vaccines: Notes about Today's ‘Microbe Hunters’</em>. Moscow: Nauka (in Russian).</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                     </li>
                     <li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-175-1" title="View reference in text"
                           id="ref-175">↵</a><div class="cit ref-cit ref-other" id="cit-55.11.1461.175"
                             data-doi="10.1078/1438-4639-00259">
                           <div class="cit-metadata"><cite><strong>Zietz, B. P. &amp; Dunkelberg, H.</strong> <strong>(</strong><span class="cit-pub-date">2004</span><strong>).</strong> The history of the plague and the research on the causative agent <em>Yersinia pestis</em>. <span class="cit-source">Int J Hyg Environ Health</span> <span class="cit-vol">207</span>, <span class="cit-fpage">165</span>–178.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1078/1438-4639-00259&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=15031959&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                     </li>
                  </ol>
               </div><span class="highwire-journal-article-marker-end"></span></div>
            <div class="social-bookmarking">
               
               <ul class="social-bookmark-links">
                  <li class="social-bookmarking-item social-bookmarking-item-citeulike"><a href="/external-ref?tag_url=http://jmm.sgmjournals.org/cgi/content/long/55/11/1461&amp;title=Treatment%20of%20plague%3A%20promising%20alternatives%20to%20antibiotics+--+Anisimov%20and%20Amoako%2055%20%2811%29%3A%201461+--+&amp;doi=10.1099/jmm.0.46697-0&amp;link_type=CITEULIKE"><img src="/shared/img/common/social-bookmarking/citeulike.gif"
                             alt="Add to CiteULike"
                             title="CiteULike" /></a><span class="soc-bm-link-text">CiteULike</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-delicious"><a href="/external-ref?tag_url=http://jmm.sgmjournals.org/cgi/content/long/55/11/1461&amp;title=Treatment%20of%20plague%3A%20promising%20alternatives%20to%20antibiotics+--+Anisimov%20and%20Amoako%2055%20%2811%29%3A%201461+--+&amp;doi=10.1099/jmm.0.46697-0&amp;link_type=DEL_ICIO_US"><img src="/shared/img/common/social-bookmarking/delicious.gif"
                             alt="Add to Delicious"
                             title="Delicious" /></a><span class="soc-bm-link-text">Delicious</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-digg"><a href="/external-ref?tag_url=http://jmm.sgmjournals.org/cgi/content/long/55/11/1461&amp;title=Treatment%20of%20plague%3A%20promising%20alternatives%20to%20antibiotics+--+Anisimov%20and%20Amoako%2055%20%2811%29%3A%201461+--+&amp;doi=10.1099/jmm.0.46697-0&amp;link_type=DIGG"><img src="/shared/img/common/social-bookmarking/digg.gif" alt="Add to Digg"
                             title="Digg" /></a><span class="soc-bm-link-text">Digg</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-facebook"><a href="/external-ref?tag_url=http://jmm.sgmjournals.org/cgi/content/short/55/11/1461&amp;title=Treatment%20of%20plague%3A%20promising%20alternatives%20to%20antibiotics+--+Anisimov%20and%20Amoako%2055%20%2811%29%3A%201461+--+&amp;doi=10.1099/jmm.0.46697-0&amp;link_type=FACEBOOK"
                        class="sb-facebook"
                        rel="external-nw"><img src="/shared/img/common/social-bookmarking/facebook.gif" alt="Add to Facebook"
                             title="Facebook" /></a><span class="soc-bm-link-text">Facebook</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-googleplus"><a href="/external-ref?tag_url=http://jmm.sgmjournals.org/cgi/content/long/55/11/1461&amp;title=Treatment%20of%20plague%3A%20promising%20alternatives%20to%20antibiotics+--+Anisimov%20and%20Amoako%2055%20%2811%29%3A%201461+--+&amp;doi=10.1099/jmm.0.46697-0&amp;link_type=GOOGLEPLUS&amp;log_only=yes"><img src="/shared/img/common/social-bookmarking/googleplus.jpg" alt="Add to Google+"
                             title="Google+" /></a><span class="soc-bm-link-text">Google+</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-linkedin"><a href="/external-ref?tag_url=http://jmm.sgmjournals.org/cgi/content/long/55/11/1461&amp;title=Treatment%20of%20plague%3A%20promising%20alternatives%20to%20antibiotics+--+Anisimov%20and%20Amoako%2055%20%2811%29%3A%201461+--+&amp;doi=10.1099/jmm.0.46697-0&amp;link_type=LINKEDIN"><img src="/shared/img/common/social-bookmarking/linkedin.gif" alt="Add to LinkedIn"
                             title="LinkedIn" /></a><span class="soc-bm-link-text">LinkedIn</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-mendeley"><a href="/external-ref?tag_url=http://jmm.sgmjournals.org/cgi/content/long/55/11/1461&amp;title=Treatment%20of%20plague%3A%20promising%20alternatives%20to%20antibiotics+--+Anisimov%20and%20Amoako%2055%20%2811%29%3A%201461+--+&amp;doi=10.1099/jmm.0.46697-0&amp;link_type=MENDELEY"><img src="/shared/img/common/social-bookmarking/mendeley.gif" alt="Add to Mendeley"
                             title="Mendeley" /></a><span class="soc-bm-link-text">Mendeley</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-reddit"><a href="/external-ref?tag_url=http://jmm.sgmjournals.org/cgi/content/long/55/11/1461&amp;title=Treatment%20of%20plague%3A%20promising%20alternatives%20to%20antibiotics+--+Anisimov%20and%20Amoako%2055%20%2811%29%3A%201461+--+&amp;doi=10.1099/jmm.0.46697-0&amp;link_type=REDDIT"><img src="/shared/img/common/social-bookmarking/reddit.gif" alt="Add to Reddit"
                             title="Reddit" /></a><span class="soc-bm-link-text">Reddit</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-twitter"><a href="/external-ref?tag_url=http://jmm.sgmjournals.org/cgi/content/long/55/11/1461&amp;title=Treatment%20of%20plague%3A%20promising%20alternatives%20to%20antibiotics+--+Anisimov%20and%20Amoako%2055%20%2811%29%3A%201461+--+&amp;doi=10.1099/jmm.0.46697-0&amp;link_type=TWITTER"><img src="/shared/img/common/social-bookmarking/twitter.gif" alt="Add to Twitter"
                             title="Twitter" /></a><span class="soc-bm-link-text">Twitter</span></li>
               </ul>
               
               <p class="social-bookmarking-help"><a href="/help/social_bookmarks.dtl">What's this?</a></p>
               
            </div><span id="related-urls"></span></div>
         <div id="col-2">
            
            <div class="article-nav sidebar-nav">
               <a href="/content/55/10/1457.short" title="Previous article" class="previous">« Previous</a><span class="article-nav-sep"> | </span><a href="/content/55/11/1477.short" title="Next article" class="next">Next Article »</a>
               
               <span class="toc-link">
                  				<a href="/content/55/11.toc" title="Table of Contents">Table of Contents</a>
                  			</span>
               
               
            </div>
            <div class="content-box" id="article-cb-main">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>This Article</span></h3>
                  <div class="cb-section cb-slug">
                     <ol>
                        <li>
                           <div id="slugline">
                              
                              
                              	    
                              
                              doi:
                              <span title="10.1099/jmm.0.46697-0" class="slug-doi">10.1099/jmm.0.46697-0
                                 </span>
                              <cite>
                                 	    <abbr title="Journal of Medical Microbiology" class="slug-jnl-abbrev">
                                    J Med Microbiol</abbr><span class="slug-pub-date" itemprop="datePublished">
                                    	    November 2006 
                                    </span>
                                 	    <span class="slug-vol">
                                    vol. 55 
                                    </span><span class="slug-issue">
                                    no. 11 
                                    </span><span class="slug-pages">
                                    1461-1475
                                    </span>
                                 </cite>
                              
                              	           
                              
                              
                              
                           </div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section cb-views">
                     <ol>
                        <li class="abstract-view-link primary"><a href="/content/55/11/1461.abstract" rel="view-abstract">Abstract</a><span class="free">Free</span></li>
                        <li class="notice full-text-view-link primary"><span class="variant-indicator">» <span>Full Text</span></span><span class="free">Free</span></li>
                        <li class="notice full-text-pdf-view-link primary"><a href="/content/55/11/1461.full.pdf+html" rel="view-full-text.pdf">Full Text (PDF)</a><span class="free">Free</span></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-cat">
                     <h4 class="cb-section-header"><span>Classifications</span></h4>
                     <ol>
                        <li>
                           <ul class="subject-headings last-child">
                              <li><a class="tocsection-search"
                                    href="/search?tocsectionid=REVIEW&amp;sortspec=date&amp;submit=Submit">REVIEW</a></li>
                           </ul>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-svcs">
                     <h4 class="cb-section-header"><span>Services</span></h4>
                     <ol>
                        <li class="mail-a-friend-link icon-link"><a href="/email?gca=medmicro%3B55%2F11%2F1461&amp;current-view-path=/content/55/11/1461.full">
                              Email this article to a colleague</a></li>
                        <li class="alert-link icon-link"><a href="/cgi/alerts/ctalert?alertType=citedby&amp;addAlert=cited_by&amp;cited_by_criteria_resid=medmicro%3B55%2F11%2F1461&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://jmm.sgmjournals.org/content/55/11/1461.full">Alert me when this article is cited</a></li>
                        <li class="alert-link icon-link"><a href="/cgi/alerts/ctalert?alertType=correction&amp;addAlert=correction&amp;correction_criteria_value=55/11/1461&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://jmm.sgmjournals.org/content/55/11/1461.full">Alert me if a correction is posted</a></li>
                        <li class="similar-link"><a href="/search?qbe=medmicro%3B55%2F11%2F1461&amp;citation=Anisimov%20and%20Amoako%2055%20%2811%29:%201461&amp;submit=yes">Similar articles in this journal</a></li>
                        <li class="similar-link"><a href="/external-ref?access_num=medmicro%3B55%2F11%2F1461&amp;link_type=ISI_RELATEDRECORDS"
                              id="cb-isi-similar-articles"
                              class="similar-link">Similar articles in Web of Science</a></li>
                        <li class="similar-link"><a href="/external-ref?access_num=17030904&amp;link_type=MED_NBRS"
                              class="similar-link">Similar articles in PubMed</a></li>
                        <li class="cit-man-link icon-link cite-link"><a href="/citmgr?gca=medmicro%3B55%2F11%2F1461">Download to citation manager</a></li>
                        <li class="copyright-link icon-link"><a href="/external-ref?link_type=PERMISSIONDIRECT"><img src="/shared/img/content/permissions.gif" /></a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-cit">
                     <h4 class="cb-section-header"><span>Citing Articles</span></h4>
                     <ol>
                        <li class="hw-citing-link"><a href="/content/55/11/1461.full?cited-by=yes&amp;legid=medmicro;55/11/1461#cited-by"
                              id="cb-hw-citing-articles">Load citing article information</a></li>
                        <li><a href="/cgi/crossref-forward-links/55/11/1461" rel="external-nw"
                              id="cb-crossref-citing-articles">Citing articles via CrossRef</a></li>
                        <li><a href="/external-ref?access_num=%2Fmedmicro%2F55%2F11%2F1461&amp;link_type=ISI_CITING&amp;accnum_type=native"
                              rel="external-nw"
                              id="cb-isi-citing-articles">Citing articles via Web of Science</a></li>
                        <li><a href="/external-ref?access_num=http://jmm.sgmjournals.org/content/55/11/1461.abstract&amp;link_type=GOOGLESCHOLAR">Citing articles via Google Scholar</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-gs">
                     <h4 class="cb-section-header"><span>Google Scholar</span></h4>
                     <ol>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3AAnisimov%20author%3AA.P.%22"
                              class="cb-art-gs-auth author-link">Articles by  Anisimov, A. P.</a></li>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3AAmoako%20author%3AK.K.%22"
                              class="cb-art-gs-auth author-link">Articles by  Amoako, K. K.</a></li>
                        <li class="cb-art-gs-rel similar-link"><a href="/external-ref?access_num=http://jmm.sgmjournals.org/content/55/11/1461.abstract&amp;link_type=GOOGLESCHOLARRELATED">Search for related content</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-pm">
                     <h4 class="cb-section-header"><span>PubMed</span></h4>
                     <ol>
                        <li class="cb-art-pm-cite cite-link icon-link"><a href="/external-ref?access_num=17030904&amp;link_type=PUBMED"
                              class="cb-art-pm-cite cite-link icon-link">PubMed citation</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Anisimov%20AP&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Anisimov, A. P.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Amoako%20KK&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Amoako, K. K.</a></li>
                        <li>
                           <div id="cb-entrez-links-placeholder"><a href="/entrez-links/17030904"></a></div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-rel">
                     <h4 class="cb-section-header"><span>Related Content</span></h4>
                     <ol>
                        <li><a href="/content/55/11/1461.full?related-urls=yes&amp;legid=medmicro;55/11/1461#related-urls"
                              id="cb-related-urls">Load related web page information</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed soc-links icon-link"
                       id="cb-art-soc">
                     <h4 class="cb-section-header"><span>Social Bookmarking</span></h4>
                     <ol>
                        <li>
                           <div class="social-bookmarking">
                              
                              <ul class="social-bookmark-links">
                                 <li class="social-bookmarking-item social-bookmarking-item-citeulike"><a href="/external-ref?tag_url=http://jmm.sgmjournals.org/cgi/content/long/55/11/1461&amp;title=Treatment%20of%20plague%3A%20promising%20alternatives%20to%20antibiotics+--+Anisimov%20and%20Amoako%2055%20%2811%29%3A%201461+--+&amp;doi=10.1099/jmm.0.46697-0&amp;link_type=CITEULIKE"><img src="/shared/img/common/social-bookmarking/citeulike.gif"
                                            alt="Add to CiteULike"
                                            title="CiteULike" /></a><span class="soc-bm-link-text">CiteULike</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-delicious"><a href="/external-ref?tag_url=http://jmm.sgmjournals.org/cgi/content/long/55/11/1461&amp;title=Treatment%20of%20plague%3A%20promising%20alternatives%20to%20antibiotics+--+Anisimov%20and%20Amoako%2055%20%2811%29%3A%201461+--+&amp;doi=10.1099/jmm.0.46697-0&amp;link_type=DEL_ICIO_US"><img src="/shared/img/common/social-bookmarking/delicious.gif"
                                            alt="Add to Delicious"
                                            title="Delicious" /></a><span class="soc-bm-link-text">Delicious</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-digg"><a href="/external-ref?tag_url=http://jmm.sgmjournals.org/cgi/content/long/55/11/1461&amp;title=Treatment%20of%20plague%3A%20promising%20alternatives%20to%20antibiotics+--+Anisimov%20and%20Amoako%2055%20%2811%29%3A%201461+--+&amp;doi=10.1099/jmm.0.46697-0&amp;link_type=DIGG"><img src="/shared/img/common/social-bookmarking/digg.gif" alt="Add to Digg"
                                            title="Digg" /></a><span class="soc-bm-link-text">Digg</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-facebook"><a href="/external-ref?tag_url=http://jmm.sgmjournals.org/cgi/content/short/55/11/1461&amp;title=Treatment%20of%20plague%3A%20promising%20alternatives%20to%20antibiotics+--+Anisimov%20and%20Amoako%2055%20%2811%29%3A%201461+--+&amp;doi=10.1099/jmm.0.46697-0&amp;link_type=FACEBOOK"
                                       class="sb-facebook"
                                       rel="external-nw"><img src="/shared/img/common/social-bookmarking/facebook.gif" alt="Add to Facebook"
                                            title="Facebook" /></a><span class="soc-bm-link-text">Facebook</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-googleplus"><a href="/external-ref?tag_url=http://jmm.sgmjournals.org/cgi/content/long/55/11/1461&amp;title=Treatment%20of%20plague%3A%20promising%20alternatives%20to%20antibiotics+--+Anisimov%20and%20Amoako%2055%20%2811%29%3A%201461+--+&amp;doi=10.1099/jmm.0.46697-0&amp;link_type=GOOGLEPLUS&amp;log_only=yes"><img src="/shared/img/common/social-bookmarking/googleplus.jpg" alt="Add to Google+"
                                            title="Google+" /></a><span class="soc-bm-link-text">Google+</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-linkedin"><a href="/external-ref?tag_url=http://jmm.sgmjournals.org/cgi/content/long/55/11/1461&amp;title=Treatment%20of%20plague%3A%20promising%20alternatives%20to%20antibiotics+--+Anisimov%20and%20Amoako%2055%20%2811%29%3A%201461+--+&amp;doi=10.1099/jmm.0.46697-0&amp;link_type=LINKEDIN"><img src="/shared/img/common/social-bookmarking/linkedin.gif" alt="Add to LinkedIn"
                                            title="LinkedIn" /></a><span class="soc-bm-link-text">LinkedIn</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-mendeley"><a href="/external-ref?tag_url=http://jmm.sgmjournals.org/cgi/content/long/55/11/1461&amp;title=Treatment%20of%20plague%3A%20promising%20alternatives%20to%20antibiotics+--+Anisimov%20and%20Amoako%2055%20%2811%29%3A%201461+--+&amp;doi=10.1099/jmm.0.46697-0&amp;link_type=MENDELEY"><img src="/shared/img/common/social-bookmarking/mendeley.gif" alt="Add to Mendeley"
                                            title="Mendeley" /></a><span class="soc-bm-link-text">Mendeley</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-reddit"><a href="/external-ref?tag_url=http://jmm.sgmjournals.org/cgi/content/long/55/11/1461&amp;title=Treatment%20of%20plague%3A%20promising%20alternatives%20to%20antibiotics+--+Anisimov%20and%20Amoako%2055%20%2811%29%3A%201461+--+&amp;doi=10.1099/jmm.0.46697-0&amp;link_type=REDDIT"><img src="/shared/img/common/social-bookmarking/reddit.gif" alt="Add to Reddit"
                                            title="Reddit" /></a><span class="soc-bm-link-text">Reddit</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-twitter"><a href="/external-ref?tag_url=http://jmm.sgmjournals.org/cgi/content/long/55/11/1461&amp;title=Treatment%20of%20plague%3A%20promising%20alternatives%20to%20antibiotics+--+Anisimov%20and%20Amoako%2055%20%2811%29%3A%201461+--+&amp;doi=10.1099/jmm.0.46697-0&amp;link_type=TWITTER"><img src="/shared/img/common/social-bookmarking/twitter.gif" alt="Add to Twitter"
                                            title="Twitter" /></a><span class="soc-bm-link-text">Twitter</span></li>
                              </ul>
                              
                              <p class="social-bookmarking-help"><a href="/help/social_bookmarks.dtl">What's this?</a></p>
                              
                           </div>
                        </li>
                     </ol>
                  </div>
               </div>
            </div>
            
            
            <div class="content-box" id="article-dyn-nav">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>Navigate This Article</span></h3>
                  <div class="cb-section" id="cb-art-nav">
                     <ol>
                        <li><a href="#content-block">Top</a></li>
                        <li><a href="#abstract-1">Abstract</a></li>
                        <li><a href="#ack-1">Acknowledgments</a></li>
                        <li><a href="#ref-list-1">References</a></li>
                     </ol>
                  </div>
               </div>
            </div>
            
         </div>
         <div id="col-3">
            
            <div class="content-box" id="sidebar-current-issue">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>This Month's Issue</span></h3>
                  <div class="cb-section">
                     <ol>
                        <li><span><a href="/content/current" rel="current-issue">January 2015, 64 (Pt 1)</a></span></li>
                     </ol>
                  </div>
                  <div class="cb-section">
                     <ol>
                        <li>
                           <div class="current-issue"><a href="/content/current" rel="current-issue"><img src="/content/64/Pt_1.cover.gif" width="67" height="89" alt="Current Issue" /></a></div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section sidebar-etoc-link">
                     <ol>
                        <li><a href="/cgi/alerts/etoc">Alert me to new issues of JMM</a></li>
                     </ol>
                  </div>
               </div>
            </div>
            <div id="sidebar-global-nav">
               
               		
               <ul class="button-list pub-links">
                  <li class="first"><a href="/site/misc/about.xhtml" title="ABOUT JMM"><span>ABOUT JMM</span></a></li>
                  <li><a href="/site/misc/edboard.xhtml" title="EDITORIAL BOARD &amp; STAFF"><span>EDITORIAL BOARD &amp; STAFF</span></a></li>
                  <li><a href="http://www.editorialmanager.com/jmm/" title="SUBMIT A MANUSCRIPT"><span>SUBMIT A MANUSCRIPT</span></a></li>
                  <li><a href="/site/misc/ifora.xhtml" title="INFORMATION FOR AUTHORS"><span>INFORMATION FOR AUTHORS</span></a></li>
                  <li><a href="/site/misc/iforr.xhtml" title="INFORMATION FOR REVIEWERS"><span>INFORMATION FOR REVIEWERS</span></a></li>
                  <li><a href="http://www.sgmjournals.org/site/librarians/index.xhtml"
                        title="INFORMATION FOR LIBRARIANS"><span>INFORMATION FOR LIBRARIANS</span></a></li>
                  <li><a href="/site/misc/reprints.xhtml" title="PERMISSIONS AND REPRINTS"><span>PERMISSIONS AND REPRINTS</span></a></li>
                  <li><a href="http://www.sgmjournals.org/subscriptions" title="SUBSCRIPTIONS"><span>SUBSCRIPTIONS</span></a></li>
                  <li><a href="/site/misc/addir.xhtml" title="ADVERTISING"><span>ADVERTISING</span></a></li>
                  <li class="rss-img-button"><a href="/site/misc/alerts_feeds.xhtml" title="ALERTS &amp; FEEDS"><span>ALERTS &amp; FEEDS</span></a></li>
                  <li class="last"><a href="/feedback" title="FEEDBACK"><span>FEEDBACK</span></a></li>
               </ul>
               		
               <ul class="button-list pub-links umbrella-links">
                  <li class="first"><a href="http://mic.sgmjournals.org" title="MICROBIOLOGY"><span>MICROBIOLOGY</span></a></li>
                  <li><a href="http://vir.sgmjournals.org" title="J GEN VIROL"><span>J GEN VIROL</span></a></li>
                  <li><a href="http://ijs.sgmjournals.org" title="INT J SYST EVOL MICROBIOL"><span>INT J SYST EVOL MICROBIOL</span></a></li>
                  <li><a href="http://jmmcr.sgmjournals.org" title="JMM CASE REPORTS"><span>JMM CASE REPORTS</span></a></li>
                  <li class="last"><a href="http://www.sgmjournals.org" title="ALL SGM JOURNALS"><span>ALL SGM JOURNALS</span></a></li>
               </ul>
               		
               <div class="sidebar-icon-group">
                  			
                  <div class="icons">
                     				<a href="http://www.sgm.ac.uk/" rel="external-nw"><img src="/publisher/img/society_logo.gif" class="publisher-icon" alt="Society Logo" /></a>
                     				<a href="http://highwire.stanford.edu/" rel="external-nw"><img src="/publisher/img/hplogo.gif" class="hw-icon" alt="HighWire Press Logo" /></a>
                     			
                  </div>
                  			
                  <div class="sidebar-icon-text"><span>The <a href="http://www.sgmjournals.org"> Society for General Microbiology</a> publishes online with the assistance of <a href="http://highwire.stanford.edu">HighWire Press®</a>.</span></div>
                  		
               </div>
               	
            </div>
            <div class="most-links-box js-marker">
               
               <div class="most-header">
                  
                  <h3>Most</h3>
                  
               </div>
               
               <ul>
                  <li class="most-cur-sel">
                     <h4>Viewed</h4>
                     
                     
                     <div class="most-list">
                        
                        <ol>
                           <li class="first-item"><a href="http://jmm.sgmjournals.org/cgi/content/short/62/Pt_10/1491?rss=1&amp;ssource=mfr">Malaria rapid diagnostic tests: challenges and prospects</a></li>
                           <li><a href="http://jmm.sgmjournals.org/cgi/content/short/63/Pt_1/1?rss=1&amp;ssource=mfr">Microbiological investigation in male infertility: a practical overview</a></li>
                           <li><a href="http://jmm.sgmjournals.org/cgi/content/short/63/Pt_10/1241?rss=1&amp;ssource=mfr">Mycobacterium abscessus infection in cystic fibrosis: molecular typing and clinical outcomes</a></li>
                           <li><a href="http://jmm.sgmjournals.org/cgi/content/short/63/Pt_5/627?rss=1&amp;ssource=mfr">Detection of potential microbial antigens by immuno-PCR (PCR-amplified immunoassay)</a></li>
                           <li class="last-item"><a href="http://jmm.sgmjournals.org/cgi/content/short/63/Pt_8/1023?rss=1&amp;ssource=mfr">Cronobacter spp. - opportunistic food-borne pathogens. A review of their virulence and environmental-adaptive traits</a></li>
                        </ol>
                        <a href="http://jmm.sgmjournals.org/reports/mfr1.dtl" class="view-all">» View all Most Viewed articles</a>
                        
                     </div>
                     
                     
                  </li>
                  <li>
                     <h4>Cited</h4>
                     
                     
                     <div class="most-list">
                        
                        <ol>
                           <li class="first-item"><a href="http://jmm.sgmjournals.org/cgi/content/short/62/Pt_10/1506?rss=1&amp;ssource=mfc">Lysins: the arrival of pathogen-directed anti-infectives</a></li>
                           <li><a href="http://jmm.sgmjournals.org/cgi/content/short/63/Pt_5/772?rss=1&amp;ssource=mfc">Impact of the isolation medium for detection of carbapenemase-producing Enterobacteriaceae using an updated version of the
                                 Carba NP test</a></li>
                           <li><a href="http://jmm.sgmjournals.org/cgi/content/short/62/Pt_11/1707?rss=1&amp;ssource=mfc">Prevalence and molecular epidemiology of plasmid-mediated fosfomycin resistance genes among blood and urinary Escherichia
                                 coli isolates</a></li>
                           <li><a href="http://jmm.sgmjournals.org/cgi/content/short/62/Pt_12/1914?rss=1&amp;ssource=mfc">Bacteraemia due to meticillin-resistant Staphylococcus aureus carrying the mecC gene in a patient with urothelial carcinoma</a></li>
                           <li class="last-item"><a href="http://jmm.sgmjournals.org/cgi/content/short/63/Pt_1/45?rss=1&amp;ssource=mfc">A national quality assurance survey of Neisseria gonorrhoeae testing</a></li>
                        </ol>
                        <a href="http://jmm.sgmjournals.org/reports/mfc1.dtl" class="view-all">» View all Most Cited articles</a>
                        
                     </div>
                     
                     
                  </li>
               </ul>
               
               
            </div>
            
            
            
         </div>
         <div id="footer">
            
            <div class="bar">
               
               <div class="footer-group footer-col-left">
                  	    
                  	    
                  <p class="copyright">Copyright ©
                     		2015 Society for General Microbiology
                     	
                  </p>
                  	  
               </div>
               
               <div class="footer-group footer-col-right">
                  	    
                  <ul class="issns">
                     <li>
                        <span>Print ISSN: </span>
                        <span class="issn">0022-2615</span>
                        
                     </li>
                     <li>
                        <span>Online ISSN: </span>
                        <span class="issn">1473-5644</span>
                        
                     </li>
                  </ul>
                  	  
               </div>
               	  
            </div>
            
            
            <div class="block-2 sb-div"></div>
            
         </div><script type="text/javascript">
        var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
        document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
        </script><script type="text/javascript">
        try {
        var pageTracker = _gat._getTracker("UA-189672-25");
        pageTracker._setDomainName(".sgmjournals.org");
        pageTracker._trackPageview();
        } catch(err) {}
        </script><script type="text/javascript">
	(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
		(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
		m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
	})(window,document,'script','//www.google-analytics.com/analytics.js','ga');

	ga('create', 'UA-48529861-1', '.sgmjournals.org');
	ga('send', 'pageview');
	</script></div>
   </body>
</html>yTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
	})(window,document,'script','//www.google-analytics.com/analytics.js','ga');

	ga('create', 'UA-48529861-1', '.sgmjournals.org');
	ga('send